rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGCCCGTAGGGCGGGAGTAGACTACAATGAGCAGTTCTTCGGGCCA	CASSARRAGVDYNEQFF	In	VDJ	2	130	0.0016347266234092853	0.0018315276349342763	51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	2	3	8	4	23	36	51	44	55			01,02										Vb 1	CASSARRAGVDYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCTTAACCGGACAGACTGAAGCTTTCTTTGGACAA	CASSLTGQTEAFF	In	VDJ	2	96	0.0012071827372868568	0.0013525127150283887	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	5	5	6	0	23	35	-1	41	47			01,02										Vb 1	CASSLTGQTEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTCCAGCCTCTGGGAGGAATAGATACGCAGTATTTTGGCCCA	CASSLQPLGGIDTQYF	In	VDJ	1	65	8.173633117046427E-4	9.157638174671381E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	9	1	5	11	3	23	35	52	46	55			01,02										Vb 1	CASSLQPLGGIDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGGCCACGGGGAGCTGTTTTTTGGAGAA	CASSVGGHGELFF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	7	0	7	0	2	23	-1	44	39	46			01,02										Vb 1	CASSVGGHGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAAAGATGGGGCGCACAGATACGCAGTATTTTGGCCCA	CASSVKMGRTDTQYF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	1	5	0	23	38	-1	43	48			01,02										Vb 1	CASSVKMGRTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACGGGCTAGCGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CASSVRASGGQETQYF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	4	1	2	4	0	23	38	-1	42	53			01,02										Vb 1	CASSVRASGGQETQYF+TCRBV09-01+TCRBJ02-05	TCRBV09-01	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCTCCATGGCCAGGGCCACAGATACGCAGTATTTTGGCCCA	CASSMARATDTQYF	In	VDJ	1	46	5.784417282832855E-4	6.480790092844363E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	7	4	3	2	8	1	23	32	45	40	46			01,02										Vb 1	CASSMARATDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGATGTCTTAACCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSVDVLTSYNEQFF	In	VDJ	1	46	5.784417282832855E-4	6.480790092844363E-4	48	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	0	3	7	0	8	0	23	39	-1	47	49			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVDVLTSYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGACCAGGGATGGAACGAGCAGTACTTCGGGCCG	CASSVDQGWNEQYF	In	VDJ	1	42	5.281424475629999E-4	5.9172431282492E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	5	2	5	23	39	46	41	51			01,02										Vb 1	CASSVDQGWNEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGTTGGCCCAGCTCCAGCATTTTGGTGAT	CASSVGLAQLQHF	In	VDJ	1	39	4.904179870227856E-4	5.494582904802829E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-05	01	0	4	5	12	8	2	23	39	50	47	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSVGLAQLQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAACCGGGACAGGGTCCCCTAGGGCAGTACTTCGGGCCG		Out	VDJ	1	37	4.6526834666264273E-4		43	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	9	4	9	23	34	47	38	56			01,02										Vb 1	X+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGAAAGCGGGGGGATCAACAATGAGCAGTTCTTCGGGCCA	CASSESGGINNEQFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	6	1	5	2	4	23	36	47	38	51			01,02										Vb 1	CASSESGGINNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGAAAAGCGGGAGGACCTAACAATGAGCAGTTCTTCGGGCCA	CASRKAGGPNNEQFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	45	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	6	1	5	3	5	23	34	46	37	51			01,02										Vb 1	CASRKAGGPNNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTATACGACTCGTCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVYDSSNTGELFF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	1	2	10	0	3	3	23	38	45	41	48			01,02			01,02							Vb 1	CASSVYDSSNTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCTCCTAGCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLLAGGSTDTQYF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	48	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	4	0	0	3	0	23	35	-1	38	50			01,02										Vb 1	CASSLLAGGSTDTQYF+TCRBV09-01+TCRBJ02-03	TCRBV09-01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTTGGACAGGGGGCGAGCTATGGCTACACCTTCGGTTCG	CASSVGQGASYGYTF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	0	4	1	3	23	37	49	38	52			01,02										Vb 1	CASSVGQGASYGYTF+TCRBV09-01+TCRBJ01-02	TCRBV09-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGGGGACAGGTACAATGAGCAGTTCTTCGGGCCA	CASSVGDRYNEQFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	42	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	0	4	4	0	0	23	-1	-1	39	47			01,02										Vb 1	CASSVGDRYNEQFF+TCRBV09-01+TCRBJ02-01	TCRBV09-01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGAGGTCAGGGGGACCGGGGAGCTGTTTTTTGGAGAA	CASSVEVRGTGELFF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	1	5	4	0	23	39	-1	43	50			01,02										Vb 1	CASSVEVRGTGELFF+TCRBV09-01+TCRBJ02-02	TCRBV09-01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTACTAGTGGAGGCCACTGAAGCTTTCTTTGGACAA	CASSVLVEATEAFF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	1	4	5	1	23	38	48	43	49			01,02										Vb 1	CASSVLVEATEAFF+TCRBV09-01+TCRBJ01-01	TCRBV09-01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCCGCCTGGGAGACGAGCAGTACTTCGGGCCG	CASSRLGDEQYF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	36	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	9	2	5	5	0	23	35	-1	40	45			01,02										Vb 1	CASSRLGDEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTCCAGAACCGCGCTACGAGCAGTACTTCGGGCCG	CASSPEPRYEQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	39	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-07	01	5	4	5	3	2	7	23	34	39	36	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSPEPRYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGTAGTGATGGTTTACTAGCGGGGGTACGAGCAGTACTTCGGGCCG	CASSVVMVY*RGYEQYF	Stop	VDJ	1	17	2.1377194306121421E-4		51	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	3	2	4	9	0	23	39	-1	48	59			01,02										Vb 1	CASSVVMVY*RGYEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGGACACCGACTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSGTPTSNQPQHF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	6	0	0	5	23	-1	41	36	46			01,02										Vb 1	CASSGTPTSNQPQHF+TCRBV09-01+TCRBJ01-05	TCRBV09-01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCCCTAGTACCGGCGGGAGAGCGGCGAGCAGTACTTCGGGCCG	CASSP*YRRESGEQYF	Stop	VDJ	1	46	5.784417282832855E-4		48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	2	6	11	5	19	31	49	42	54														CASSP*YRRESGEQYF+TCRBV11-01+TCRBJ02-07	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCTTACGATTAGCGGGATCCGGGGAGCTGTTTTTTGGAGAA	CASSLRLAGSGELFF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	45	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	5	3	6	4	1	19	34	46	38	47														CASSLRLAGSGELFF+TCRBV11-01+TCRBJ02-02	TCRBV11-01*01	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCCCGCACGGGGGCGAAACTATGGCTACACCTTCGGTTCG	CASSPARGRNYGYTF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	45	TCRBV11	TCRBV11-01	01				TCRBJ01	TCRBJ01-02	01	5	6	0	2	7	2	19	31	44	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPARGRNYGYTF+TCRBV11-01+TCRBJ01-02	TCRBV11-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTACCGGGACTAGCGACCGAGCAGTACTTCGGGCCG	CASSLPGLATEQYF	In	VDJ	4	238	0.002992807202856999	0.0033531044393412136	42	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	6	6	4	2	29	42	56	46	58						01,02							Vb 16	CASSLPGLATEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGGGGTGGAGCAGGAGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQEGWSRRGTDTQYF	In	VDJ	4	220	0.0027664604396157133	0.0030995083052733907	54	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	0	1	11	0	27	44	-1	55	61													Vb 16	CASSQEGWSRRGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATGCGGGAGGGCGTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	191	0.002401790654393642		47	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	7	0	1	1	2	29	46	56	47	58													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCGAGGACATCTATGGCTACACCTTCGGTTCG		Out	VDJ	2	121	0.0015215532417886424		37	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	1	6	4	2	1	29	42	49	44	50													Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGATCGGGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSQDRGGTDTQYF	In	VDJ	1	76	9.556863336854283E-4	0.0010707392327308077	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	8	1	1	4	0	29	43	-1	47	54													Vb 16	CASSQDRGGTDTQYF+TCRBV14-01+TCRBJ02-03	TCRBV14-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGGGACTTAGGAATGGGTGAGCAGTACTTCGGGCCG	CASRDLGMGEQYF	In	VDJ	1	63	7.922136713444998E-4	8.875864692373801E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	1	10	7	0	11	29	-1	45	40	56						01,02							Vb 16	CASRDLGMGEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCCCGACAGGGTCTATGGCTACACCTTCGGTTCG	CASSPDRVYGYTF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	4	4	1	29	40	51	44	52													Vb 16	CASSPDRVYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGATCTAATGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDLMDTGELFF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	45	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	4	9	3	1	4	29	46	50	47	54						01,02							Vb 16	CASSQDLMDTGELFF+TCRBV14-01+TCRBJ02-02	TCRBV14-01*01	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAACGGAGATGGCTGAAGCTTTYTTTGGACAA	CASSQTEMAEAFF	In	VDJ	1	52	6.538906493637141E-4	7.326110539737106E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	10	2	6	2	4	29	44	50	46	54													Vb 16	CASSQTEMAEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCATAGTTGAGGTCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	49	6.161661888234998E-4		41	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	1	4	5	3	29	43	52	48	55													Vb 16	X+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGTCCCTTGGGGTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSPLGFSYNEQFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	45	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-01	01	6	6	2	0	6	2	29	40	50	46	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSPLGFSYNEQFF+TCRBV14-01+TCRBJ02-01	TCRBV14-01*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCTCGACAGAGGGAGATGAAAAACTGTTTTTTGGCAGT	CASSSTEGDEKLFF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-04	01	5	2	5	6	2	6	29	41	48	43	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSSTEGDEKLFF+TCRBV14-01+TCRBJ01-04	TCRBV14-01*01		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGACGAAACAGTATGGGGAAACACTGAAGCTTTCTTTGGACAA	CASSQDETVWGNTEAFF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	51	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-01	01	0	0	8	2	12	0	29	46	-1	58	62				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQDETVWGNTEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGTAGGACCAGGACAGGGTAGCAACTATGGCTACACCTTCGGTTCG	CASSQVGPGQGSNYGYTF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	54	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	3	2	8	4	27	43	59	51	63													Vb 16	CASSQVGPGQGSNYGYTF+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAATAATCTGGGGACGGACGGAAGAGCAGTACTTCGGGCCG	CASSQIIWGRTEEQYF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	48	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	2	0	7	7	8	8	29	44	57	52	65				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQIIWGRTEEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGGCTTACCCCCCTACGAGCAGTACTTCGGGCCG	CASSQGLPPYEQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	42	TCRBV14	TCRBV14-01	01				TCRBJ02	TCRBJ02-07	01	1	3	7	2	4	3	29	45	51	49	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	CASSQGLPPYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAAAAGACGGACGGACTGCTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	17	2.1377194306121421E-4		43	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	1	10	5	10	3	29	39	54	49	57						01,02							Vb 16	X+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCGAGACCTAATCGATCAGCCCCAGCATTTTGGTGAT	CASSRDLIDQPQHF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	5	2	7	5	3	7	24	36	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDLIDQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGGCGGTAGCGGGAGGGGAAAGGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	32	4.023942457622856E-4		52	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	5	0	4	4	6	24	40	55	44	61														X+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCACGGGGGGGGCACTACGAGCAGTACTTCGGGCCG	CASSARGGHYEQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	0	3	3	3	24	36	47	39	50														CASSARGGHYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGACAAGACAGGGACAATGGCTACACCTTCGGTTCG	CASRQDRDNGYTF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	6	4	3	24	35	46	39	49														CASRQDRDNGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCGACTGGGACAGGGACGGAATGAGCAGTTCTTCGGGCCA	CASSRLGQGRNEQFF	In	VDJ	1	70	8.802374126049997E-4	9.862071880415333E-4	45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	3	7	5	4	18	30	44	35	48														CASSRLGQGRNEQFF+TCRBV07-06+TCRBJ02-01	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCGCCCCGGGCAAGCAACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CASSAPGKQQSRANVLTF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	54	TCRBV07	TCRBV07-06	01				TCRBJ02	TCRBJ02-06	01	5	8	0	5	5	13	18	30	39	35	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAPGKQQSRANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01		TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTAACGGACAGGTAACTCCTACGAGCAGTACTTCGGGCCG	CASS*RTGNSYEQYF	Stop	VDJ	1	29	3.646697852220713E-4		45	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	0	3	3	18	31	41	34	44														CASS*RTGNSYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCCGGTTGCGGGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSPRLRGTSTDTQYF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	51	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	0	8	3	18	30	45	38	48														CASSPRLRGTSTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGAGTACTAGCGGGAGATAACTACGAGCAGTACTTCGGGCCG	CASRVLAGDNYEQYF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	45	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	3	2	3	3	4	18	29	43	32	47														CASRVLAGDNYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGAAAACCTGAATGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	19	2.3892158342135708E-4		46	TCRBV07	TCRBV07-06	01				TCRBJ01	TCRBJ01-04	01	6	2	8	0	7	3	18	29	38	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV07-06+TCRBJ01-04	TCRBV07-06*01		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCTGGCGGGCTTAACTATGGCTACACCTTCGGTTCG	CASSPGGLNYGYTF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	4	1	4	2	18	30	39	34	41						01,02								CASSPGGLNYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD02-01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTACTAAGGTATCAGGGCCGAGCATTTTGGTGAT		Out	VDJ	3	171	0.0021502942507922135		40	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	4	3	14	9	3	19	34	48	43	51														X+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGGCGGGGGCGTAGGGGTTGGCTACACCTTCGGTTCG	CASSLGGGVGVGYTF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	7	2	7	0	9	19	-1	42	35	51														CASSLGGGVGVGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD02-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCCTAGATAGGGCGCCCCTTTCACCCCTCCACTTTGGGAAC	CASSLDRAPLSPLHF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	45	TCRBV07	TCRBV07-05	01				TCRBJ01	TCRBJ01-06	01	0	5	3	9	2	7	19	35	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDRAPLSPLHF+TCRBV07-05+TCRBJ01-06	TCRBV07-05*01		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTGCGGACAGGGGCAAACACTGAAGCTTTCTTTGGACAA	CASSLRTGANTEAFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	45	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	1	2	2	2	2	19	33	44	35	46														CASSLRTGANTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTTTTTACAGGGGAGAATGGCTACACCTTCGGTTCG	CASSFFTGENGYTF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	2	6	4	3	19	33	44	37	47														CASSFFTGENGYTF+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGAAGGAGGGCTCAACGAGCAGTACTTCGGGCCG	CAWSEGGLNEQYF	In	VDJ	6	360	0.004526935264825713	0.005071922681356458	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	0	5	2	4	26	39	47	41	51			unresolved										Vb 20	CAWSEGGLNEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAATTCAGACGATGAAAAACTGTTTTTTGGCAGT	CAWNSDDEKLFF	In	VDJ	6	316	0.0039736431769025705	0.00445202102030178	36	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-04	01	4	2	7	6	5	1	26	36	44	41	45			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWNSDDEKLFF+TCRBV30-01+TCRBJ01-04	TCRBV30-01*02		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGTCTGAGGGGGATAGGGGAGACCCAGTACTTCGGGCCA	CACLRGIGETQYF	In	VDJ	4	236	0.0029676575624968562	0.0033249270911114557	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	5	1	5	4	6	26	34	44	38	50			unresolved										Vb 20	CACLRGIGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGAGGTCGGGAGAGACCCAGTACTTCGGGCCA	CAWSVRSGETQYF	In	VDJ	3	145	0.0018233489261103566	0.002042857746657462	39	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	4	4	5	0	26	40	-1	45	49						01,02							Vb 20	CAWSVRSGETQYF+TCRBV30-01+TCRBJ02-05	TCRBV30-01*01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGACCTCCGTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	102	0.0012826316583672854		34	TCRBV30	TCRBV30-01	01				TCRBJ02	TCRBJ02-07	01	5	2	7	3	0	6	26	-1	38	35	44			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	X+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGTGGGGGAAGGCAGCCCCAGCATTTTGGTGAT	CAWSSGGRQPQHF	In	VDJ	2	98	0.0012323323776469997	0.0013806900632581467	39	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-05	01	2	6	1	7	3	4	26	38	46	41	50			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSSGGRQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTTGTATGGGCGGGAGGCCTTACTTCTACAATGAGCAGTTCTTCGGGCCA	CCMGGRPYFYNEQFF	In	VDJ	1	79	9.934107942256426E-4	0.001113005255075445	45	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	11	7	1	3	7	8	26	29	44	36	52			unresolved										Vb 20	CCMGGRPYFYNEQFF+TCRBV30-01+TCRBJ02-01	TCRBV30-01*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGGGCTTCTGGTCGCAATCAGCCCCAGCATTTTGGTGAT	CAWGASGRNQPQHF	In	VDJ	1	77	9.682611538654998E-4	0.0010848279068456867	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	7	0	2	0	8	26	-1	40	35	48			unresolved										Vb 20	CAWGASGRNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTGGGCGGGGGGGCTCTCGTCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	73	9.17961873145214E-4		52	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	7	0	4	5	7	26	40	54	45	61													Vb 20	X+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTGGGGGGAGATACGCAGTATTTTGGCCCA	CAWSVGGDTQYF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	36	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	9	1	5	0	0	26	-1	-1	40	46			unresolved										Vb 20	CAWSVGGDTQYF+TCRBV30-01+TCRBJ02-03	TCRBV30-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACTCCCAGGGAAACCTACACCTTCGGTTCG	CAWSTPRETYTF	In	VDJ	1	51	6.413158291836427E-4	7.185223798588314E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	10	5	4	26	38	48	43	52													Vb 20	CAWSTPRETYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGCGGACAGCAATCAGCCCCAGCATTTTGGTGAT	CAWSADSNQPQHF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-05	01	1	1	7	1	1	0	26	39	-1	40	44			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSADSNQPQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCGGGGATCGAACACTGAAGCTTTCTTTGGACAA	CAWSPRGSNTEAFF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	42	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	1	3	3	26	38	46	41	49													Vb 20	CAWSPRGSNTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCCCCGACAGCCCTATGGCTACACCTTCGGTTCG	CAWSPRQPYGYTF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	39	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	5	4	4	2	26	38	47	42	49													Vb 20	CAWSPRQPYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGGTCGGCAGGTTAACGAGCAGTACTTCGGGCCG	CAWGRQVNEQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	4	5	6	3	26	35	45	41	48			unresolved										Vb 20	CAWGRQVNEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGATGGACAGAGAACTATGGCTACACCTTCGGTTCG	CAWRWTENYGYTF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	39	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	2	2	2	26	37	45	39	47													Vb 20	CAWRWTENYGYTF+TCRBV30-01+TCRBJ01-02	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCTGGGGACCCGCCTACGAGCAGTACTTCGGGCCG	CASSQVWGPAYEQYF	In	VDJ	3	193	0.002426940294753785	0.0027191141041716564	45	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	1	0	7	2	4	3	23	39	48	43	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVWGPAYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATAGCCTAGCGGGGGGGCTAGATACGCAGTATTTTGGCCCA	CASSQDSLAGGLDTQYF	In	VDJ	2	132	0.0016598762637694282	0.0018597049831640343	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	4	0	5	4	2	23	40	56	44	58														CASSQDSLAGGLDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGCCAAGATCGCCTAGCGGGAAGGATACGCAGTATTTTGGCCCA		Out	VDJ	1	68	8.550877722448569E-4		47	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	3	6	4	2	23	40	53	44	55														X+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGATGGTAATGAGCAGTTCTTCGGGCCA	CASSQDGNEQFF	In	VDJ	1	54	6.79040289723857E-4	7.607884022034686E-4	36	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-01	01	0	0	10	7	1	1	23	40	43	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCTGACAGGGAAGGATTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	45	5.658669081032141E-4		46	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	4	3	7	23	36	46	39	53														X+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCCAGAGAGGGAACGGCTACACCTTCGGTTCG	CASSPQRGNGYTF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	11	0	8	6	3	23	36	47	42	50														CASSPQRGNGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01	TCRBD02-01*02	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGTCCACAGGGAAATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	33	4.1496906594235705E-4		43	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	3	3	4	3	3	23	39	48	42	51														X+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGGGGGGCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQGGLSGANVLTF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	48	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	3	9	0	0	0	2	23	-1	44	37	46														CASSQGGLSGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAGGACGGAGAGGAGACTGAAGCTTTCTTTGGACAA	CASSQDGEETEAFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-01	01	3	1	7	5	0	9	23	-1	41	37	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDGEETEAFF+TCRBV01-01+TCRBJ01-01	TCRBV01-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGATTCAAGTCTCTGGAAACACCATATATTTTGGAGAG	CASSQGIQVSGNTIYF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	48	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-03	01	1	1	8	0	0	7	23	-1	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGIQVSGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGAGGATACAATGAGCAGTTCTTCGGGCCA	CASSQGGYNEQFF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	39	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	1	11	1	4	0	1	23	-1	43	39	44														CASSQGGYNEQFF+TCRBV01-01+TCRBJ02-01	TCRBV01-01*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCTCTGCGCGGGAAAACATTCAGTACTTCGGCGCC	CASSPSARENIQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	7	4	5	7	0	23	36	-1	43	48						01,02								CASSPSARENIQYF+TCRBV01-01+TCRBJ02-04	TCRBV01-01*01	TCRBD02-01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGTAATGACTAGCGGGATTGGGAGACCCAGTACTTCGGGCCA	CASSND*RDWETQYF	Stop	VDJ	7	383	0.004816156128967356		45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	2	3	5	4	4	19	30	45	34	49													Vb 5.1	CASSND*RDWETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCGGAACGGGACAGAATAATGAAAAACTGTTTTTTGGCAGT	CASGTGQNNEKLFF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	0	5	4	5	2	19	28	40	33	42													Vb 5.1	CASGTGQNNEKLFF+TCRBV05-01+TCRBJ01-04	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCCCGGTTCCGGGACAAACCTACGAGCAGTACTTCGGGCCG	CASSPVPGQTYEQYF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	2	8	2	19	31	45	39	47													Vb 5.1	CASSPVPGQTYEQYF+TCRBV05-01+TCRBJ02-07	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGGACCATTCTAGCACAGATACGCAGTATTTTGGCCCA	CASSLADHSSTDTQYF	In	VDJ	1	43	5.407172677430712E-4	6.05812986939799E-4	48	TCRBV05	TCRBV05-01	01				TCRBJ02	TCRBJ02-03	01	0	1	7	0	1	6	19	35	40	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 5.1	CASSLADHSSTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGACAGGCACATGAACACTGAAGCTTTCTTTGGACAA	CASSDRHMNTEAFF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	4	0	0	4	19	-1	37	31	41													Vb 5.1	CASSDRHMNTEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGTCTTATAGCAATCAGCTCCAGCATTTTGGTGAT	CASSLGSYSNQLQHF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	5	7	12	7	8	19	35	46	42	54						01,02							Vb 5.1	CASSLGSYSNQLQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD02-01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGGGCAGGGGGCCGTCAATGAGCAGTTCTTCGGGCCA	CASSLGQGAVNEQFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	45	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	4	0	6	2	3	19	35	45	37	48													Vb 5.1	CASSLGQGAVNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAAAGCTAGCGGGAGTGTCGGACAGATACGCAGTATTTTGGCCCA	CASSLES*RECRTDTQYF	Stop	VDJ	1	26	3.2694532468185706E-4		54	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	4	2	3	4	6	19	35	49	39	55													Vb 5.1	CASSLES*RECRTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCACGACAGTCTACAATGAGCAGTTCTTCGGGCCA	CASSSTTVYNEQFF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	2	5	3	4	1	19	32	41	36	42													Vb 5.1	CASSSTTVYNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGAACTAGCGGGAGGTCAAGAGACCCAGTACTTCGGGCCA	CASSLELAGGQETQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	3	1	2	1	1	19	35	48	36	49													Vb 5.1	CASSLELAGGQETQYF+TCRBV05-01+TCRBJ02-05	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCGGACAGTGGTCCAATGAGCAGTTCTTCGGGCCA	CASSSGQWSNEQFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	1	5	6	2	5	19	32	40	34	45													Vb 5.1	CASSSGQWSNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCGCGGGGGCGGGGGGGCAGGATACGCAGTATTTTGGCCCA	CASSAGAGGQDTQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	0	6	6	3	19	31	46	37	49													Vb 5.1	CASSAGAGGQDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGAGGGCCCAGGGTGGGGCGTCTGAAGCTTTCTTTGGACAA	CASSLRAQGGASEAFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	4	3	6	6	8	19	34	45	40	53													Vb 5.1	CASSLRAQGGASEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCAGACAGGGGAATCACTGAAGCTTTCTTTGGACAA	CASSSDRGITEAFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	4	2	3	19	32	42	34	45													Vb 5.1	CASSSDRGITEAFF+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCACACCGAAGAGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	16	2.011971228811428E-4		43	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	6	1	1	7	19	32	36	33	43													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGTCTGTGGGGGGTGCAGATACGCAGTATTTTGGCCCA	CASSLSVGGADTQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	9	1	4	5	2	19	34	45	39	47													Vb 5.1	CASSLSVGGADTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCCACGGGACACTCAGTTCTCACAGATACGCAGTATTTTGGCCCA	CASSLATGHSVLTDTQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	54	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	6	2	4	9	19	35	45	39	54													Vb 5.1	CASSLATGHSVLTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGGGACAGGGCGCTCACCCCTCCACTTTGGGAAC	CASSGTGRSPLHF	In	VDJ	10	545	0.006853276998138927	0.007678327392609082	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	3	10	0	3	25	-1	46	37	49													Vb 3	CASSGTGRSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGGAGTCCGCGGGGAGGGAGCACAGATACGCAGTATTTTGGCCCA	CASWSPRGGSTDTQYF	In	VDJ	6	318	0.003998792817262713	0.004480198368531537	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	9	0	0	11	0	25	34	-1	45	52													Vb 3	CASWSPRGGSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTCAGGGGGCGAGTGGAAACACCATATATTTTGGAGAG	CASSLFQGASGNTIYF	In	VDJ	5	294	0.003696997132940999	0.00414207018977444	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	4	0	3	2	3	25	41	51	43	54													Vb 3	CASSLFQGASGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCACGGGGTTACGACCTACGAGCAGTACTTCGGGCCG	CASSHGVTTYEQYF	In	VDJ	4	203	0.0025526884965544993	0.002860000845320447	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	5	8	3	2	2	6	25	37	44	39	50													Vb 3	CASSHGVTTYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACTGTTGTTTTCCTACGAGCAGTACTTCGGGCCG	CASSLLLFSYEQYF	In	VDJ	3	157	0.001974246768271214	0.0022119218360360108	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	10	1	0	7	25	-1	42	40	49						01,02							Vb 3	CASSLLLFSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCCAGGAGCGCACTGAAGCTTTCTTTGGACAA	CASTQERTEAFF	In	VDJ	3	150	0.0018862230270107138	0.002113301117231857	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	7	4	4	4	2	4	25	35	41	37	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTQERTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATATCGAGGGGTTGAGGACACCATATATTTTGGAGAG	CASSLYRGVEDTIYF	In	VDJ	2	139	0.001747900005029928	0.001958325701968188	45	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-03	01	1	5	2	8	4	6	25	41	50	45	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLYRGVEDTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCCGGGACCTAATTACCCCAAAAAACACTGAAGCTTTCTTTGGACAA	CASSRDLITPKNTEAFF	In	VDJ	2	115	0.0014461043207082138	0.0016201975232110906	51	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	8	0	7	2	4	15	25	34	43	38	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSRDLITPKNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGGGAACAGGGCAGAATACACCTTCGGTTCG		Out	VDJ	2	113	0.001420954680348071		41	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	3	3	11	6	5	25	40	52	46	57													Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCGGGACCCTCATGGTAGATACGCAGTATTTTGGCCCA	CASGTLMVDTQYF	In	VDJ	2	103	0.0012952064785473568	0.001451133433832542	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-03	01	8	0	7	5	0	9	25	-1	39	34	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASGTLMVDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTCCTGGACAGGGCGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSSWTGRANTEAFF	In	VDJ	2	101	0.001270056838187214	0.001422956085602784	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	1	3	5	25	38	49	41	54													Vb 3	CASSSWTGRANTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTAGGACAAGGCGCTCACCCCTCCACTTTGGGAAC	CASSRTRRSPLHF	In	VDJ	2	100	0.0012574820180071425	0.0014088674114879048	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	6	10	1	6	25	37	43	38	49													Vb 3	CASSRTRRSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACCAGGGGATGAATGAGCAGTTCTTCGGGCCA	CASNQGMNEQFF	In	VDJ	2	93	0.0011694582767466425	0.0013102466926837514	36	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	4	2	7	2	3	25	35	43	37	46													Vb 3	CASNQGMNEQFF+TCRBV28-01+TCRBJ02-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACTCTCGACGGCTCCTACGAGCAGTACTTCGGGCCG	CASTLDGSYEQYF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	7	2	7	0	5	2	25	35	43	40	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASTLDGSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGAGCCGATGAACACTGAAGCTTTCTTTGGACAA	CASSLEPMNTEAFF	In	VDJ	1	68	8.550877722448569E-4	9.580298398117754E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	6	7	0	1	3	25	40	44	41	47						01,02							Vb 3	CASSLEPMNTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPYSNQPQHF	In	VDJ	1	58	7.293395704441426E-4	8.171430986629848E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	4	10	0	1	2	25	37	40	38	42						01,02							Vb 3	CASSPYSNQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCAGACGGCCATAGTGGTTACACCTTCGGTTCG	CASSPDGHSGYTF	In	VDJ	1	55	6.916151099039283E-4	7.748770763183477E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	5	2	7	11	3	12	25	37	43	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPDGHSGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTGGGGGACTAGCGTTACCGAGCAGTACTTCGGGCCG	CASWGTSVTEQYF	In	VDJ	1	52	6.538906493637141E-4	7.326110539737106E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	0	6	6	3	4	25	34	47	37	51						01,02							Vb 3	CASWGTSVTEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAACGGGGGGAGATACGCAGTATTTTGGCCCA	CASSLTGGDTQYF	In	VDJ	1	51	6.413158291836427E-4	7.185223798588314E-4	39	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	1	5	1	0	25	40	-1	41	48													Vb 3	CASSLTGGDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGCGACAGCTAATCTCTGGAAACACCATATATTTTGGAGAG	CASSLRQLISGNTIYF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	2	5	0	2	5	25	39	46	41	51													Vb 3	CASSLRQLISGNTIYF+TCRBV28-01+TCRBJ01-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTGGACAGGGATTACGAGCAGTACTTCGGGCCG	CASSLLDRDYEQYF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	3	4	1	2	25	41	50	42	52													Vb 3	CASSLLDRDYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTGGGGGGTCTCGTGGCGAGCAGTACTTCGGGCCG	CASSFGGSRGEQYF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	9	1	6	1	8	25	39	46	40	54													Vb 3	CASSFGGSRGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGGTGGCAGGGCTCCGAGCAGTACTTCGGGCCG	CASSLGWQGSEQYF	In	VDJ	1	43	5.407172677430712E-4	6.05812986939799E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	3	6	6	3	25	40	51	46	54													Vb 3	CASSLGWQGSEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTAAGGGGGGTAAGAGACCCAGTACTTCGGGCCA	CASS*GG*ETQYF	Stop	VDJ	1	42	5.281424475629999E-4		39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	4	5	1	3	1	2	25	38	45	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASS*GG*ETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCGCTGGGGCCGGATACTATGGCTACACCTTCGGTTCG	CASTAGAGYYGYTF	In	VDJ	1	42	5.281424475629999E-4	5.9172431282492E-4	42	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	7	0	3	5	5	25	35	45	40	50													Vb 3	CASTAGAGYYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACGGGGCAGTACTTTAGCTTTCTTTGGACAA	CASRRGSTLAFF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	7	0	10	2	8	25	36	43	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRRGSTLAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACGCCCCCCGAGGGGGCGCGATCTGATGGCTACACCTTCGGTTCG	CASTPPEGARSDGYTF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	5	0	6	9	8	25	35	51	44	59													Vb 3	CASTPPEGARSDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGACGCCCCAGGGAAAACTGTTTTTTGGCAGT	CASSLTPQGKLFF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	3	10	7	0	25	39	-1	46	51													Vb 3	CASSLTPQGKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCTTACCGGGACAGGTCCTAAAGGGGGATACGAGCAGTACTTCGGGCCG	CASSLTGTGPKGGYEQYF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	54	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	4	4	6	13	25	37	51	43	64													Vb 3	CASSLTGTGPKGGYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCACAGGGGAGGGATGGCTACACCTTCGGTTCG	CASSPQGRDGYTF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	39	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	6	3	2	6	3	4	25	36	46	39	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSPQGRDGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGACACGGTTCGACTGAAGCTTTCTTTGGACAA	CASRHGSTEAFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-01	01	6	3	6	5	0	7	25	-1	39	36	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASRHGSTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTGGACAGGGCTGAATATCAGCCCCAGCATTTTGGTGAT	CASSLDRAEYQPQHF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	1	3	5	0	6	25	-1	47	39	53													Vb 3	CASSLDRAEYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTACAACTCAACTCCTACGAGCAGTATTTCGGGCCG	CASSLQLNSYEQYF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	42	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-07	01	2	4	5	16	18	3	25	40	61	58	64				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASSLQLNSYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTGCGGGACCCTACGAGCAGTACTTCGGGCCG	CASSAGPYEQYF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	2	0	1	25	-1	43	37	44													Vb 3	CASSAGPYEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCGAGGAGGGGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSRGGASGANVLTF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	10	0	0	3	2	25	37	46	40	48													Vb 3	CASSRGGASGANVLTF+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTAGGCGGGACAGGCTACTATGGCTACACCTTCGGTTCG	CASSLGGTGYYGYTF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	4	3	3	2	25	40	51	43	53													Vb 3	CASSLGGTGYYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCCGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASRQGYTGELFF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	39	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	2	2	3	1	1	25	34	43	35	44													Vb 3	CASRQGYTGELFF+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATCTAACTATGGCTACACCTTCGGTTCG	CASSLSNYGYTF	In	VJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	36	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	1	0	0	0	0	0	25	-1	-1	-1	41													Vb 3	CASSLSNYGYTF+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCACCATATCACTGATGAATTCACCCCTCCACTTTGGGAAC	CASTISLMNSPLHF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	7	3	10	7	7	4	25	35	45	42	49						01,02							Vb 3	CASTISLMNSPLHF+TCRBV28-01+TCRBJ01-06	TCRBV28-01*01	TCRBD02-01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGTGTGCGTCCGACGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	2.3892158342135708E-4		49	TCRBV28	TCRBV28-01	01				TCRBJ01	TCRBJ01-02	01	4	2	7	4	10	7	25	38	51	48	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ01-02	TCRBV28-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTCCCCCCACAGGGCGTTATCAGCCCCAGCATTTTGGTGAT	CASSPPTGRYQPQHF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	3	5	6	4	25	37	49	43	53													Vb 3	CASSPPTGRYQPQHF+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGACCACAGGGGGCCAAGACTGAAGCTTTCTTTGGACAA	CASS*PQGAKTEAFF	Stop	VDJ	1	18	2.2634676324128565E-4		45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	5	4	4	25	38	51	42	55													Vb 3	CASS*PQGAKTEAFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCACTACTATCCTCGGGAGGAAACTGTTTTTTGGCAGT	CATTILGRKLFF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	10	8	1	11	10	0	25	32	-1	42	49													Vb 3	CATTILGRKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTATTTGGAGGAGCAACTTTCTTTGGACAA	CASSLFGGATFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	36	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	1	10	1	12	2	5	25	41	48	43	53													Vb 3	CASSLFGGATFF+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCTTTGACTAGCACTGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	16	2.011971228811428E-4		44	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	6	2	7	6	5	4	25	36	48	41	52						01,02							Vb 3	X+TCRBV28-01+TCRBJ02-02	TCRBV28-01*01	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCCCTAGTAGCGGGAGGACTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	56	7.041899300839998E-4		47	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	5	1	3	5	1	18	30	45	35	46														X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCAAGTCGCTTATAACCGCTTCGGGCTAGCGGGAATTCAGAGTTCTTCGGGCCA	CASRL*PLRASGNSEFF	Stop	VDJ	1	33	4.1496906594235705E-4		51	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	3	14	13	6	18	33	55	46	61														CASRL*PLRASGNSEFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCACCACGGAACTAGCGGGGTACAATGAGCAGTTCTTCGGGCCA	CATTELAGYNEQFF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	42	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	12	3	3	4	9	0	18	23	-1	32	42														CATTELAGYNEQFF+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGCGAGGGGGCCTACGAGCAGTACTTCGGGCCG	CSGGEGAYEQYF	In	VDJ	16	905	0.01138021226296464	0.01275025007396554	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	5	1	2	6	0	25	32	-1	38	44													Vb 4	CSGGEGAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATGAGGGCAGGGGAGGTGGAAACACCATATATTTTGGAGAG	CSVDEGRGGGNTIYF	In	VDJ	9	477	0.00599818922589407	0.006720297552797306	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-03	01	3	4	2	3	6	3	25	36	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDEGRGGGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTAAGGTTTGAGATAGGGACGGATGAACACTGAAGCTTTCTTTGGACAA	CSV*GLR*GRMNTEAFF	Stop	VDJ	6	337	0.00423771440068407		51	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	1	0	7	0	10	3	25	38	53	48	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSV*GLR*GRMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGGGACAGGTAACAATGAGCAGTTCTTCGGGCCA	CSAGTGNNEQFF	In	VDJ	3	147	0.0018484985664704995	0.00207103509488722	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	4	5	2	2	25	32	42	34	44													Vb 4	CSAGTGNNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTTCATAGGAGAGGAACACCATATATTTTGGAGAG	CSVS*ERNTIYF	Stop	VDJ	2	137	0.0017227503646697851		36	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	5	10	2	7	5	3	25	34	43	39	46													Vb 4	CSVS*ERNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAGGTCCGTTTTTACAATGAGCAGTTCTTCGGGCCA	CSVEEVRFYNEQFF	In	VDJ	2	126	0.0015844273426889996	0.0017751729384747601	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	1	4	0	8	25	-1	41	36	49													Vb 4	CSVEEVRFYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGAGCGGCCAGATCACCGACCGGGGAGCTGTTTTTTGGAGAA	CSVGAARSPTGELFF	In	VDJ	2	101	0.001270056838187214	0.001422956085602784	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	6	5	5	1	11	25	35	41	36	52						01,02							Vb 4	CSVGAARSPTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTAACAGGGGCTCTGGAAACACCATATATTTTGGAGAG	CSANRGSGNTIYF	In	VDJ	2	95	0.0011946079171067854	0.0013384240409135097	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	7	3	2	0	3	0	25	32	-1	35	42													Vb 4	CSANRGSGNTIYF+TCRBV29-01+TCRBJ01-03	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCTGACCCGGACAGGATCATACTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	77	9.682611538654998E-4		47	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	4	0	3	6	25	36	46	39	52													Vb 4	X+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGTTTTGTGCGGGGCCAGTACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	68	8.550877722448569E-4		50	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	3	0	6	5	25	38	50	44	55													Vb 4	X+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCTCTAGGGGGACTAGCGGGATAGAGACCCAGTACTTCGGGCCA	CSSRGTSGIETQYF	In	VDJ	1	61	7.670640309843569E-4	8.59409121007622E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	8	0	3	4	6	1	25	31	50	37	51													Vb 4	CSSRGTSGIETQYF+TCRBV29-01+TCRBJ02-05	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGCAGCCCCCTATGGCTACACCTTCGGTTCG	CSVEAAPYGYTF	In	VDJ	1	58	7.293395704441426E-4	8.171430986629848E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	3	4	5	4	2	4	25	36	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEAAPYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGAACTAGTCCCCCCACAGATACGCAGTATTTTGGCCCA	CSGTSPPTDTQYF	In	VDJ	1	55	6.916151099039283E-4	7.748770763183477E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	3	8	2	2	6	25	32	39	34	45						01,02							Vb 4	CSGTSPPTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGCCGCACAGATACGCAGTATTTTGGCCCA	CSVEGRTDTQYF	In	VDJ	1	46	5.784417282832855E-4	6.480790092844363E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	1	10	0	1	0	1	25	-1	40	38	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGRTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCACAATCGGACAGGGAGGCAATGAGCAGTTCTTCGGGCCA	CSTIGQGGNEQFF	In	VDJ	1	46	5.784417282832855E-4	6.480790092844363E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	1	3	6	6	3	25	31	45	37	48													Vb 4	CSTIGQGGNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGCCTAGCGGGAGGACTTAATGAGCAGTTCTTCGGGCCA	CSGLAGGLNEQFF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	7	4	1	7	2	4	25	32	45	34	49													Vb 4	CSGLAGGLNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACGCGACATGAACACTGAAGCTTTCTTTGGACAA	CSVERDMNTEAFF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	6	0	3	0	25	37	-1	40	44													Vb 4	CSVERDMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGCGGACAGGGTAAGGGAGCAGTACTTCGGGCCG	CSAADRVREQYF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	36	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	7	4	5	25	32	44	36	49													Vb 4	CSAADRVREQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGACAGGCCATCAATCAGCCCCAGCATTTTGGTGAT	CSVGQAINQPQHF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	0	4	3	0	4	25	-1	41	33	45													Vb 4	CSVGQAINQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGTCCAGTTTAAATGAAAAACTGTTTTTTGGCAGT	CSVESSLNEKLFF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	4	5	5	3	4	25	36	42	39	46													Vb 4	CSVESSLNEKLFF+TCRBV29-01+TCRBJ01-04	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGTCGGACGCCGCCTATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	26	3.2694532468185706E-4		44	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-06	01	4	1	7	2	3	4	25	35	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGTATTAGCCGGGTCGGGAGAAGCTTTCTTTGGACAA	CSVVLAGSGEAFF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	4	8	3	8	12	0	25	35	-1	47	52													Vb 4	CSVVLAGSGEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCGGGAAACAGGGCCATGAACACTGAAGCTTTCTTTGGACAA	CSVEPGNRAMNTEAFF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	0	7	3	25	37	50	44	53													Vb 4	CSVEPGNRAMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGGGAAGAGGGCCTACGAGCAGTACTTCGGGCCG	CSVEGKRAYEQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	11	0	2	6	0	25	36	-1	42	47													Vb 4	CSVEGKRAYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGAGGGGGAACACTGAAGCTTTCTTTGGACAA	CSVERGNTEAFF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-01	01	3	5	2	1	1	0	25	36	-1	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVERGNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAATAAAGGGCATTCGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	21	2.6407122378149995E-4		43	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	2	5	3	3	3	6	25	37	44	40	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	X+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGGGGGACAGGGACCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	21	2.6407122378149995E-4		38	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	0	3	3	1	2	25	32	42	33	44													Vb 4	X+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCGTAGCGGGGGCTCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CSAVAGALNTGELFF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	45	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	7	5	2	1	3	4	25	32	44	35	48													Vb 4	CSAVAGALNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGCCCGCAGGACCGCCAATAACCTATATGGCTACACCTTCGGTTCG	CSARRTANNLYGYTF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	45	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-02	01	7	1	7	5	6	13	25	32	42	38	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSARRTANNLYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCCAATTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSVGQFSGANVLTF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	42	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-06	01	4	4	6	0	2	3	25	35	39	37	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVGQFSGANVLTF+TCRBV29-01+TCRBJ02-06	TCRBV29-01*01		TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGATAGAAACAGGGGAGGAGTGAACACTGAAGCTTTCTTTGGACAA	CSVDRNRGGVNTEAFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	48	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	0	5	5	25	36	48	41	53													Vb 4	CSVDRNRGGVNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGATCCGCACAGGGGCCTTGAAGCTTTCTTTGGACAA	CSVEDPHRGLEAFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	3	2	7	5	3	25	39	51	44	54													Vb 4	CSVEDPHRGLEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCAGGGCGGGGGCCCAGGAGATACGCAGTATTTTGGCCCA	CSVQGGGPGDTQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	7	2	5	4	6	25	34	45	38	51													Vb 4	CSVQGGGPGDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGGGGCAGGGAAGGGAATGAAAAACTGTTTTTTGGCAGT	CASRGREGNEKLFF	In	VDJ	8	440	0.005532920879231427	0.0061990166105467814	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	4	3	5	3	5	23	34	42	37	47													Vb 22	CASRGREGNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGGGGAGACAGGGGCCCCTGAAGCTTTCTTTGGACAA	CASSGETGAPEAFF	In	VDJ	2	128	0.0016095769830491425	0.0018033502867045182	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	2	6	6	3	23	34	48	40	51													Vb 22	CASSGETGAPEAFF+TCRBV02-01+TCRBJ01-01	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGGGACTAGCGGGGGATTGTACTTCGGCGCC	CASSGTSGGLYF	In	VDJ	1	74	9.305366933252855E-4	0.0010425618845010497	36	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	6	0	2	15	1	3	23	34	49	35	52													Vb 22	CASSGTSGGLYF+TCRBV02-01+TCRBJ02-04	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGATCAGGAAAGCAATCAGCCCCAGCATTTTGGTGAT	CASSDQESNQPQHF	In	VDJ	1	38	4.7784316684271416E-4	5.353696163654039E-4	42	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	4	1	1	2	23	37	42	38	44													Vb 22	CASSDQESNQPQHF+TCRBV02-01+TCRBJ01-05	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAAACCGTCTACAGGGGAATACACCTTCGGTTCG	CASKPSTGEYTF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	36	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	3	2	11	8	2	23	33	48	41	50													Vb 22	CASKPSTGEYTF+TCRBV02-01+TCRBJ01-02	TCRBV02-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCATCAGGAGCGGGGGATCCTACGAGCAGTACTTCGGGCCG	CASIRSGGSYEQYF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	42	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	7	6	2	1	5	1	23	33	46	38	47													Vb 22	CASIRSGGSYEQYF+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGCCCCCCTAGGACAGGGGATTAGGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSAPLGQGIRGANVLTF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	57	TCRBV02	TCRBV02-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	2	4	8	6	23	36	53	44	59													Vb 22	CASSAPLGQGIRGANVLTF+TCRBV02-01+TCRBJ02-06	TCRBV02-01*01	TCRBD01-01*01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAGCGGGGGCAAAGCACAGATACGCAGTATTTTGGCCCA	CASSERGQSTDTQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	45	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	2	0	0	3	23	-1	44	37	47													Vb 22	CASSERGQSTDTQYF+TCRBV02-01+TCRBJ02-03	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGACCCTAGACAGGGCCCCTGTGAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	26	3.2694532468185706E-4		53	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	2	3	4	4	9	28	43	54	47	63			01,02											X+TCRBV06-04+TCRBJ01-05	TCRBV06-04	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCGATTCCGAAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	3.017956843217142E-4		31	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-05	01	8	2	8	6	0	6	28	-1	39	37	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-04+TCRBJ02-05	TCRBV06-04		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGAACAGGGGAGCACTGAAGCTTTCTTTGGACAA	CASSEQGSTEAFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	39	TCRBV06	TCRBV06-04		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	4	0	2	28	-1	49	42	51			01,02											CASSEQGSTEAFF+TCRBV06-04+TCRBJ01-01	TCRBV06-04	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACGGGAGGGGTGAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	59	7.419143906242141E-4		46	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	0	1	0	5	26	-1	48	41	53														X+TCRBV06-07+TCRBJ01-01	TCRBV06-07*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCACCAAGTAGGGCGGTTTATGGGAGCAGTACTTCGGGCCG	CASTK*GGLWEQYF	Stop	VDJ	1	41	5.155676273829285E-4		42	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-07	01	7	5	3	7	6	10	26	36	46	42	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASTK*GGLWEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTAGCTGGACAGGGGCAATCTGGGACCAGACCTACGAGCAGTACTTCGGGCCG	CASSSWTGAIWDQTYEQYF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	57	TCRBV06	TCRBV06-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	2	2	4	15	24	36	49	40	64														CASSSWTGAIWDQTYEQYF+TCRBV06-07+TCRBJ02-07	TCRBV06-07*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTTACTCGACTCGGGACGGTCGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYSTRDGRGSYNEQFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	57	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	8	2	1	13	0	24	41	-1	54	60														CASSYSTRDGRGSYNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCGACGCCTTCTTCGACTCTAAACGAGGCAATGAGCAGTTCTTCGGGCCA	CASDAFFDSKRGNEQFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	51	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	8	2	10	6	12	10	26	35	51	47	61						01,02								CASDAFFDSKRGNEQFF+TCRBV06-07+TCRBJ02-01	TCRBV06-07*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTTAGTCCACAGCTCTTATAATTCACCCCTCCACTTTGGGAAC	CASSLVHSSYNSPLHF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	48	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	3	5	4	3	4	19	35	42	38	46														CASSLVHSSYNSPLHF+TCRBV07-07+TCRBJ01-06	TCRBV07-07*01	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCGTCCGGGACTGGTCCTTTTCCACAGATACGCAGTATTTTGGCCCA	CASSVRDWSFSTDTQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	51	TCRBV07	TCRBV07-07	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	2	4	10	19	31	41	35	51						01,02								CASSVRDWSFSTDTQYF+TCRBV07-07+TCRBJ02-03	TCRBV07-07*01	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCGCGGGACTAGCGACAGATACGCAGTATTTTGGCCCA	CASSAGLATDTQYF	In	VDJ	2	124	0.0015592777023288567	0.001746995590245002	42	TCRBV07	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	0	6	3	2	0	19	31	-1	33	43		TCRBV07-05,TCRBV07-07				01,02								CASSAGLATDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCACCGATCTACAGGGTGATTTTGAAAAACTGTTTTTTGGCAGT	CASTDLQGDFEKLFF	In	VDJ	2	92	0.001156883456566571	0.0012961580185688725	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	3	7	7	6	23	33	46	40	52		TCRBV06-07,TCRBV06-08												CASTDLQGDFEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGTTCGCCGCACAGGACTAGCAGAGAGACCCAGTACTTCGGGCCA	CASSPHRTSRETQYF	In	VDJ	1	81	0.0010185604345857855	0.001141182603305203	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	9	1	7	4	11	2	23	31	50	42	52		TCRBV06-04,TCRBV06-08				01,02								CASSPHRTSRETQYF+TCRBV06-X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCACCGTCCCGGGGGAGATACTCTACGAGCAGTACTTCGGGCCG	CATVPGEILYEQYF	In	VDJ	1	67	8.425129520647854E-4	9.439411656968963E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	10	8	2	3	6	7	26	33	45	39	52		TCRBV10-01,TCRBV10-02												CATVPGEILYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGAACCCAATGGCGGGATAACACCGGGGAGCTGTTTTTTGGAGAA	CASRTQWRDNTGELFF	In	VDJ	1	63	7.922136713444998E-4	8.875864692373801E-4	48	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	7	3	2	9	1	26	37	52	46	53		TCRBV06-07,TCRBV06-08												CASRTQWRDNTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCCAACCCATAGACTAGCGGGACAGTTCACAGATACGCAGTATTTTGGCCCA	CASSPTHRLAGQFTDTQYF	In	VDJ	1	61	7.670640309843569E-4	8.59409121007622E-4	57	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	3	2	10	5	23	35	56	45	61		TCRBV10-01,TCRBV10-02												CASSPTHRLAGQFTDTQYF+TCRBV10-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTTAGGTTTGGGGGCAGGGGACTAATGAAAAACTGTTTTTTGGCAGT	CASS*VWGQGTNEKLFF	Stop	VDJ	1	57	7.167647502640712E-4		51	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	4	2	2	12	0	23	35	-1	47	53		TCRBV10-01,TCRBV10-02												CASS*VWGQGTNEKLFF+TCRBV10-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACCCTGGGGACAGGGTACACTGAAGCTTTCTTTGGACAA	CASTLGTGYTEAFF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	42	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	0	3	3	5	1	22	32	46	37	47		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASTLGTGYTEAFF+TCRBV12-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCACGGGGGGCAGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSHGGQPNEKLFF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	45	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	5	8	1	3	2	4	26	38	47	40	51		TCRBV06-07,TCRBV06-08												CASSHGGQPNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCATTAGACAGGGTTGTAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	44	5.532920879231427E-4		43	TCRBV10	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	2	3	5	26	36	46	39	51		TCRBV10-01,TCRBV10-02												X+TCRBV10-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTTACCGAGGGTTCAATGAAAAACTGTTTTTTGGCAGT	CASSYRGFNEKLFF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	42	TCRBV06	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	2	11	0	5	1	3	23	38	44	39	47		TCRBV06-07,TCRBV06-08												CASSYRGFNEKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACCCCACAGGGTTGGTCGACTGAAGCTTTCTTTGGACAA	CASTPQGWSTEAFF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	42	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	5	4	7	22	32	42	36	49		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASTPQGWSTEAFF+TCRBV12-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCACTGTTTGTCTGACTAGCTCCTACGAGCAGTACTTCGGGCCG	CASTVCLTSSYEQYF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	45	TCRBV10	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	2	8	0	10	0	26	36	-1	46	52		TCRBV10-01,TCRBV10-02				01,02								CASTVCLTSSYEQYF+TCRBV10-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGTACCCTCYCAGACATCTGTGTACTTSTGTGCCAGCAGGGGACGGTCTTACAATGAGCAGTTCTTTGGGCCA	CASRGRSYNEQFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	39	TCRBV06	unresolved					TCRBJ02			6	0	7	22	0	23	23	-1	39	34	62		TCRBV06-04,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01			TCRBJ02-01,TCRBJ02-05						CASRGRSYNEQFF+TCRBV06-X+TCRBJ02-X	unresolved		TCRBJ02	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGACTAGCGGGAGTCGGGCAGTTCTTCGGGCCA		Out	VDJ	1	31	3.898194255822142E-4		41	TCRBV11	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	4	2	12	0	4	18	-1	45	35	49		TCRBV11-01,TCRBV11-03												X+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCRTGTATCKCTGTGCCAGCAGGCGGACAGGGAGTAATTCATCCCTCCACTTTGGGAAC	CASRRTGSNSSLHF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	1	3	14	2	10	19	30	40	32	50		TCRBV07-02,TCRBV07-07												CASRRTGSNSSLHF+TCRBV07-X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGACTCTGACAGGGTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	29	3.646697852220713E-4		44	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	2	3	1	1	0	28	45	-1	46	53		TCRBV06-04,TCRBV06-07												X+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTAGGGACAGGTCTCTACGAGCAGTACTTCGGGCCG	CASSLGTGLYEQYF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	42	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	4	3	0	3	19	-1	42	35	45		TCRBV11-01,TCRBV11-03												CASSLGTGLYEQYF+TCRBV11-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTTGGAACCCCCCTACCTGAAGCTTTCTTTGGACAA	CASSFGTPLPEAFF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	42	TCRBV11	unresolved					TCRBJ01	TCRBJ01-01	01	3	1	8	6	1	10	19	33	37	34	47		TCRBV11-01,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFGTPLPEAFF+TCRBV11-X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTGAAGAAGGACAGGGAAACCCCTACGAGCAGTACTTCGGGCCG	CASSEEGQGNPYEQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	48	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	3	2	4	5	28	42	54	46	59		TCRBV06-04,TCRBV06-07												CASSEEGQGNPYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGYWCCCTCYCAGACATCTGTRTACTTCTGTGCCAGCAGCCTTCTCTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	3.1437050450178563E-4		34	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	10	7	1	5	28	39	42	40	47		TCRBV06-04,TCRBV06-09				01,02								X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCCAGAGGGGCAAGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	25	3.1437050450178563E-4		40	TCRBV10	unresolved					TCRBJ01	TCRBJ01-02	01	8	5	2	2	3	5	23	32	40	35	45		TCRBV10-01,TCRBV10-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV10-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGAGTAAACACGAACACAGATACGCAGTATTTTGGCCCA	CASRVNTNTDTQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	42	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	6	2	5	4	18	29	37	34	41		TCRBV07-02,TCRBV07-06												CASRVNTNTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCCCCAGGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASSPPGGYTGELFF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	3	5	2	23	34	46	39	48		TCRBV06-07,TCRBV06-08												CASSPPGGYTGELFF+TCRBV06-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGGGCAGGCCATGGACACCGGGGAGCTGTTTTTTGGAGAA	CASSLGQAMDTGELFF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	48	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	4	4	3	2	6	19	35	41	37	47		TCRBV07-06,TCRBV07-07												CASSLGQAMDTGELFF+TCRBV07-X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCTGGACAGGGAGCTTTCATTTGAAGCTTTCTTTGGACAA	CASSLDRELSFEAFF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	45	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	7	2	10	19	31	41	33	51		TCRBV07-05,TCRBV07-07												CASSLDRELSFEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCYCARACWTCTGTKTACTTCTGTGCCAGCAGTGACGGCGGGGCTCAGCCCCAGCATTTTGGTGAT	CASSDGGAQPQHF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	39	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	7	3	6	4	1	26	38	48	42	49		TCRBV06-02,TCRBV06-03,TCRBV06-07												CASSDGGAQPQHF+TCRBV06-X+TCRBJ01-05	unresolved	TCRBD02-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGCCCGGGAAAGACTAGCGGGCAATCCTACGAGCAGTACTTCGGGCCG	CASSPGKTSGQSYEQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	4	1	9	3	23	34	53	43	56		TCRBV06-08,TCRBV06-09				01,02								CASSPGKTSGQSYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATCKCTGTGCCAGCAGCCTCAAGGGGGGAGCGGGAGTCGAAGAGACCCAGTACTTCGGGCCA	CASSLKGGAGVEETQYF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	51	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	6	2	3	11	3	18	30	49	41	52		TCRBV07-02,TCRBV07-06												CASSLKGGAGVEETQYF+TCRBV07-X+TCRBJ02-05	unresolved	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCAGTTACACAGGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASSYTGTGAYEQYF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	2	6	0	28	40	-1	46	56		TCRBV06-04,TCRBV06-07												CASSYTGTGAYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCATGGACAGTCCCACAGATACGCAGTATTTTGGCCCA	CASMDSPTDTQYF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	39	TCRBV12	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	12	1	5	2	6	3	26	31	43	37	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASMDSPTDTQYF+TCRBV12-X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCCCCTGGTCAGGGGGCCATAGCTACGAGCAGTACTTCGGGCCG	CASSPWSGGHSYEQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	48	TCRBV05	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	4	0	3	7	5	19	31	46	38	51		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSPWSGGHSYEQYF+TCRBV05-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCATGTATCGCTGTGCCAGCAGCTTAGAGGGCGGGAGTACAGATACGCAGTATTTTGGCCCA	CASSLEGGSTDTQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	45	TCRBV07	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	7	2	3	3	1	18	34	44	37	45		TCRBV07-06,TCRBV07-07												CASSLEGGSTDTQYF+TCRBV07-X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTGAACCCGCAGATTCCGTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	17	2.1377194306121421E-4		49	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	5	1	7	6	26	38	48	45	54		TCRBV06-01,TCRBV06-07,TCRBV06-08												X+TCRBV06-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGGGGACTYGGCYGTGTATCTCTGTGCCAGCAGCCAGGGAAACAATCAGCCCCAGCATTTTGGTGAT	CASSQGNNQPQHF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	39	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	4	3	3	0	3	22	-1	39	34	42		TCRBV07-01,TCRBV07-02												CASSQGNNQPQHF+TCRBV07-X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCACCACGGGGAAGCAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	16	2.011971228811428E-4		46	TCRBV12	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	7	8	3	0	3	6	22	32	40	35	46		TCRBV12-03,TCRBV12-04,TCRBV12-05												X+TCRBV12-X+TCRBJ01-03	unresolved	TCRBD02-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCCCCCAGGGACAGGTTATTTCGGATGAGCAGTTCTTCGGGCCA	CASSPQGQVISDEQFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	48	TCRBV11	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	8	5	9	19	31	44	36	53		TCRBV11-01,TCRBV11-03												CASSPQGQVISDEQFF+TCRBV11-X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CACCAGCCAAACAGCTTTGTACTTCTGTGCCACCGGGGACAGTTTATGGCTACACCTTCGGTTCG		Out	VDJ	1	35	4.4011870630249986E-4		34	TCRBV22	TCRBV22-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	13	0	5	5	7	2	25	28	42	35	44														X+TCRBV22-01+TCRBJ01-02	TCRBV22-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGGACTCGGCCCTGTATCTCTGTGCCAGCAGATCGGAAGGGGCAGATACGCAGTATTTTGGCCCA	CASRSEGADTQYF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	39	TCRBV05	TCRBV05-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	2	4	6	0	20	31	-1	37	42														CASRSEGADTQYF+TCRBV05-08+TCRBJ02-03	TCRBV05-08*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTCGACAGGGTCGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	38	4.7784316684271416E-4		41	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	3	3	0	3	22	-1	43	36	46														X+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCAAACAGGGGGCGTATGAAGCTTTCTTTGGACAA	CASSKQGAYEAFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	39	TCRBV07	TCRBV07-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	0	7	2	3	22	34	45	36	48														CASSKQGAYEAFF+TCRBV07-01+TCRBJ01-01	TCRBV07-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCTTGATGGGGATGAGCTATGGCTACACCTTCGGTTCG	CASSLMGMSYGYTF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV07	TCRBV07-01	01				TCRBJ01	TCRBJ01-02	01	4	0	8	4	5	4	22	35	44	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLMGMSYGYTF+TCRBV07-01+TCRBJ01-02	TCRBV07-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGGACTCCGCCGTGTATCTCTGTGCCAGCTCTTACAGGGAGGACTACGAGCAGTACTTCGGGCCG	CASSYREDYEQYF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	39	TCRBV07	TCRBV07-08					TCRBJ02	TCRBJ02-07	01	8	3	3	3	4	4	20	29	39	33	43			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYREDYEQYF+TCRBV07-08+TCRBJ02-07	TCRBV07-08		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTTTACAGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSLQGSTDTQYF	In	VDJ	2	85	0.0010688597153060712	0.0011975372997647192	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	0	2	0	23	35	-1	37	44													Vb 12	CASSLQGSTDTQYF+TCRBV10-02+TCRBJ02-03	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCCGACAGGGCCTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	74	9.305366933252855E-4		40	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	3	5	2	3	23	36	45	38	48													Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGTGAGAGGGGCCTCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSVRGASTNEKLFF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	48	TCRBV10	TCRBV10-02	01				TCRBJ01	TCRBJ01-04	01	4	5	2	0	4	3	23	36	45	40	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSVRGASTNEKLFF+TCRBV10-02+TCRBJ01-04	TCRBV10-02*01		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGAGATACCAACAGGGGCCTGAACTATGGCTACACCTTCGGTTCG	CASRDTNRGLNYGYTF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	2	2	8	4	23	34	49	42	53													Vb 12	CASRDTNRGLNYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAGCAGACTAGCGGGGGGGGAGAGACCCAGTACTTCGGGCCA	CAISEQTSGGGETQYF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	2	0	4	2	1	24	39	55	41	56													Vb 12	CAISEQTSGGGETQYF+TCRBV10-03+TCRBJ02-05	TCRBV10-03*01	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGGTCCCCATGAGCAGTTCTTCGGGCCA	CAISEGPHEQFF	In	VDJ	1	65	8.173633117046427E-4	9.157638174671381E-4	36	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-01	01	2	0	10	8	0	5	23	-1	40	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEGPHEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGCCCACAGAGTCTAATGAAAAACTGTTTTTTGGCAGT	CAISEPTESNEKLFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	5	3	3	3	23	38	45	41	48													Vb 12	CAISEPTESNEKLFF+TCRBV10-03+TCRBJ01-04	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGCGGGACGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CAISGTGNTGELFF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	42	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-02	01	6	0	7	1	1	3	24	35	41	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISGTGNTGELFF+TCRBV10-03+TCRBJ02-02	TCRBV10-03*01		TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCTATCAGTGAGTCCGGCAGGTTCAATCAGCCCCAGCATTTTGGTGAT	CAISESGRFNQPQHF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	4	4	3	3	2	23	40	47	43	49													Vb 12	CAISESGRFNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAGCCCCAACGGGCGGGAGAGCAGTTCTTCGGGCCA	CAISEPQRAGEQFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	42	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	7	3	10	9	0	24	39	-1	48	54													Vb 12	CAISEPQRAGEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGTTAGGGGGGCAGCCTCACGAGCAGTTCTTCGGGCCA	CAISELGGQPHEQFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	45	TCRBV10	TCRBV10-03	01				TCRBJ02	TCRBJ02-01	01	1	5	1	10	1	10	23	39	46	40	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISELGGQPHEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAGGCGGCGTCCATATCCTACAATGAGCAGTTCTTCGGGCCA	CAISEAASISYNEQFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	48	TCRBV10	TCRBV10-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	7	5	1	0	8	23	-1	42	38	50						01,02							Vb 12	CAISEAASISYNEQFF+TCRBV10-03+TCRBJ02-01	TCRBV10-03*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGTTTAACAGGGTGGTCGGGAGAGCAGTACTTCGGGCCG	CASSMGLTGWSGEQYF	In	VDJ	17	940	0.01182033096926714	0.013243353667986306	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	7	7	9	27	41	54	48	63			01,02										Vb 17	CASSMGLTGWSGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCACTAGCGGAGACTACAATGAGCAGTTCTTCGGGCCA	CASSPTSGDYNEQFF	In	VDJ	15	837	0.010525124490719783	0.011792220234153763	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	3	3	3	27	39	50	42	53			01,02			01,02							Vb 17	CASSPTSGDYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTTAGGACTACACGCGAGACCCAGTACTTCGGGCCA	CASSFRTTRETQYF	In	VDJ	11	621	0.007808963331824355	0.008749066625339889	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	1	9	5	5	5	27	38	49	43	54			01,02			01,02							Vb 17	CASSFRTTRETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACTAGCGGGAGTCTCAACGAGCAGTACTTCGGGCCG	CASSRTSGSLNEQYF	In	VDJ	9	525	0.006601780594537498	0.007396553910311501	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	1	2	5	0	5	27	-1	53	40	58			01,02										Vb 17	CASSRTSGSLNEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGGCGGGGGAAGGGCGAGCTTTCTTTGGACAA	CASKAGEGRAFF	In	VDJ	7	397	0.004992203611488355	0.005593203623606983	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	7	7	2	10	2	7	27	37	46	39	53			01,02										Vb 17	CASKAGEGRAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGACTAGCGGGAGCATGGATACGCAGTATTTTGGCCCA	CASSRTSGSMDTQYF	In	VDJ	5	275	0.0034580755495196417	0.0038743853815917384	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	2	6	2	4	27	38	53	40	57			01,02										Vb 17	CASSRTSGSMDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGCGGAAACTACGAGCAGTACTTCGGGCCG	CASSRGNYEQYF	In	VDJ	5	268	0.0033700518082591417	0.0037757646627875853	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	7	5	3	1	3	27	39	44	40	47			01,02			01,02							Vb 17	CASSRGNYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCTGGGGACAGGGGTGGTTTACGAGCAGTACTTCGGGCCG	CASSIDLGTGVVYEQYF	In	VDJ	4	242	0.003043106483577285	0.0034094591358007297	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	4	4	5	27	44	58	48	63			01,02										Vb 17	CASSIDLGTGVVYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGACAGTCTACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSETVYSYNEQFF	In	VDJ	4	226	0.002841909360696142	0.003184040349962665	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	5	0	2	4	27	39	46	41	50			01,02										Vb 17	CASSETVYSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACTAACGGGAGGGACCACAGATACGCAGTATTTTGGCCCA	CASSILTGGTTDTQYF	In	VDJ	4	211	0.002653287057995071	0.0029727102382394793	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	8	0	2	4	2	27	42	54	46	56			01,02										Vb 17	CASSILTGGTTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGATACGTCCGTGGGGCACTGAAGCTTTCTTTGGACAA	CASSIMIRPWGTEAFF	In	VDJ	4	207	0.002602987777274785	0.002916355541779963	48	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	2	6	2	4	13	0	27	42	-1	55	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIMIRPWGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCAGACTAGCGGGAGAGTCTACAATGAGCAGTTCTTCGGGCCA	CASRQTSGRVYNEQFF	In	VDJ	4	199	0.0025023892158342136	0.002803646148860931	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	2	2	3	3	3	27	38	53	41	56			01,02										Vb 17	CASRQTSGRVYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGACTAGCGGGAGATTTGATACGCAGTATTTTGGCCCA	CASSRTSGRFDTQYF	In	VDJ	3	158	0.0019868215884512853	0.00222601051015089	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	4	1	2	6	0	4	27	-1	53	40	57			01,02										Vb 17	CASSRTSGRFDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTACTTTCGACGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSLLSTGNQPQHF	In	VDJ	3	158	0.0019868215884512853	0.00222601051015089	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	8	4	4	11	1	27	38	53	49	54			01,02			01,02							Vb 17	CASSLLSTGNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGACTAGCGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSRTSGSYNEQFF	In	VDJ	3	158	0.0019868215884512853	0.00222601051015089	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	1	5	1	2	1	27	38	50	40	51			01,02			01,02							Vb 17	CASSRTSGSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCAGGGACAGCTAACTATGGCTACACCTTCGGTTCG	CASSPGTANYGYTF	In	VDJ	3	158	0.0019868215884512853	0.00222601051015089	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	0	4	0	27	38	-1	42	49			01,02										Vb 17	CASSPGTANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGTTTCGGGCTTACGAGCAGTACTTCGGGCCG		Out	VDJ	3	153	0.001923947487550928		35	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	8	8	0	4	6	1	27	36	46	42	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTCTGGCAGGGGGCTATGGCTACACCTTCGGTTCG	CASSILAGGYGYTF	In	VDJ	3	152	0.0019113726673708567	0.0021414784654616155	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	1	4	5	0	27	41	-1	46	53			01,02										Vb 17	CASSILAGGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGGGGACAGGAATATGGATCCGGGGAGCTGTTTTTTGGAGAA	CASSRGQEYGSGELFF	In	VDJ	3	142	0.0017856244655701423	0.002000591724312825	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	4	6	1	9	27	40	49	41	58			01,02										Vb 17	CASSRGQEYGSGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTTCGGGACGGCGGGCCAAGAGACCCAGTACTTCGGGCCA	CASSFGTAGQETQYF	In	VDJ	2	130	0.0016347266234092853	0.0018315276349342763	45	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	0	7	1	4	6	27	38	47	42	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSFGTAGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSRGLNTEAFF	In	VDJ	2	129	0.0016221518032292139	0.0018174389608193973	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	4	1	7	0	2	0	27	40	-1	42	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSRGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGGACAGGGAGGAGCACTGAAGCTTTCTTTGGACAA	CASSIGGTGRSTEAFF	In	VDJ	2	124	0.0015592777023288567	0.001746995590245002	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	0	3	4	2	5	27	43	54	45	59			01,02										Vb 17	CASSIGGTGRSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACAGGCTAACTATGGCTACACCTTCGGTTCG	CASSIQANYGYTF	In	VDJ	2	123	0.0015467028821487853	0.001732906916130123	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	4	0	0	0	27	-1	-1	42	46			01,02										Vb 17	CASSIQANYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTAAGCGGGACGGACCCTACGAGCAGTACTTCGGGCCG	CASTKRDGPYEQYF	In	VDJ	2	119	0.0014964036014284995	0.0016765522196706068	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	6	3	2	3	5	27	37	47	40	52			01,02										Vb 17	CASTKRDGPYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCGGTCCGGGGGACTGTCTTACGAGCAGTACTTCGGGCCG	CASSRSGGLSYEQYF	In	VDJ	2	118	0.0014838287812484281	0.0016624635455557279	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	0	10	4	9	4	27	38	53	47	57			01,02			01,02							Vb 17	CASSRSGGLSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGACTAGCGGGAGTCCGGCGGAGCAGTACTTCGGGCCG	CASSMTSGSPAEQYF	In	VDJ	2	117	0.0014712539610683567	0.0016483748714408487	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	2	2	7	0	7	27	-1	53	41	60			01,02										Vb 17	CASSMTSGSPAEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATTTCTGGCGGGGGAATAACAATGAGCAGTTCTTCGGGCCA	CASSIDFWRGNNNEQFF	In	VDJ	2	117	0.0014712539610683567	0.0016483748714408487	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	2	5	6	4	27	44	57	50	61			01,02										Vb 17	CASSIDFWRGNNNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCACAGGGAGGCGGCGAGCAGTACTTCGGGCCG	CASSAQGGGEQYF	In	VDJ	2	105	0.0013203561189074997	0.0014793107820623	39	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	5	3	3	6	2	6	27	39	47	41	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAQGGGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTACGCTAGGACTAGCGGGGAAGACAGATACGCAGTATTTTGGCCCA	CASSITLGLAGKTDTQYF	In	VDJ	2	104	0.0013077812987274283	0.0014652221079474211	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	1	3	3	7	3	27	41	60	48	63			01,02										Vb 17	CASSITLGLAGKTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGACAGATCTATGGCTACACCTTCGGTTCG	CASSIGQIYGYTF	In	VDJ	2	103	0.0012952064785473568	0.001451133433832542	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	5	4	1	2	27	41	48	42	50			01,02										Vb 17	CASSIGQIYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCTCGACAGGGGCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPSTGASGANVLTF	In	VDJ	2	102	0.0012826316583672854	0.0014370447597176629	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	2	2	0	5	1	27	39	52	44	53			01,02										Vb 17	CASSPSTGASGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAGCCCGGTTGGCCCGGGAAGGCTACACCTTCGGTTCG	CASSPARLAREGYTF	In	VDJ	2	98	0.0012323323776469997	0.0013806900632581467	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	3	8	15	1	27	39	59	54	60			01,02										Vb 17	CASSPARLAREGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGTGATCTTCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	97	0.0012197575574669282		43	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-04	01	3	2	8	3	3	4	27	41	46	44	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCGGGTTGGCGTGGACTCCCAGCATTTTGGTGAT	CASRRVGVDSQHF	In	VDJ	2	94	0.001182033096926714	0.0013243353667986306	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	6	1	10	11	12	0	27	38	-1	50	55			01,02			01,02							Vb 17	CASRRVGVDSQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD02-01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTGGGCGGGGGATCCGGAAACACCATATATTTTGGAGAG	CASSIVGGGSGNTIYF	In	VDJ	2	93	0.0011694582767466425	0.0013102466926837514	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	1	7	2	4	3	4	27	43	53	46	57			01,02										Vb 17	CASSIVGGGSGNTIYF+TCRBV19-01+TCRBJ01-03	TCRBV19-01	TCRBD02-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGACCAAACCAGGGGCATGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	90	0.0011317338162064282		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	2	0	7	2	27	38	51	45	53			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGACAGGGGGGAAGCGCAGTATTTTGGCCCA	CASDRGEAQYF	In	VDJ	2	89	0.0011191589960263567	0.0012538919962242353	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	2	1	10	0	4	27	-1	45	36	49			01,02										Vb 17	CASDRGEAQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATAGGGCCGGGGGAAAAACTGTTTTTTGGCAGT	CASIGPGEKLFF	In	VDJ	2	88	0.0011065841758462853	0.0012398033221093564	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-04	01	7	8	3	8	6	0	27	37	-1	43	48			01,02										Vb 17	CASIGPGEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD02-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGACGCCGGGTCCTACGAGCAGTACTTCGGGCCG	CASSIDAGSYEQYF	In	VDJ	2	88	0.0011065841758462853	0.0012398033221093564	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	8	4	1	3	0	27	44	-1	47	51			01,02			01,02							Vb 17	CASSIDAGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAATGGCTAGCGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSIMASGSTDTQYF	In	VDJ	2	84	0.0010562848951259998	0.00118344862564984	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	4	4	0	4	0	27	42	-1	46	54			01,02			01,02							Vb 17	CASSIMASGSTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCGACTTTCTGGGTCCCACAATGAGCAGTTCTTCGGGCCA	CASSRLSGSHNEQFF	In	VDJ	1	83	0.0010437100749459284	0.001169359951534961	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	5	1	11	27	39	44	40	55			01,02			01,02							Vb 17	CASSRLSGSHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGAAATCGAGCGGGACGAAGGGGAGATACGCAGTATTTTGGCCCA	CASRNRAGRRGDTQYF	In	VDJ	1	78	9.808359740455712E-4	0.0010989165809605658	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	6	3	5	6	8	27	38	51	44	59			01,02										Vb 17	CASRNRAGRRGDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSMGSGANVLTF	In	VDJ	1	72	9.053870529651426E-4	0.0010143845362712916	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	3	0	9	0	0	0	27	-1	-1	41	44			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSMGSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATCAACAGGGGACAATGAGCAGTTCTTCGGGCCA	CASSISTGDNEQFF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	2	5	3	0	27	42	-1	45	52			01,02										Vb 17	CASSISTGDNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTGACTAGCGGAGCCTACAATGAGCAGTTCTTCGGGCCA	CASSLTSGAYNEQFF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	2	5	2	3	2	27	38	50	41	52			01,02			01,02							Vb 17	CASSLTSGAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGGCCCGGGGGTTGTGGCAGGGGGCGAATCAGCCCCAGCATTTTGGTGAT	CASSMARGLWQGANQPQHF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	4	0	4	16	1	24	38	62	54	63			01,02										Vb 17	CASSMARGLWQGANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGCAGGACGACGAGCAGTACTTCGGGCCG	CASGQDDEQYF	In	VDJ	1	67	8.425129520647854E-4	9.439411656968963E-4	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	8	1	7	5	5	1	27	36	45	41	46			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASGQDDEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCGAGGGGTCCTACGAGCAGTACTTCGGGCCG	CASSEGSYEQYF	In	VDJ	1	67	8.425129520647854E-4	9.439411656968963E-4	36	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	6	5	2	1	2	0	27	38	-1	40	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSEGSYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCCCAGGGGAGGTTAGCTTTCTTTGGACAA	CASSAQGRLAFF	In	VDJ	1	65	8.173633117046427E-4	9.157638174671381E-4	36	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	4	2	10	3	5	27	39	48	42	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSAQGRLAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGAGGGGGCGGCCTCTGAAGCTTTCTTTGGACAA	CASSIEGAASEAFF	In	VDJ	1	61	7.670640309843569E-4	8.59409121007622E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	5	0	6	2	5	27	41	50	43	55			01,02										Vb 17	CASSIEGAASEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAGCGGGTCATGACAGGGGGCGATCACACTGAAGCTTTCTTTGGACAA	CASKRVMTGGDHTEAFF	In	VDJ	1	61	7.670640309843569E-4	8.59409121007622E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	0	3	10	4	27	37	57	47	61			01,02										Vb 17	CASKRVMTGGDHTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAACGGCAGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSITAGSNQPQHF	In	VDJ	1	60	7.544892108042855E-4	8.45320446892743E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	1	4	0	27	42	-1	46	51			01,02										Vb 17	CASSITAGSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTTCATTGGGAACACTGAAGCTTTCTTTGGACAA	CASTFIGNTEAFF	In	VDJ	1	59	7.419143906242141E-4	8.312317727778639E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	7	0	10	1	8	0	27	37	-1	45	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTFIGNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGTTAGTCAGCCCCAGCATTTTGGTGAT	CASSIGVSQPQHF	In	VDJ	1	58	7.293395704441426E-4	8.171430986629848E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	1	0	9	6	0	4	27	-1	46	43	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGVSQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAACGAGGGGCCTAACTTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	55	6.916151099039283E-4		50	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	4	5	2	2	5	8	27	40	50	45	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTACCTTTCGGGACTAGCCTACGAGCAGTACTTCGGGCCG	CASSYLSGLAYEQYF	In	VDJ	1	51	6.413158291836427E-4	7.185223798588314E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	0	8	2	8	0	27	39	-1	47	55			01,02			01,02							Vb 17	CASSYLSGLAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTAGGGGACAGGGCTGGGGGACTGAAGCTTTCTTTGGACAA	CASSIRGQGWGTEAFF	In	VDJ	1	51	6.413158291836427E-4	7.185223798588314E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	3	5	3	7	27	41	53	44	60			01,02										Vb 17	CASSIRGQGWGTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGGCTACCGTCGTGGAGCAGTTCTTCGGGCCA	CASGATVVEQFF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	8	7	0	10	0	10	27	-1	41	36	51			01,02										Vb 17	CASGATVVEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACTCCAAGCCCGGGAGGGGGTGGCTACACCTTCGGTTCG	CASTPSPGGGGYTF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	7	8	0	7	9	2	27	37	54	46	56			01,02										Vb 17	CASTPSPGGGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*02	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAACCCAGCGGGGGTGGCTACACCTTCGGTTCG	CASKPSGGGYTF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	7	6	2	7	5	0	27	37	-1	42	50			01,02										Vb 17	CASKPSGGGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD02-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCCCGCTAGCGGGGGACCCGACCAAGAGACCCAGTACTTCGGGCCA	CASSTPASGGPDQETQYF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	54	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	2	0	6	5	27	40	56	46	61			01,02										Vb 17	CASSTPASGGPDQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGACTAGCGGGAGCGGAGAGCAGTACTTCGGGCCG	CASSPTSGSGEQYF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	2	2	7	3	4	27	38	53	41	57			01,02										Vb 17	CASSPTSGSGEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGACAGGGGGGTCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	46	5.784417282832855E-4		43	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	1	4	3	3	27	39	51	42	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTTCCGACAGGGGGGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	45	5.658669081032141E-4		38	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	1	5	3	2	27	36	48	39	50			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACAGGGTGGGCAGATACGCAGTATTTTGGCCCA	CASSTGWADTQYF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	4	3	4	0	4	27	-1	45	40	49			01,02										Vb 17	CASSTGWADTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGACAGGTTTTGGGACTATGGCTACACCTTCGGTTCG	CASSEDRFWDYGYTF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	4	3	2	7	27	39	48	41	55			01,02										Vb 17	CASSEDRFWDYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCCCGGAGCGACACTGAAGCTTTCTTTGGACAA	CASSIARSDTEAFF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	6	6	3	5	0	27	43	-1	48	52			01,02			01,02							Vb 17	CASSIARSDTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACCCAGGGTCATGGCTACACCTTCGGTTCG	CASSTQGHGYTF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	6	2	2	27	40	47	42	49			01,02										Vb 17	CASSTQGHGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCTCTACCGGGACAGGGGGTACCTACGAGCAGTACTTCGGGCCG	CASTSTGTGGTYEQYF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	1	2	8	2	27	37	56	45	58			01,02										Vb 17	CASTSTGTGGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCGGAAGAGACCCAGTACTTCGGGCCA	CASSSEETQYF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	33	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	8	5	3	1	0	27	39	-1	40	43			01,02			01,02							Vb 17	CASSSEETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGAGGGCAGGGGGCGGACCGGGGAGCTGTTTTTTGGAGAA	CASSEGRGRTGELFF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	4	0	5	5	2	27	39	52	44	54			01,02										Vb 17	CASSEGRGRTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATACTAGCGGGAGGGTTCAATGAGCAGTTCTTCGGGCCA	CASSILAGGFNEQFF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	4	0	6	0	2	27	-1	54	42	56			01,02										Vb 17	CASSILAGGFNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCGCCAGGGGCCCCCTGGAAGCTTTCTTTGGACAA	CAARGPLEAFF	In	VDJ	1	38	4.7784316684271416E-4	5.353696163654039E-4	33	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	11	4	2	8	2	7	27	33	41	35	48			01,02										Vb 17	CAARGPLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACTATGGACAGGTATAATTCACCCCTCCACTTTGGGAAC	CATMDRYNSPLHF	In	VDJ	1	38	4.7784316684271416E-4	5.353696163654039E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	10	1	4	4	4	0	27	34	-1	38	45			01,02										Vb 17	CATMDRYNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAAAATTTCAGGGATATGGTATGGCTACACCTTCGGTTCG	CASKISGIWYGYTF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	4	3	5	6	6	27	37	48	43	54			01,02										Vb 17	CASKISGIWYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGTCCCCACGACTGAAGCTTTCTTTGGACAA	CASSIVPTTEAFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	1	3	7	5	5	1	27	43	50	48	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIVPTTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGTAGCGGGGGGCATAATGAGCAGTTCTTCGGGCCA	CASSIGSGGHNEQFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	5	1	7	1	3	27	43	54	44	57			01,02										Vb 17	CASSIGSGGHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAGAACTAGCGGGGCCTACAATGAACAGTTCTTCGGGCCA	CASSRTSGAYNEQFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	3	3	13	2	11	27	40	52	42	63			01,02										Vb 17	CASSRTSGAYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGAGGGGGGATTATAACTATGGCTACACCTTCGGTTCG	CASRRGDYNYGYTF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-02	01	6	5	1	1	1	5	27	38	45	39	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASRRGDYNYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACGGACAGGGAGGGGTCACCCCTCCACTTTGGGAAC	CASSTDREGSPLHF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	1	3	10	1	5	27	40	49	41	54			01,02										Vb 17	CASSTDREGSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTATCTCTCTCGACGGACAGACATACTATGGCTACACCTTCGGTTCG	CASISLDGQTYYGYTF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	5	3	11	4	27	37	54	48	58			01,02										Vb 17	CASISLDGQTYYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTTTAGGGCTAGCGGGGGTGATGAGCAGTTCTTCGGGCCA	CASSFRASGGDEQFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	4	2	8	7	2	27	39	56	46	58			01,02										Vb 17	CASSFRASGGDEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTACTTTGACAGGGCCTGTAGGGGAGACCCAGTACTTCGGGCCA	CASSTLTGPVGETQYF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	2	3	5	4	9	27	40	51	44	60			01,02										Vb 17	CASSTLTGPVGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAAGACAGGGTGAGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	29	3.646697852220713E-4		46	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	4	3	4	0	5	27	-1	49	44	54			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGGACTCCAGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRTPANTGELFF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	1	10	0	1	4	27	36	42	37	46			01,02			01,02							Vb 17	CASRTPANTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATATTCGGGACTAATTCACCCCTCCACTTTGGGAAC	CASSIFGTNSPLHF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	2	0	7	6	3	0	27	42	-1	45	50			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIFGTNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGAGGGGCCTGTTGGGGCGCAAGCTGGCTACACCTTCGGTTCG	CASSIEGPVGAQAGYTF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	51	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	7	0	7	0	16	27	-1	49	44	65			01,02										Vb 17	CASSIEGPVGAQAGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCCGGGGGGGACAGGTGGGGCCAACGTCCTGATTTTCGGGGCC	CASTPGGTGGANVLIF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-06	01	7	0	4	21	8	18	27	37	53	45	71			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASTPGGTGGANVLIF+TCRBV19-01+TCRBJ02-06	TCRBV19-01		TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCAATCACCCTTTCAAATCAGCCCCAGCATTTTGGTGAT	CASSPITLSNQPQHF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	5	3	7	4	6	7	27	39	47	45	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPITLSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCCGGGACAGGCAAATCAGCCCCAGCATTTTGGTGAT	CASSIPGQANQPQHF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	4	4	3	2	27	41	52	44	54			01,02										Vb 17	CASSIPGQANQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTGAACCGACTTACTCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	3.017956843217142E-4		43	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	2	10	3	8	4	27	38	50	46	54			01,02			01,02							Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCATCTCTCAGGGGGTCGTTAACACCGGGGAGCTGTTTTTTGGAGAA	CAISQGVVNTGELFF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	4	1	2	5	5	27	34	46	39	51			01,02										Vb 17	CAISQGVVNTGELFF+TCRBV19-01+TCRBJ02-02	TCRBV19-01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGCTAAGGCGGGGGGGCGGAATACGCAGTATTTTGGCCCA	CASSIAKAGGRNTQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	1	7	0	7	5	4	27	43	57	48	61			01,02										Vb 17	CASSIAKAGGRNTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGCAAAACTCACAATGAGCAGTTCTTCGGGCCA	CASSIGKTHNEQFF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-01	01	3	9	0	5	1	7	27	41	45	42	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIGKTHNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTATCGGACGGGCGCGCCAGGAGAGACCCAGTACTTCGGGCCA	CASSYRTGAPGETQYF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	48	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-05	01	6	1	7	4	5	12	27	38	47	43	59			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSYRTGAPGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGCCGGGACAGGTCCTATGGCTACACCTTCGGTTCG	CASRDRSYGYTF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	9	0	4	4	2	2	27	35	45	37	47			01,02										Vb 17	CASRDRSYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTCGCCCGGGACAGGGTTATGGCTACACCTTCGGTTCG	CASRPGQGYGYTF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	3	5	5	1	27	36	50	41	51			01,02										Vb 17	CASRPGQGYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGTCGGGACGGGCTGAAGCTTTCTTTGGACAA	CASSGSGRAEAFF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	5	0	7	6	5	3	27	39	49	44	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSGSGRAEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGATAACTTGGGATTCCAAACGAGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	2.3892158342135708E-4		46	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	9	0	8	5	7	12	27	35	46	42	58			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	X+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCTATCAGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSYQSNQPQHF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-05	01	6	4	5	1	4	0	27	38	-1	42	45			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSYQSNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACAGGGGTGGTAATGAAAAACTGTTTTTTGGCAGT	CASNRGGNEKLFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	39	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	3	2	4	0	3	27	-1	44	37	47			01,02										Vb 17	CASNRGGNEKLFF+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCCGCTGGGACCACTTTACGAGCAGTACTTCGGGCCG	CASSPLGPLYEQYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-07	01	6	0	7	4	6	5	27	38	49	44	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSPLGPLYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCACCCGCAGGGGGCAAGAGACCCAGTACTTCGGGCCA	CATRRGQETQYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	10	4	1	2	4	0	27	34	-1	38	45			01,02										Vb 17	CATRRGQETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGTAACTAGCGGGAGCTTTGAGACCCAGTACTTCGGGCCA	CASSVTSGSFETQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	45	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	5	3	2	5	3	4	27	39	53	42	57			01,02										Vb 17	CASSVTSGSFETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAAGGAAGGAAGGGGGCGGAGTACTGAAGCTTTCTTTGGACAA	CASSKEGRGRSTEAFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	48	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	5	0	5	8	5	27	40	55	48	60			01,02										Vb 17	CASSKEGRGRSTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCATACCGGGACTAGCGGGAGAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	15	1.8862230270107137E-4		46	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	0	2	7	2	0	27	42	-1	44	58			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCAGAGGGATCGGTGAGGGCAGGGGGTTAAATCAGCCCCAGCATTTTGGTGAT	CASSRGIGEGRGLNQPQHF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	57	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	4	1	4	18	3	24	35	60	53	63			01,02										Vb 17	CASSRGIGEGRGLNQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGAGACTCAAGGGTACAGAGGGGCTACACCTTCGGTTCG	CASRDSRVQRGYTF	In	VDJ	3	188	0.002364066193853428	0.002648670733597261	42	TCRBV25	TCRBV25-01	01				TCRBJ01	TCRBJ01-02	01	6	3	5	8	12	3	23	34	50	46	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASRDSRVQRGYTF+TCRBV25-01+TCRBJ01-02	TCRBV25-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGACAGGATTCCTACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	115	0.0014461043207082138		43	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	4	2	0	7	23	-1	41	37	48													Vb 11	X+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGAGAAGCTATCCGAGCAGTACTTCGGGCCG	CASSEEKLSEQYF	In	VDJ	2	111	0.001395805039987928	0.0015638428267515745	39	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	4	9	6	6	2	23	38	47	44	49						01,02							Vb 11	CASSEEKLSEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGTACCGAAGATTCGGGGGTAAATTTCATGGGCTACGAGCAGTACTTCGGGCCG	CASTEDSGVNFMGYEQYF	In	VDJ	1	69	8.676625924249283E-4	9.721185139266544E-4	54	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	9	8	2	3	11	13	23	31	48	42	61													Vb 11	CASTEDSGVNFMGYEQYF+TCRBV25-01+TCRBJ02-07	TCRBV25-01*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTCCCCACGCGGCAGTAAATCGATCCGGAAACACCATATATTTTGGAGAG	CASSPHAAVNRSGNTIYF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	54	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	7	5	4	6	14	23	35	45	41	59						01,02							Vb 11	CASSPHAAVNRSGNTIYF+TCRBV25-01+TCRBJ01-03	TCRBV25-01*01	TCRBD02-01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCACCTACCGGGAAGAGACCCAGTACTTCGGGCCA	CASTYREETQYF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	36	TCRBV25	TCRBV25-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	7	8	4	3	5	0	23	33	-1	38	42						01,02							Vb 11	CASTYREETQYF+TCRBV25-01+TCRBJ02-05	TCRBV25-01*01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCGGGGGGCTATACATGGACAATGAGCAGTTCTTCGGGCCA	CASGGLYMDNEQFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	42	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-01	01	8	6	0	5	1	9	23	32	39	33	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASGGLYMDNEQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTATAAGACGAAAACTGGACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	29	3.646697852220713E-4		56	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	1	6	5	14	5	23	35	54	49	59													Vb 11	X+TCRBV25-01+TCRBJ02-06	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGAGACGACAGCCAACACTGAAGCTTTCTTTGGACAA	CASSEETTANTEAFF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	2	5	2	5	2	23	38	48	43	50													Vb 11	CASSEETTANTEAFF+TCRBV25-01+TCRBJ01-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAACTCGGCAGGGCGCAGTTCTTCGGGCCA	CASSELGRAQFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	36	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	4	3	12	5	1	23	38	48	43	49													Vb 11	CASSELGRAQFF+TCRBV25-01+TCRBJ02-01	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCCTATCGAGGGGGCGACTAATGAAAAACTGTTTTTTGGCAGT	CASSPIEGATNEKLFF	In	VDJ	1	76	9.556863336854283E-4	0.0010707392327308077	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	5	0	2	6	1	23	36	49	42	50													Vb 7.1	CASSPIEGATNEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGGGAGAATTACTTACGAGCAGTACTTCGGGCCG	CASSQGRITYEQYF	In	VDJ	1	66	8.299381318847141E-4	9.298524915820172E-4	42	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	1	10	2	4	0	7	23	-1	43	39	50													Vb 7.1	CASSQGRITYEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCGTAAGGGGCCGGAGGGCGGCAATCAGCCCCAGCATTTTGGTGAT	CASSRKGPEGGNQPQHF	In	VDJ	1	59	7.419143906242141E-4	8.312317727778639E-4	51	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	4	10	0	2	10	2	23	36	52	46	54													Vb 7.1	CASSRKGPEGGNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGACGGACAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSQDGQGNQPQHF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	45	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	1	4	2	1	0	23	40	-1	41	48													Vb 7.1	CASSQDGQGNQPQHF+TCRBV04-01+TCRBJ01-05	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGTTAGCGGGGGCCTGGGGGAGCAGTACTTCGGGCCG	CASSQVSGGLGEQYF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	45	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	5	2	7	1	7	23	39	49	40	56													Vb 7.1	CASSQVSGGLGEQYF+TCRBV04-01+TCRBJ02-07	TCRBV04-01*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAACCCACGCAGAACAGCAAGAGGGCCCACCATATATTTTGGAGAG		Out	VDJ	1	21	2.6407122378149995E-4		52	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	2	11	0	9	17	2	23	38	60	55	62													Vb 7.1	X+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTCCCTCCCAGACATCTGTATACTTCTGTGCCAGCAGCGGGACGGTTCTCGAGCAGTACTTCGGGCCG	CASSGTVLEQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	36	TCRBV06	TCRBV06-09	01				TCRBJ02	TCRBJ02-07	01	6	0	7	6	1	6	26	37	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 13.1	CASSGTVLEQYF+TCRBV06-09+TCRBJ02-07	TCRBV06-09*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGCCACCAACCAGGGGTGGGACAGGGATTTAGTATTAGGGACTAGGTGACGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	80	0.001005985614405714		70	TCRBV10	TCRBV10-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	0	3	6	12	25	-1	5	26	17	51			01,02										Vb 12	X+TCRBV10-01+TCRBJ02-02	TCRBV10-01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAGCCCCCGGGGCGGCTCGGACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	53	6.664654695437856E-4		46	TCRBV10	TCRBV10-01					TCRBJ02	TCRBJ02-03	01	6	7	0	3	5	7	26	37	47	42	54			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	X+TCRBV10-01+TCRBJ02-03	TCRBV10-01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGGGCGGAGCCGCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	29	3.646697852220713E-4		34	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	9	7	5	3	1	5	26	34	39	35	44			01,02			01,02							Vb 12	X+TCRBV10-01+TCRBJ02-07	TCRBV10-01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTTTTTGATCCCCGGGGGACCAGAAAACATTCAGTACTTCGGCGCC	CASSFLIPGGPENIQYF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	51	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	8	2	5	8	5	22	37	51	45	56														CASSFLIPGGPENIQYF+TCRBV12-01+TCRBJ02-04	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGATCCGGAGGGGGTTCTGCGAATTCACCCCTCCACTTTGGGAAC	CATSRSGGGSANSPLHF	In	VDJ	56	3146	0.039560384286504706	0.04432296876540949	51	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-06	01	2	5	1	7	5	7	18	33	44	38	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRSGGGSANSPLHF+TCRBV15-01+TCRBJ01-06	TCRBV15-01*01		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACAAGGAAGCCCAGCCCCAGCATTTTGGTGAT	CATSRDKEAQPQHF	In	VDJ	27	1515	0.019050852572808207	0.021344341284041758	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	0	1	8	7	3	4	18	35	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDKEAQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCGGGGGTTCCTTTGACACTGAAGCTTTCTTTGGACAA	CATSGGSFDTEAFF	In	VDJ	18	981	0.012335898596650068	0.013820989306696346	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	5	6	1	3	0	8	18	-1	35	30	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGGSFDTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCATGGGGGAGGGAGGCCCAATAAATCAGCCCCAGCATTTTGGTGAT	CATMGEGGPINQPQHF	In	VDJ	2	97	0.0012197575574669282	0.0013666013891432678	48	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	7	9	0	4	3	10	18	28	38	31	48														CATMGEGGPINQPQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD02-01*02	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGCGACCGACTAGCGATCACCCGGTAGTTCTTCGGGCCA		Out	VDJ	1	54	6.79040289723857E-4		47	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	1	2	6	14	5	10	18	34	47	39	57						01,02								X+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTTACAGGGGGCGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	46	5.784417282832855E-4		47	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	0	2	2	0	18	34	-1	36	45														X+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGACCGGGGGACCGGGGAGACCCAGTACTTCGGGCCA	CATSRDRGTGETQYF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	0	8	2	5	1	6	18	35	42	36	48														CATSRDRGTGETQYF+TCRBV15-01+TCRBJ02-05	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGGGCCGGGACAGGGTCAAGTGGCTACACCTTCGGTTCG	CATSRAGTGSSGYTF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	3	7	4	5	18	32	45	36	50														CATSRAGTGSSGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGATCCGGACACCTCTCTGGAAACACCATATATTTTGGAGAG	CATRSGHLSGNTIYF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	6	0	4	3	18	29	38	33	41														CATRSGHLSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGGGGAAGGGCAATGAGCAGTTCTTCGGGCCA	CATSREGKGNEQFF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	0	0	8	6	1	4	18	35	40	36	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSREGKGNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGAGACAGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CATSRDRRQGYTGELFF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	2	2	3	5	1	18	35	48	40	49														CATSRDRRQGYTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGACGGACAGGGAACACCGGAGAGCTGTTTTTTGGAGAA	CATSRDRRTGNTGELFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	51	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	1	3	11	5	9	18	35	48	40	57														CATSRDRRTGNTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCACGGCCTCACGGCCCAGCATTTTGGTGAT	CATSRDHGLTAQHF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-05	01	0	9	0	11	4	7	18	35	42	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDHGLTAQHF+TCRBV15-01+TCRBJ01-05	TCRBV15-01*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGAGGGACAGGGGGCGCGGAGACCCAGTACTTCGGGCCA	CASSQGGTGGAETQYF	In	VDJ	18	1013	0.012738292842412353	0.014271826878372477	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	1	0	0	5	2	3	23	39	53	41	56	TCRBV01,TCRBV04													CASSQGGTGGAETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTCTCCGGGACACCCGACTTGTACTTCGGGCCG	CASSLSGTPDLYF	In	VDJ	15	855	0.010751471253961068	0.012045816368221586	39	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	12	5	8	26	39	50	44	58		TCRBV03-01,TCRBV03-02												CASSLSGTPDLYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCGCGGCGAGGGCTAACCTACAATGAGCAGTTCTTCGGGCCA	CATSSRRGLTYNEQFF	In	VDJ	9	527	0.006626930234897641	0.007424731258541259	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	11	0	2	7	4	24	36	48	43	52		TCRBV24-01,TCRBV24-or09_02												CATSSRRGLTYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYRGRRGACWCAGCMMKGTAYTTCTGTGCCAGCACCACGCGCGGGGGCTTGGACACTGAAGCTTTCTTTGGACAA	CASTTRGGLDTEAFF	In	VDJ	8	425	0.0053442985765303555	0.005987686498823596	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	10	7	2	3	9	5	24	31	47	40	52	TCRBV02,TCRBV21													CASTTRGGLDTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCCCTAGACTAGCGGGAGGGGGAAGCACAGATACGCAGTATTTTGGCCCA	CASPRLAGGGSTDTQYF	In	VDJ	6	330	0.004149690659423571	0.004649262457910086	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	2	0	0	4	3	18	27	45	31	48	TCRBV07,TCRBV11													CASPRLAGGGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGGAGCGGGAGGCCCCTACAATGAGCAGTTCTTCGGGCCA	CATSDLGAGGPYNEQFF	In	VDJ	6	322	0.004049092097982999	0.004536553064991054	51	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	6	1	2	2	2	24	42	53	44	55		TCRBV24-01,TCRBV24-or09_02												CATSDLGAGGPYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCTGGTGGCAGGGGGCTTGGTGGAGATACGCAGTATTTTGGCCCA	CASSQAGGRGLGGDTQYF	In	VDJ	5	304	0.0038227453347417133	0.004282956930923231	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	1	4	0	5	7	7	23	39	54	46	61	TCRBV01,TCRBV04													CASSQAGGRGLGGDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGTTGGCTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQGWLNTGELFF	In	VDJ	5	278	0.003495800010059856	0.003916651403936376	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	9	0	2	3	2	26	42	48	45	50		TCRBV03-01,TCRBV03-02												CASSQGWLNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCCTGCTGGCGGAGGCAGCCAAAAACATTCAGTACTTCGGCGCC	CSAPLLAEAAKNIQYF	In	VDJ	4	245	0.003080830944117499	0.003451725158145367	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-04	01	5	10	1	0	11	1	26	35	51	46	52		TCRBV20-01,TCRBV20-or09_02												CSAPLLAEAAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD02-01*02	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATCGGGGACCTGGGGGGAGACCCAGTACTTCGGGCCA	CASSLSGTWGETQYF	In	VDJ	4	233	0.002929933101956642	0.0032826610687668183	45							TCRBJ02	TCRBJ02-05	01	6	0	7	5	6	7	24	36	47	42	54	TCRBV24,TCRBV27	TCRBV24-01,TCRBV24-or09_02,TCRBV27-01		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGTWGETQYF+X+TCRBJ02-05			TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATACAGGGGGCCCCGTAATTCACCCCTCCACTTTGGGAAC	CASSLYRGPRNSPLHF	In	VDJ	4	233	0.002929933101956642	0.0032826610687668183	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	3	0	6	4	4	24	36	49	40	53	TCRBV24,TCRBV27													CASSLYRGPRNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGACAGGGTCTGGCTACACCTTCGGTTCG	CSATGTGSGYTF	In	VDJ	4	231	0.002904783461596499	0.0032544837205370604	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	7	2	2	26	36	47	38	49		TCRBV20-01,TCRBV20-or09_02												CSATGTGSGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATGTGGGTAGCGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSQDVGSGGSYEQYF	In	VDJ	4	225	0.0028293345405160705	0.003169951675847786	51	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	0	6	0	23	40	-1	46	55	TCRBV04,TCRBV23													CASSQDVGSGGSYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGCTCGGGAGCGAACACTGAAGCTTTCTTTGGACAA	CASSQEGSGANTEAFF	In	VDJ	4	208	0.0026155625974548565	0.0029304442158948423	48	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	2	1	5	1	26	43	54	48	55		TCRBV03-01,TCRBV03-02												CASSQEGSGANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGACGACAGCCAATTCACCCCTCCACTTTGGGAAC	CSARTTANSPLHF	In	VDJ	3	194	0.0024395151149338564	0.0027332027782865356	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	2	5	7	3	2	26	37	45	40	47		TCRBV20-01,TCRBV20-or09_02												CSARTTANSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATGACATAGGTGGGGCCGCCGGGAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	186	0.002338916553493285		47	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	7	0	5	11	7	26	34	50	45	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAAAAGACTAGCGGGAAGGTGTCGGGGAGCTGTTTTTTGGAGAA	CSVKD*REGVGELFF	Stop	VDJ	3	180	0.0022634676324128564		45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	2	3	7	5	6	26	33	49	38	55		TCRBV20-01,TCRBV20-or09_02												CSVKD*REGVGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGAATACCGACAGGGGAAGAGGAGAGACCCAGTACTTCGGGCCA	CATSDPNTDRGRGETQYF	In	VDJ	3	176	0.0022131683516925706	0.0024796066442187127	54	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	2	2	4	9	6	24	39	56	48	62		TCRBV24-01,TCRBV24-or09_02												CATSDPNTDRGRGETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACTGCCCACCTAGCGGGAGGGACCTACAATGAGCAGTTCTTCGGGCCA	CATAHLAGGTYNEQFF	In	VDJ	3	164	0.002062270509531714	0.002310542554840164	48	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	10	4	0	2	7	1	24	32	51	39	52		TCRBV24-01,TCRBV24-or09_02												CATAHLAGGTYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGACGGGAGTTCTTCGGGCCA	CASSQEGREFF	In	VDJ	3	162	0.002037120869171571	0.002282365206610406	33	TCRBV03						TCRBJ02	TCRBJ02-01	01	0	1	7	14	1	3	26	43	48	44	51		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGREFF+TCRBV03-X+TCRBJ02-01	TCRBV03		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACGCTCCTCCACAGATACGCAGTATTTTGGCCCA	CASRRSSTDTQYF	In	VDJ	3	161	0.0020245460489914996	0.002268276532495527	39	TCRBV03						TCRBJ02	TCRBJ02-03	01	6	3	7	2	0	7	26	-1	39	37	46		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRSSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGACTTCGTTGACTGAAGCTTTCTTTGGACAA	CASSQATSLTEAFF	In	VDJ	3	153	0.001923947487550928	0.0021555671395764946	42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	2	10	5	1	6	26	42	47	43	53		TCRBV03-01,TCRBV03-02				01,02								CASSQATSLTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATCGGGACTAGCGGGAGGAACGGGGGAGCTGTTTTTTGGAGAA	CSASGLAGGTGELFF	In	VDJ	3	148	0.001861073386650571	0.0020851237690020993	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	6	0	1	8	3	4	26	34	52	37	56		TCRBV20-01,TCRBV20-or09_02												CSASGLAGGTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCTGAAGGCGGGGTCTTTTTACAATGAGCAGTTCTTCGGGCCA	CSALKAGSFYNEQFF	In	VDJ	2	138	0.0017353251848498566	0.0019442370278533088	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	7	3	4	6	6	26	35	47	41	53		TCRBV20-01,TCRBV20-or09_02												CSALKAGSFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTATTTTTGGGCGGTGAGCAGTTCTTCGGGCCA	CASSLFLGGEQFF	In	VDJ	2	137	0.0017227503646697851	0.0019301483537384296	39	unresolved						TCRBJ02	TCRBJ02-01	01	6	8	0	9	8	2	24	36	48	44	50	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLFLGGEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGATCCCAACCCCCCCAATGAGCAGTTCTTCGGGCCA	CSARDPNPPNEQFF	In	VDJ	2	137	0.0017227503646697851	0.0019301483537384296	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	1	8	6	0	12	26	-1	40	37	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPNPPNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACCACCATTCCTACGAGCAGTACTTCGGGCCG	CASSQDHHSYEQYF	In	VDJ	2	134	0.0016850259041295708	0.0018878823313937926	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	0	3	7	1	2	3	26	43	47	45	50		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDHHSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAAAGGGGCTCATTTTTGGCATCATCAGCCCCAGCATTTTGGTGAT	CASSKGAHFWHHQPQHF	In	VDJ	2	134	0.0016850259041295708	0.0018878823313937926	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	8	0	5	0	14	26	-1	46	42	60		TCRBV03-01,TCRBV03-02												CASSKGAHFWHHQPQHF+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCTCCCCGGAGGGACCTACGAGCAGTACTTCGGGCCG	CASSLPGGTYEQYF	In	VDJ	2	134	0.0016850259041295708	0.0018878823313937926	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	10	0	2	6	1	26	38	50	44	51		TCRBV12-03,TCRBV12-04												CASSLPGGTYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTTATGAACGAGGGGCGGTCACCCCTCCACTTTGGGAAC	CSVMNEGRSPLHF	In	VDJ	2	132	0.0016598762637694282	0.0018597049831640343	39	TCRBV20						TCRBJ01	TCRBJ01-06	01	7	5	2	10	9	3	26	33	47	42	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVMNEGRSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGGCCTAGCGGTGCACAGATACGCAGTATTTTGGCCCA	CASSQAA*RCTDTQYF	Stop	VDJ	2	131	0.0016473014435893568		48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	5	1	4	1	26	42	53	46	54		TCRBV03-01,TCRBV03-02				01,02								CASSQAA*RCTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCACCAGTGAGCCGGGACTAGGGTCGTTCACCGGGGAGCTGTTTTTTGGAGAA	CVTSEPGLGSFTGELFF	In	VDJ	2	128	0.0016095769830491425	0.0018033502867045182	51	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	0	8	4	3	7	24	38	49	41	56		TCRBV24-01,TCRBV24-or09_02				01,02								CVTSEPGLGSFTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCACTGGCGGGGCCCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDPLAGPSYNEQFF	In	VDJ	2	126	0.0015844273426889996	0.0017751729384747601	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	3	0	7	2	24	38	51	45	53		TCRBV24-01,TCRBV24-or09_02												CATSDPLAGPSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACCGGGACCCCAGGGAGACCCAGTACTTCGGGCCA	CASSYRDPRETQYF	In	VDJ	2	125	0.0015718525225089282	0.001761084264359881	42	TCRBV24						TCRBJ02	TCRBJ02-05	01	6	0	7	5	4	6	24	36	45	40	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYRDPRETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCATGCGGACACAAGAGACCCAGTACTTCGGGCCA	CSAMRTQETQYF	In	VDJ	2	125	0.0015718525225089282	0.001761084264359881	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	6	2	5	0	26	34	-1	39	44		TCRBV20-01,TCRBV20-or09_02												CSAMRTQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCACCGGCGACAGGCAGCCCTACGAGCAGTACTTCGGGCCG	CTGDRQPYEQYF	In	VDJ	2	121	0.0015215532417886424	0.0017047295679003649	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	4	2	5	4	26	30	41	35	45		TCRBV20-01,TCRBV20-or09_02												CTGDRQPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGATGGGACAGGGGTTTGGCTACACCTTCGGTTCG	CASSLMGQGFGYTF	In	VDJ	2	117	0.0014712539610683567	0.0016483748714408487	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	0	2	7	3	2	18	32	45	35	47	TCRBV05,TCRBV11													CASSLMGQGFGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCTAACCCCCGGGACAGGGGGAAACTACGAGCAGTACTTCGGGCCG	CASSLTPGTGGNYEQYF	In	VDJ	2	114	0.0014335295005281424	0.0016061088490962115	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	1	3	9	3	23	35	55	44	58	TCRBV09,TCRBV12													CASSLTPGTGGNYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCCGACTAGCGGGGGGGTTAATGAGCAGTTCTTCGGGCCA	CASSPTSGGVNEQFF	In	VDJ	2	113	0.001420954680348071	0.0015920201749813326	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	2	0	7	2	2	19	31	47	33	49	TCRBV05,TCRBV07													CASSPTSGGVNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGGGGGGAGCACGAGCAGTACTTCGGGCCG	CASRGEHEQYF	In	VDJ	2	111	0.001395805039987928	0.0015638428267515745	33	TCRBV03						TCRBJ02	TCRBJ02-07	01	6	6	1	5	0	3	26	-1	42	37	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGEHEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTATCCAGGCTAGACTCTGGAAACACCATATATTTTGGAGAG	CSVSRLDSGNTIYF	In	VDJ	2	110	0.0013832302198078566	0.0015497541526366954	42	TCRBV20						TCRBJ01	TCRBJ01-03	01	7	4	4	0	4	5	26	33	41	37	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSVSRLDSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCGAAGACTAGCGGTTCAGATACGCAGTATTTTGGCCCA	CSARDPKTSGSDTQYF	In	VDJ	2	110	0.0013832302198078566	0.0015497541526366954	48	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	2	5	4	6	2	26	40	55	46	57		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDPKTSGSDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCACGTCGGGACTAGCGGGGGGGTTCACAGATACGCAGTATTTTGGCCCA	CATSGLAGGFTDTQYF	In	VDJ	2	110	0.0013832302198078566	0.0015497541526366954	48	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	0	0	2	4	2	26	33	53	37	55		TCRBV03-01,TCRBV03-02												CATSGLAGGFTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGCGGGACTAGCGGGGGACTTGGAGCAGTTCTTCGGGCCA	CATSDAGLAGDLEQFF	In	VDJ	2	107	0.0013455057592676426	0.0015074881302920581	48	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	0	2	10	2	5	24	39	55	41	60		TCRBV24-01,TCRBV24-or09_02												CATSDAGLAGDLEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGAACGCGGGAATAACTATGGCTACACCTTCGGTTCG	CAISERGNNYGYTF	In	VDJ	2	106	0.0013329309390875711	0.0014933994561771792	42				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	7	3	1	1	1	23	38	45	39	46	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-08,TCRBV10-03												CAISERGNNYGYTF+X+TCRBJ01-02		TCRBD02-01*02	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGACAGGATCGAACACTGAAGCTTTCTTTGGACAA	CASSQEGTGSNTEAFF	In	VDJ	2	106	0.0013329309390875711	0.0014933994561771792	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	4	1	1	3	26	43	52	44	55		TCRBV03-01,TCRBV03-02												CASSQEGTGSNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAGGGAAGCCTGAACACTGAAGCTTTCTTTGGACAA	CASSQEGSLNTEAFF	In	VDJ	2	103	0.0012952064785473568	0.001451133433832542	45	unresolved						TCRBJ01	TCRBJ01-01	01	0	0	8	0	0	4	23	-1	44	40	48	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGSLNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGCCGCACCGGGGCTACACCTTCGGTTCG	CSARDGPHRGYTF	In	VDJ	2	102	0.0012826316583672854	0.0014370447597176629	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	8	0	8	1	8	26	40	45	41	53		TCRBV20-01,TCRBV20-or09_02												CSARDGPHRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGACATTCTACAATGAGCAGTTCTTCGGGCCA	CSARDRTFYNEQFF	In	VDJ	2	102	0.0012826316583672854	0.0014370447597176629	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	0	1	6	3	2	2	26	40	47	42	49		TCRBV20-01,TCRBV20-or09_02												CSARDRTFYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCCTCGGGACTAGCGCATCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASLGTSASNTGELFF	In	VDJ	2	102	0.0012826316583672854	0.0014370447597176629	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	8	0	6	0	3	3	26	35	48	38	51		TCRBV03-01,TCRBV03-02				01,02								CASLGTSASNTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCGAGGACAGGATGACTTCACTGAAGCTTTCTTTGGACAA	CASSRGQDDFTEAFF	In	VDJ	2	101	0.001270056838187214	0.001422956085602784	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	4	4	2	7	23	36	45	38	52	TCRBV01,TCRBV04													CASSRGQDDFTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCCCCGGGAGGGAGGCACATCCGCTATGGCTACACCTTCGGTTCG	CASSSPGGRHIRYGYTF	In	VDJ	2	101	0.001270056838187214	0.001422956085602784	51	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	5	8	0	4	4	11	26	38	50	42	61		TCRBV03-01,TCRBV03-02												CASSSPGGRHIRYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD02-01*02	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGCGGACAGGGGTTGGAAACACCATATATTTTGGAGAG	CSARTGVGNTIYF	In	VDJ	2	100	0.0012574820180071425	0.0014088674114879048	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	2	3	2	1	26	34	45	36	46		TCRBV20-01,TCRBV20-or09_02												CSARTGVGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGAGCAGGGGTAAACATTCAGTACTTCGGCGCC		Out	VDJ	2	99	0.001244907197827071		43	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	2	6	4	1	26	42	52	46	53		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-04	TCRBV03	TCRBD01-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGTCGCGGGGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSLASRGGSYNEQFF	In	VDJ	2	98	0.0012323323776469997	0.0013806900632581467	51				TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	1	3	1	18	35	47	38	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLASRGGSYNEQFF+X+TCRBJ02-01		TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCTAGGAGGTGGAGAGACCCAGTACTTCGGGCCA	CSASLGGGETQYF	In	VDJ	2	98	0.0012323323776469997	0.0013806900632581467	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	10	1	4	4	3	26	37	46	41	49		TCRBV20-01,TCRBV20-or09_02												CSASLGGGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGTCGCACCGGGGCTACACCTTCGGTTCG	CSARDGSHRGYTF	In	VDJ	2	98	0.0012323323776469997	0.0013806900632581467	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	0	9	8	1	9	26	40	44	41	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDGSHRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCGACAGGGAAGAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRQGRTNEKLFF	In	VDJ	2	96	0.0012071827372868568	0.0013525127150283887	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	7	2	3	1	2	3	24	35	44	37	47		TCRBV24-01,TCRBV24-or09_02												CASSRQGRTNEKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCCTAATAGGCCCAGGGGGGAACCGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	96	0.0012071827372868568		53	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	4	1	8	12	5	26	40	59	52	64		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCCGACAGTAAGGAGGTACGAGCAGTACTTCGGGCCG	CASSPTVRRYEQYF	In	VDJ	2	95	0.0011946079171067854	0.0013384240409135097	42	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	2	5	4	3	8	24	35	43	38	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTVRRYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTGGAAGGGGGCCCAAGAGACCCAGTATTTCGGGCCA	CSARDWKGAQETQYF	In	VDJ	2	95	0.0011946079171067854	0.0013384240409135097	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02			0	5	0	19	5	16	26	40	52	45	68		TCRBV20-01,TCRBV20-or09_02						TCRBJ02-01,TCRBJ02-05						CSARDWKGAQETQYF+TCRBV20-X+TCRBJ02-X	TCRBV20	TCRBD01-01*01	TCRBJ02	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTCGCGGGAGGGCTTTACAATGAGCAGTTCTTCGGGCCA	CASSFAGGLYNEQFF	In	VDJ	2	94	0.001182033096926714	0.0013243353667986306	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	7	0	4	1	3	18	32	42	33	45	TCRBV07,TCRBV11													CASSFAGGLYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGGAACACTGGGTTGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	94	0.001182033096926714		50	TCRBV24						TCRBJ02	TCRBJ02-07	01	3	0	9	0	8	5	24	39	50	47	55		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCCTTTTCCATTCGTGGCTACACCTTCGGTTCG	CSARPFSIRGYTF	In	VDJ	2	93	0.0011694582767466425	0.0013102466926837514	39	TCRBV20						TCRBJ01	TCRBJ01-02	01	2	4	6	7	8	4	26	38	48	46	52		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARPFSIRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCACGGGGGCAGGGGGAGAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	2	91	0.0011443086363864996		53				TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	1	3	9	3	18	35	51	44	54	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-05		TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCAGGGCTCCTACGAGCAGTACTTCGGGCCG	CSASQGSYEQYF	In	VDJ	2	89	0.0011191589960263567	0.0012538919962242353	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	3	0	1	0	26	37	-1	38	43		TCRBV20-01,TCRBV20-or09_02												CSASQGSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCTCCGGACAGGATAATCAAAAACATTCAGTACTTCGGCGCC	CSAPPDRIIKNIQYF	In	VDJ	2	89	0.0011191589960263567	0.0012538919962242353	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	6	1	4	3	6	5	26	34	47	40	52		TCRBV20-01,TCRBV20-or09_02												CSAPPDRIIKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGAGCGGGGGCCTACGAGCAGTACTTCGGGCCG	CASSQGAGAYEQYF	In	VDJ	2	89	0.0011191589960263567	0.0012538919962242353	42	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	6	2	2	1	0	26	42	-1	43	51		TCRBV03-01,TCRBV03-02												CASSQGAGAYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACCTGGGGACGGAATATCCTACGAGTAGTACTTCGGGCCG	CASRPGDGISYE*YF	Stop	VDJ	2	87	0.0010940093556662139		45	TCRBV24						TCRBJ02	TCRBJ02-07	01	7	0	7	11	5	16	24	35	45	40	61		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPGDGISYE*YF+TCRBV24-X+TCRBJ02-07	TCRBV24		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTTTCCGGGACAGGAGTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFSGTGVSGANVLTF	In	VDJ	2	86	0.0010814345354861424	0.001211625973879598	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	3	0	4	0	4	3	18	32	44	36	47	TCRBV05,TCRBV11													CASSFSGTGVSGANVLTF+X+TCRBJ02-06	unresolved	TCRBD01-01*01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACCGATGATGGAGAACTACGAGCAGTACTTCGGGCCG	CSARPMMENYEQYF	In	VDJ	2	86	0.0010814345354861424	0.001211625973879598	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	2	10	2	3	8	2	26	38	50	46	52		TCRBV20-01,TCRBV20-or09_02												CSARPMMENYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCCCAACGAGGGGCGAGCTTTCTTTGGACAA	CSARDPNEGRAFF	In	VDJ	2	85	0.0010688597153060712	0.0011975372997647192	39	TCRBV20						TCRBJ01	TCRBJ01-01	01	0	5	2	10	8	2	26	40	53	48	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDPNEGRAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAGGACCACACAGATACGCAGTATTTTGGCCCA	CSAEDHTDTQYF	In	VDJ	2	84	0.0010562848951259998	0.00118344862564984	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	1	7	2	2	2	26	35	41	37	43		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEDHTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTTCGATCTAAGGACAGGGTGGTTGGCTACACCTTCGGTTCG	CASSLRSKDRVVGYTF	In	VDJ	1	83	0.0010437100749459284	0.001169359951534961	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	1	3	7	11	4	24	36	55	47	59		TCRBV24-01,TCRBV24-or09_02												CASSLRSKDRVVGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGTCTAGCGACCCTTGGGAATGAGCAGTTCTTCGGGCCA	CSAGLATLGNEQFF	In	VDJ	1	83	0.0010437100749459284	0.001169359951534961	42	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	6	7	3	9	26	35	44	38	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSAGLATLGNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAAAATAAAGTCGGGCTTAAAGCAGTTCTTCGGGCCA		Out	VDJ	1	83	0.0010437100749459284		40	TCRBV20						TCRBJ02	TCRBJ02-01	01	5	8	0	11	12	4	26	35	51	47	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGCGGGACATGGCGATACGAGCAGTACTTCGGGCCG	CASSRGTWRYEQYF	In	VDJ	1	83	0.0010437100749459284	0.001169359951534961	42	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	0	6	4	2	6	26	39	47	41	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRGTWRYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTAGGGACAGGGTTCTACGAGCAGTACTTCGGGCCG	CASSLGTGFYEQYF	In	VDJ	1	81	0.0010185604345857855	0.001141182603305203	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	3	3	0	2	26	-1	50	42	52		TCRBV12-03,TCRBV12-04												CASSLGTGFYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGACACCCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSGHPNTGELFF	In	VDJ	1	79	9.934107942256426E-4	0.001113005255075445	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	6	0	0	2	24	-1	41	37	43		TCRBV24-01,TCRBV24-or09_02												CATSGHPNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCTCTAGCAGCAGCACAGATACGCAGTATTTTGGCCCA	CSARASSSSTDTQYF	In	VDJ	1	79	9.934107942256426E-4	0.001113005255075445	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	4	7	0	3	3	26	39	47	42	50		TCRBV20-01,TCRBV20-or09_02				01,02								CSARASSSSTDTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCAACGATAGACAGGCCGAAGCTTTCTTTGGACAA	CASSNDRQAEAFF	In	VDJ	1	78	9.808359740455712E-4	0.0010989165809605658	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	4	8	8	2	22	33	47	41	49		TCRBV12-03,TCRBV12-04												CASSNDRQAEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTACAGGGGCAACACTGAAGCTTTCTTTGGACAA	CSAYRGNTEAFF	In	VDJ	1	78	9.808359740455712E-4	0.0010989165809605658	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	2	2	1	1	26	35	43	36	44		TCRBV20-01,TCRBV20-or09_02												CSAYRGNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATGACCTCGTACCCCCGACGGCAGACCCAGTACTTCGGGCCA	CSAMTSYPRRQTQYF	In	VDJ	1	78	9.808359740455712E-4	0.0010989165809605658	45	TCRBV20						TCRBJ02	TCRBJ02-05	01	4	2	7	6	1	17	26	36	40	37	57		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAMTSYPRRQTQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGTACTAGCGGAACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	78	9.808359740455712E-4		44	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	1	3	5	2	2	2	26	39	49	41	51		TCRBV20-01,TCRBV20-or09_02				01,02								X+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGTCCTCCGGACAGGGGGTGAAGCTTTCTTTGGACAA	CASSQVLRTGGEAFF	In	VDJ	1	78	9.808359740455712E-4	0.0010989165809605658	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	1	1	7	8	0	26	40	-1	48	58		TCRBV03-01,TCRBV03-02												CASSQVLRTGGEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTGGACACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CATSDWTPNTGELFF	In	VDJ	1	77	9.682611538654998E-4	0.0010848279068456867	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	6	0	0	1	24	-1	45	40	46		TCRBV24-01,TCRBV24-or09_02												CATSDWTPNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGCGACAGGGTTGCATCAGCCCCAGCATTTTGGTGAT	CSAATGLHQPQHF	In	VDJ	1	77	9.682611538654998E-4	0.0010848279068456867	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	5	3	4	26	34	44	37	48		TCRBV20-01,TCRBV20-or09_02												CSAATGLHQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGGATACACTATGGCTACACCTTCGGTTCG	CASSQGIHYGYTF	In	VDJ	1	77	9.682611538654998E-4	0.0010848279068456867	39	TCRBV03						TCRBJ01	TCRBJ01-02	01	1	1	8	3	0	3	26	-1	45	42	48		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGIHYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCGTGTTAACAGCGGGACGTTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	77	9.682611538654998E-4		50	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	6	3	9	9	2	26	42	58	51	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD02-01*02	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACGACAGGACCTACAATGAGCAGTTCTTCGGGCCA	CSANDRTYNEQFF	In	VDJ	1	76	9.556863336854283E-4	0.0010707392327308077	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	4	2	2	1	26	36	44	38	45		TCRBV20-01,TCRBV20-or09_02												CSANDRTYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAAACAGTTTGTGGTCCCAGTACTTCGGGCCA	CASSENSLWSQYF	In	VDJ	1	73	9.17961873145214E-4	0.0010284732103861705	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	3	5	9	5	8	23	34	43	39	51	TCRBV02,TCRBV09													CASSENSLWSQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCCTCGATGGTTACGAGCAGTACTTCGGGCCG	CASSVLDGYEQYF	In	VDJ	1	72	9.053870529651426E-4	0.0010143845362712916	39	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	10	4	9	1	24	36	47	45	48	TCRBV09,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVLDGYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGGTGGCCAGGCCCAAGGTGGTGGGTATGGCTACACCTTCGGTTCG	CSASGGQAQGGGYGYTF	In	VDJ	1	72	9.053870529651426E-4	0.0010143845362712916	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	4	5	7	14	26	37	48	44	62		TCRBV20-01,TCRBV20-or09_02												CSASGGQAQGGGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGACAGGGGGCGCGAACTGAAGCTTTCTTTGGACAA	CASSQEGQGARTEAFF	In	VDJ	1	72	9.053870529651426E-4	0.0010143845362712916	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	0	5	1	4	26	43	55	44	59		TCRBV03-01,TCRBV03-02												CASSQEGQGARTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGACCCTCTTACGAACAATGAGCAGTTCTTCGGGCCA	CASSDPLTNNEQFF	In	VDJ	1	72	9.053870529651426E-4	0.0010143845362712916	42	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	2	7	5	1	10	26	37	41	38	51		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDPLTNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCGAGGGGGACAGGGGGACAGCACCGGGGAACTGTTTTTTGGAGAA	CASSSRGGQGDSTGELFF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	0	1	14	7	14	18	31	49	38	63	TCRBV07,TCRBV11													CASSSRGGQGDSTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTGGAGGGCAGTGCCTACGAGCAGTACTTCGGGCCG	CASSLEGSAYEQYF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	2	0	5	22	-1	42	36	47		TCRBV12-03,TCRBV12-04												CASSLEGSAYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCGAGCGCCAAGAGATCCAGTACTTCGGGCCA	CSARIERQEIQYF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	6	6	10	4	9	26	38	46	42	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARIERQEIQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATGAGCGGACAGGGGGATCACCCCTCCACTTTGGGAAC	CASSQDERTGGSPLHF	In	VDJ	1	68	8.550877722448569E-4	9.580298398117754E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	1	10	5	1	23	40	55	45	56	TCRBV01,TCRBV04													CASSQDERTGGSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGTAGCGGGAGTTCCCACGAGCAGTACTTCGGGCCG	CSARSGSSHEQYF	In	VDJ	1	68	8.550877722448569E-4	9.580298398117754E-4	39	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	5	2	5	2	5	26	35	46	37	51		TCRBV20-01,TCRBV20-or09_02												CSARSGSSHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTGGACAGGGTCACACTGAAGCTTTCTTTGGACAA	CASSLGQGHTEAFF	In	VDJ	1	68	8.550877722448569E-4	9.580298398117754E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	3	2	2	26	39	49	41	51		TCRBV03-01,TCRBV03-02												CASSLGQGHTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACAGCTTGTTTAATGAAAAACTGTTTTTTGGCAGT	CASSQDSLFNEKLFF	In	VDJ	1	68	8.550877722448569E-4	9.580298398117754E-4	45	TCRBV03						TCRBJ01	TCRBJ01-04	01	0	4	5	4	0	6	26	-1	46	43	52		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDSLFNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTAGCTACCGGGACAGGGGTTACGAGCAGTACTTCGGGCCG	CASSYRDRGYEQYF	In	VDJ	1	67	8.425129520647854E-4	9.439411656968963E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	2	4	4	1	26	38	52	42	53		TCRBV03-01,TCRBV03-02												CASSYRDRGYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGGACTAGCGGGAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	66	8.299381318847141E-4		47				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	1	2	3	0	1	18	-1	48	35	49	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												X+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGTGGCGCAGCCGAACACTGAAGCTTTCTTTGGACAA	CASSLVAQPNTEAFF	In	VDJ	1	65	8.173633117046427E-4	9.157638174671381E-4	45	unresolved						TCRBJ01	TCRBJ01-01	01	3	4	5	1	7	2	18	32	42	39	44	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVAQPNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTGCACGGGCCCATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	65	8.173633117046427E-4		47	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	8	0	0	6	3	24	36	46	42	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATCCACAGCTCGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	65	8.173633117046427E-4		47	TCRBV24						TCRBJ01	TCRBJ01-05	01	8	3	5	0	3	8	24	34	41	37	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATAACCAGGGGTCCAACCCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	65	8.173633117046427E-4		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	4	2	2	3	9	24	39	48	42	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCAGCAGGGATTCGAATGAGCAGTTCTTCGGGCCA	CSASRDSNEQFF	In	VDJ	1	65	8.173633117046427E-4	9.157638174671381E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	7	3	5	26	34	42	37	47		TCRBV20-01,TCRBV20-or09_02												CSASRDSNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CMCCAACCAGACAKCTMTKTACYTCTGTGCCAGCACCTGGGGGGGGGCTGGCAACGAGCAGTACTTCGGGCCG	CASTWGGAGNEQYF	In	VDJ	1	64	8.047884915245712E-4	9.016751433522591E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	9	0	5	6	8	24	31	44	37	52	TCRBV24,TCRBV28													CASTWGGAGNEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTATCGGGACAGGCCCCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	64	8.047884915245712E-4		43	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	4	3	3	23	36	47	39	50	TCRBV24,TCRBV27													X+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCGACAGTAGAATTGCCAAAAACATTCAGTACTTCGGCGCC	CSASDSRIAKNIQYF	In	VDJ	1	64	8.047884915245712E-4	9.016751433522591E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	5	1	3	7	26	35	43	38	50		TCRBV20-01,TCRBV20-or09_02												CSASDSRIAKNIQYF+TCRBV20-X+TCRBJ02-04	TCRBV20	TCRBD01-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACMKCTCTKTACTTCTGTGCCAGCAGTTTAGGTGGTAATGAGCAGTTCTTCGGGCCA	CASSLGGNEQFF	In	VDJ	1	60	7.544892108042855E-4	8.45320446892743E-4	36	unresolved						TCRBJ02	TCRBJ02-01	01	6	5	4	7	2	4	24	36	41	38	45	TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCGGACCGATACAAGAGACCCAGTACTTCGGGCCA	CSARAGPIQETQYF	In	VDJ	1	60	7.544892108042855E-4	8.45320446892743E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	1	1	7	2	2	5	26	39	45	41	50		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARAGPIQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGGACAGGGGGATCTTTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	60	7.544892108042855E-4		44	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	0	1	4	1	5	26	38	50	39	55		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGTGATCGACAGGATTGCCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	60	7.544892108042855E-4		43	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	2	4	6	5	4	26	37	48	42	52		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCGCGGACAGAAACACTGAAGCTTTCTTTGGACAA	CATSAADRNTEAFF	In	VDJ	1	58	7.293395704441426E-4	8.171430986629848E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	5	2	4	1	24	37	47	41	48		TCRBV24-01,TCRBV24-or09_02												CATSAADRNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGGGGCGCCCCTGGAAACACCATATATTTTGGAGAG	CSARGGGAPGNTIYF	In	VDJ	1	58	7.293395704441426E-4	8.171430986629848E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-03	01	1	9	0	2	0	5	26	-1	46	39	51		TCRBV20-01,TCRBV20-or09_02												CSARGGGAPGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD02-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCACTATAACCGGGACTAGCGGGGACGTCGGCACAGATACGCAGTATTTTGGCCCA	CASTITGTSGDVGTDTQYF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	57	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	0	3	1	8	6	23	33	54	41	60	TCRBV02,TCRBV09													CASTITGTSGDVGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
RAGACWCRGCMCTGTATCTCTGCGCCAGCAGTCAAGATCCCTCGACTAGCGGGGGGGCATATACGGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	57	7.167647502640712E-4		61	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	2	0	5	8	9	20	35	57	43	66	TCRBV04,TCRBV23													X+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGTTGACTAGCGGGGGGGGTTATAGCACAGATACGCAGTATTTTGGCCCA	CASSRLTSGGGYSTDTQYF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	57	TCRBV03			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	2	0	0	4	5	24	37	55	41	60		TCRBV03-01,TCRBV03-02												CASSRLTSGGGYSTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAACCCGGGACCTTACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASNPGPYSGANVLTF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	48	unresolved						TCRBJ02	TCRBJ02-06	01	7	0	7	0	4	4	26	36	45	40	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNPGPYSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCAACAGGGGGCCGGCCCCAGCATTTTGGTGAT	CASSSTGGRPQHF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	0	9	2	2	26	39	50	41	52		TCRBV12-03,TCRBV12-04												CASSSTGGRPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCTCCGTCAGGGGGTCAGGACGCAGTATTTTGGCCCA	CASSLRQGVRTQYF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	1	9	6	5	24	36	49	42	54		TCRBV24-01,TCRBV24-or09_02												CASSLRQGVRTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TSRRGGACTCAGCYRTGTACTTCTGTGCCAGCCTCCGCGCGGGAGGGCAGAGCACCTACGAGCAGTACTTCGGGCCG	CASLRAGGQSTYEQYF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	8	7	0	2	6	7	22	31	46	37	53	TCRBV02,TCRBV12													CASLRAGGQSTYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTCCTCGACACAGTGAATATGGCTACACCTTCGGTTCG	CSPRHSEYGYTF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	2	6	5	4	7	26	32	40	36	47		TCRBV20-01,TCRBV20-or09_02												CSPRHSEYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTCATGCGATCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	56	7.041899300839998E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	7	6	4	4	15	26	38	45	42	60		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACCAGGGACGGGAGAGGGCGGCTTTCTTTGGACAA	CASNQGRERAAFF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	39	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	8	2	11	4	6	26	40	50	44	56		TCRBV03-01,TCRBV03-02												CASNQGRERAAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGCAAGCGGGGGAACCGAGCAGTTCTTCGGGCCA	CATSDLASGGTEQFF	In	VDJ	1	55	6.916151099039283E-4	7.748770763183477E-4	45	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	6	2	10	3	4	24	42	53	45	57		TCRBV24-01,TCRBV24-or09_02												CATSDLASGGTEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATAGGGACAGGGGGACCCAAAACTATGGCTACACCTTCGGTTCG	CSARDRDRGTQNYGYTF	In	VDJ	1	55	6.916151099039283E-4	7.748770763183477E-4	51	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	0	1	2	2	6	26	40	53	42	59		TCRBV20-01,TCRBV20-or09_02												CSARDRDRGTQNYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGAAAACCTTTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSENLSGANVLTF	In	VDJ	1	54	6.79040289723857E-4	7.607884022034686E-4	45	unresolved						TCRBJ02	TCRBJ02-06	01	2	3	7	1	1	3	23	38	41	39	44	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSENLSGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGATAGACAGGCTGGGGGTCATGGCTACACCTTCGGTTCG	CASSLDRQAGGHGYTF	In	VDJ	1	54	6.79040289723857E-4	7.607884022034686E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	6	7	9	24	36	49	43	58		TCRBV24-01,TCRBV24-or09_02												CASSLDRQAGGHGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGTCAGCGGGGCAGGGACATACGAGCAGTACTTCGGGCCG	CVSGAGTYEQYF	In	VDJ	1	54	6.79040289723857E-4	7.607884022034686E-4	36	unresolved			unresolved			TCRBJ02	TCRBJ02-07	01	13	6	3	4	2	8	26	30	39	32	47	TCRBV09,TCRBV12			TCRBD01,TCRBD02										CVSGAGTYEQYF+X+TCRBJ02-07	unresolved	unresolved	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGGGATCCGTCGGGGGGGGATACGTTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	52	6.538906493637141E-4		52	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	8	0	1	4	7	24	39	51	43	58		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGTCGGGTTGGCAATCAGCCCCAGCATTTTGGTGAT	CSARRVGNQPQHF	In	VDJ	1	52	6.538906493637141E-4	7.326110539737106E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	4	2	3	3	26	35	42	38	45		TCRBV20-01,TCRBV20-or09_02				01,02								CSARRVGNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD02-01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGATAGACAGGCTTAGCCAAAAACATTCAGTACTTCGGCGCC	CASSR*TGLAKNIQYF	Stop	VDJ	1	51	6.413158291836427E-4		48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	5	2	4	0	5	3	18	30	41	35	44	TCRBV07,TCRBV11													CASSR*TGLAKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCGCGGGGTGGCACGAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	51	6.413158291836427E-4		49	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	7	3	0	3	5	24	36	45	39	50		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD02-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCCCCGGGACAGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSPGTGGTDTQYF	In	VDJ	1	51	6.413158291836427E-4	7.185223798588314E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	0	2	1	4	0	22	33	-1	37	47		TCRBV12-03,TCRBV12-04												CASSPGTGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCACAACAGGGATGGACACTGAAGCTTTCTTTGGACAA	CASSTTGMDTEAFF	In	VDJ	1	51	6.413158291836427E-4	7.185223798588314E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	3	3	4	26	38	47	41	51		TCRBV03-01,TCRBV03-02												CASSTTGMDTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGGGGACTYGGCYSTSTATCTCTGTGCCAGCAGCTTAGAGATCGGCAGGGGAGTACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	50	6.287410090035713E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	5	10	3	22	35	51	45	54	TCRBV05,TCRBV07													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTTCTCAGGGGGCGCTTTTCTATGGCTACACCTTCGGTTCG	CATSSQGALFYGYTF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	4	0	4	3	6	24	36	47	39	53		TCRBV24-01,TCRBV24-or09_02												CATSSQGALFYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CATSRGSTDTQYF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	8	2	0	1	0	24	35	-1	36	42		TCRBV24-01,TCRBV24-or09_02												CATSRGSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGATACAGCACTAGCGGGAGAGGGGAGACCCAGTACTTCGGGCCA	CSARYSTSGRGETQYF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	48	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	3	2	5	6	4	26	38	55	44	59		TCRBV20-01,TCRBV20-or09_02												CSARYSTSGRGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCAAAGACACTTCGCAGCCCCAGCATTTTGGTGAT	CSATKDTSQPQHF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	6	7	5	5	26	36	45	41	50		TCRBV20-01,TCRBV20-or09_02												CSATKDTSQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCACCGATGAGAACACTGAAGCTTTCTTTGGACAA	CASSTDENTEAFF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	4	2	8	1	2	3	24	37	41	39	44	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSTDENTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGGGAGGACAGGGAGATAGCTACGAGCAGTACTTCGGGCCG	CASRGGQGDSYEQYF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	1	3	3	4	6	24	35	47	39	53		TCRBV24-01,TCRBV24-or09_02												CASRGGQGDSYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTTGGGGATCCGAAGCTTTCTTTGGACAA	CATSDFWGSEAFF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	1	0	8	8	3	3	24	41	48	44	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDFWGSEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCAGTTTAGCAAACGAGCAGTACTTCGGGCCG	CSASSLANEQYF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	5	7	5	5	2	26	37	46	42	48		TCRBV20-01,TCRBV20-or09_02				01,02								CSASSLANEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTACGGATTCCATTTGCAAAGAAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	49	6.161661888234998E-4		52	TCRBV03						TCRBJ02	TCRBJ02-04	01	4	1	8	4	3	15	26	39	45	42	60		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-04	TCRBV03		TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGACGGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	49	6.161661888234998E-4		38	TCRBV03						TCRBJ02	TCRBJ02-07	01	4	1	7	0	0	2	26	-1	43	39	45		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-07	TCRBV03		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGCAGGGGGCTAACACTGAAGCTTTCTTTGGACAA	CASSQEGQGANTEAFF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	0	2	4	1	26	43	55	47	56		TCRBV03-01,TCRBV03-02												CASSQEGQGANTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGGTAGTGGGGATTCCGGGGAGCTGTTTTTTGGAGAA	CATSGSGDSGELFF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	42	TCRBV24						TCRBJ02	TCRBJ02-02	01	5	0	8	6	6	2	24	37	47	43	49		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSGSGDSGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACGCAGGTGTCCGCGCTTTCTTTGGACAA	CATSDAGVRAFF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	4	11	2	7	24	38	44	40	51		TCRBV24-01,TCRBV24-or09_02												CATSDAGVRAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTTCTAGCGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSVLAGGSTDTQYF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	48	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	4	0	0	4	0	22	33	-1	37	49		TCRBV12-03,TCRBV12-04												CASSVLAGGSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGACCCGGGGACTAGCGCGTACAATGAGCAGTTCTTCGGGCCA	CSADPGTSAYNEQFF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	45	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	6	4	6	2	26	35	51	41	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSADPGTSAYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAAGGGGTAAGGGGCGAGCAGTACTTCGGGCCG	CSAKGVRGEQYF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	5	2	6	1	7	26	36	42	37	49		TCRBV20-01,TCRBV20-or09_02												CSAKGVRGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACTGCCTGACAGGGGGCGTGTGGAGCTGTTTTTTGGAGAA	CASRLPDRGRVELFF	In	VDJ	1	46	5.784417282832855E-4	6.480790092844363E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	2	0	10	7	4	24	35	52	42	56		TCRBV24-01,TCRBV24-or09_02												CASRLPDRGRVELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTTTTACTAGCGACTACAATGAGCAGTTCTTCGGGCCA	CASSFTSDYNEQFF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	3	6	3	1	1	22	36	44	37	45		TCRBV12-03,TCRBV12-04				01,02								CASSFTSDYNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCATAGGACATTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSIGHFSYNEQFF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	1	6	0	3	3	19	31	39	34	42	TCRBV05,TCRBV07													CASSIGHFSYNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCCCGGGACCCGTACACAGATACGCAGTATTTTGGCCCA	CASSPRDPYTDTQYF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	45	unresolved						TCRBJ02	TCRBJ02-03	01	5	0	7	2	4	5	18	30	39	34	44	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRDPYTDTQYF+X+TCRBJ02-03	unresolved		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGGACAGGGGACACGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	44	5.532920879231427E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	1	2	2	4	0	4	26	-1	50	42	54		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGCACTAGTTTACTTCGGGCCA	CASSQDALVYF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	33	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	3	8	14	3	2	26	43	51	46	53		TCRBV03-01,TCRBV03-02				01,02								CASSQDALVYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAGAAAGGGGGCGAGGGGTTCCTATGGCTATACCTTCGGTTCG	CASSRKGARGSYGYTF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	5	0	14	4	19	26	38	49	42	68		TCRBV03-01,TCRBV03-02												CASSRKGARGSYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGGACTCGGCCSTGTATCTCTGTGCCAGCAGCTCACAGGGAGACACTGAAGCTTTCTTTGGACAA	CASSSQGDTEAFF	In	VDJ	1	43	5.407172677430712E-4	6.05812986939799E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	3	3	1	2	18	31	38	32	40	TCRBV05,TCRBV07													CASSSQGDTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCATGAGGGGTCCCATCATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	43	5.407172677430712E-4		47	TCRBV03						TCRBJ01	TCRBJ01-06	01	5	5	2	5	3	7	26	38	46	41	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-06	TCRBV03		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGATTGCCACCAGGGACCCAGTACTTCGGGCCA		Out	VDJ	1	43	5.407172677430712E-4		41	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	4	4	7	7	0	23	40	-1	47	51	TCRBV01,TCRBV04													X+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCTCACAGGAGTCCATAACGAGCAGTACTTCGGGCCG	CASRLTGVHNEQYF	In	VDJ	1	43	5.407172677430712E-4	6.05812986939799E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	4	5	4	8	26	37	46	41	54		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRLTGVHNEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCGAGGCAGGGGGAGACTGAAGCTTTCTTTGGACAA	CSAPRQGETEAFF	In	VDJ	1	42	5.281424475629999E-4	5.9172431282492E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	5	7	2	26	34	48	41	50		TCRBV20-01,TCRBV20-or09_02												CSAPRQGETEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTTTTCTAGCGGGAGAGGTGGGCACGCAGTATTTTGGCCCA		Out	VDJ	1	42	5.281424475629999E-4		50	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	1	4	2	9	4	8	26	42	56	46	64		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGGAGAGTAGAAGCGGGGGACTACAATGAGCAGTTCTTCGGGCCA	CASRRVEAGDYNEQFF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	6	6	2	3	9	1	23	34	51	43	52	TCRBV02,TCRBV09													CASRRVEAGDYNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCAAACAGGACACTTATTCACCCCTCCACTTTGGGAAC	CASSKQDTYSPLHF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	1	6	8	5	3	18	30	40	35	43	TCRBV07,TCRBV11													CASSKQDTYSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTACCGGGGGCTGGAACCGGGGAGCTGTTTTTTGGAGAA	CASSLPGAGTGELFF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	45	TCRBV24						TCRBJ02	TCRBJ02-02	01	6	6	0	5	5	4	24	36	47	41	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLPGAGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24		TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAGGGGTCCTGAACACTGAAGCTTTCTTTGGACAA	CATSDSGVLNTEAFF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	0	0	3	24	-1	46	40	49		TCRBV24-01,TCRBV24-or09_02												CATSDSGVLNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTATTAGAATAGGGACAGGGGAAGGAGAGACCCAGTACTTCGGGCCA	CSAIRIGTGEGETQYF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	4	8	4	26	36	54	44	58		TCRBV20-01,TCRBV20-or09_02												CSAIRIGTGEGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGCCCACAGGAAAATACTGAAGCTTTCTTTGGACAA	CSASPQENTEAFF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	5	3	5	26	37	45	40	50		TCRBV20-01,TCRBV20-or09_02												CSASPQENTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTAGGGGCCAACGTCCTGACTTTCGGGGCC	CSARDLGANVLTF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	0	4	9	4	1	0	26	40	-1	41	44		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTTGACTAGGGGGGGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	41	5.155676273829285E-4		43	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	9	0	6	6	0	26	40	-1	46	53		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCCCCCGGACGGAACATGAAAAACTGTTTTTTGGCAGT	CASSPRTEHEKLFF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	42	unresolved						TCRBJ01	TCRBJ01-04	01	4	1	7	6	4	5	23	35	43	39	48	TCRBV09,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRTEHEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCTCACCCTCCGGGACGACGAGCAGTACTTCGGGCCG	CASSLTLRDDEQYF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	42	unresolved						TCRBJ02	TCRBJ02-07	01	5	0	7	5	10	1	18	30	45	40	46	TCRBV05,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTLRDDEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCATAGAAGCAGGGACTAGCGGACCCTACGAGCAGTACTTCGGGCCG	CATIEAGTSGPYEQYF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	10	0	5	2	11	2	23	30	52	41	54	TCRBV06,TCRBV10					01,02								CATIEAGTSGPYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAACCGGGACGCCAACTAACTATGGCTACACCTTCGGTTCG	CASSLTGTPTNYGYTF	In	VDJ	1	40	5.02992807202857E-4	5.635469645951619E-4	48	TCRBV24						TCRBJ01	TCRBJ01-02	01	6	0	7	0	6	5	24	36	47	42	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTGTPTNYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATACCGGACTAGCAAGCAACATTCAGTACTTCGGCGCC	CATSDTGLASNIQYF	In	VDJ	1	39	4.904179870227856E-4	5.494582904802829E-4	45	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	3	1	7	7	3	4	24	39	50	42	54		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDTGLASNIQYF+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD02-01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGTCCGATCAGGGGGCCCACGAGCAGTACTTCGGGCCG	CSASDQGAHEQYF	In	VDJ	1	39	4.904179870227856E-4	5.494582904802829E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	0	5	7	2	26	34	49	41	51		TCRBV20-01,TCRBV20-or09_02												CSASDQGAHEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCGGGACAGGGGGCGCCTTTGAATGAAAAACTGTTTTTTGGCAGT	CASSPGQGAPLNEKLFF	In	VDJ	1	39	4.904179870227856E-4	5.494582904802829E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	0	0	5	1	7	26	39	52	40	59		TCRBV03-01,TCRBV03-02												CASSPGQGAPLNEKLFF+TCRBV03-X+TCRBJ01-04	TCRBV03	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAACATAGCGGGGGTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASNIAGVSYNEQFF	In	VDJ	1	38	4.7784316684271416E-4	5.353696163654039E-4	45	unresolved						TCRBJ02	TCRBJ02-01	01	0	6	1	0	0	1	18	-1	40	35	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASNIAGVSYNEQFF+X+TCRBJ02-01	unresolved		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGTAGGGCGATAGACTACGAGCAGTACTTCGGGCCG	CASSRAIDYEQYF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	39	unresolved						TCRBJ02	TCRBJ02-07	01	5	5	3	3	0	7	23	-1	39	35	46	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRAIDYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGCCATGGACAGGGGGCAGAATGAGCAGTTCTTCGGGCCA	CATSAMDRGQNEQFF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	1	0	7	4	2	24	37	52	41	54		TCRBV24-01,TCRBV24-or09_02												CATSAMDRGQNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGAACAGGGGGCCAAGGGCTACACCTTCGGTTCG	CSARDQEQGAKGYTF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	8	6	4	26	40	55	46	59		TCRBV20-01,TCRBV20-or09_02												CSARDQEQGAKGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGTGGACAATGAGCAGTTCTTCGGGCCA	CSAREVDNEQFF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	36	TCRBV20						TCRBJ02	TCRBJ02-01	01	0	0	10	5	0	3	26	-1	42	40	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREVDNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAAACCAAGACCCGGGGACGCTCCCCTCCACTTTGGGAAC	CSAKPRPGDAPLHF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	42	TCRBV20						TCRBJ01	TCRBJ01-06	01	4	0	7	13	12	3	26	36	53	48	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAKPRPGDAPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGCCTTACCCCATACGAGCAGTACTTCGGGCCG	CASSLTPYEQYF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	36	unresolved						TCRBJ02	TCRBJ02-07	01	6	3	7	4	4	4	24	35	41	39	45	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLTPYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGACAGGACCCTGGCCAAGATACGCAGTATTTTGGCCCA	CASRQDPGQDTQYF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	3	4	5	0	10	26	-1	42	37	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRQDPGQDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCGACAGAAATAAGGTCCCGCGAGCAGTACTTCGGGCCG	CSASTEIRSREQYF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	2	5	6	2	13	26	35	42	37	55		TCRBV20-01,TCRBV20-or09_02												CSASTEIRSREQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGGGGCGGGGGGACTCTACGAGCAGTACTTCGGGCCG	CSARGGAGGLYEQYF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	7	1	3	5	3	26	39	52	44	55		TCRBV20-01,TCRBV20-or09_02												CSARGGAGGLYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTCCAGGGCTTGGGATTGCGAGGCTACACCTTCGGTTCG	CASSQVQGLGLRGYTF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	8	2	13	26	42	49	44	62		TCRBV03-01,TCRBV03-02												CASSQVQGLGLRGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGGGGGGGCAGTGGGAATTCACCCCTCCACTTTGGGAAC	CASRGGSGNSPLHF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	42	unresolved						TCRBJ01	TCRBJ01-06	01	5	6	0	7	1	6	19	30	37	31	43	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGGSGNSPLHF+X+TCRBJ01-06	unresolved		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTGTCTTCGCGGGGAGTTTTCTACAATGAGCAGTTCTTCGGGCCA	CASSLSSRGVFYNEQFF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	51	TCRBV05			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	3	3	5	6	19	34	45	39	51		TCRBV05-06,TCRBV05-07												CASSLSSRGVFYNEQFF+TCRBV05-X+TCRBJ02-01	TCRBV05	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGAGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLEYSNQPQHF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	42	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	1	5	5	0	0	2	18	-1	36	34	38	TCRBV07,TCRBV11			TCRBD01,TCRBD02										CASSLEYSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAATACAGGGTATCTGCCCCTCCACTTTGGGAAC	CASSQNTGYLPLHF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	3	3	13	3	6	26	41	50	44	56		TCRBV03-01,TCRBV03-02												CASSQNTGYLPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATCGGGGACGTGGGGTGAAAAACTGTTTTTTGGCAGT	CASSLSGTWGEKLFF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	45	unresolved						TCRBJ01	TCRBJ01-04	01	6	0	7	7	6	6	24	36	47	42	53	TCRBV06,TCRBV24,TCRBV27			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSGTWGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGCAGCATCCTACAATGAGCAGTTCTTCGGGCCA	CATSDLAASYNEQFF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	45	TCRBV24						TCRBJ02	TCRBJ02-01	01	1	4	5	1	2	2	24	41	46	43	48		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLAASYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGAATGGACAGGGCCACCCAGAGACCCAGTACTTCGGGCCA	CATSDPNGQGHPETQYF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	51	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	1	3	4	7	6	24	38	53	45	59		TCRBV24-01,TCRBV24-or09_02												CATSDPNGQGHPETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCCACAGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDPTESSYNEQFF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	3	5	0	4	4	24	38	46	42	50		TCRBV24-01,TCRBV24-or09_02												CATSDPTESSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGTTTTGGACTAGCGGGAGCTGCAGATACGCAGTATTTTGGCCCA	CASSFGLAGAADTQYF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	48	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	1	2	4	4	3	26	37	54	41	57	TCRBV03,TCRBV12													CASSFGLAGAADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGGAGGGACAGGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASRRDRGNTGELFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	2	1	2	0	23	34	-1	36	46	TCRBV09,TCRBV12													CASRRDRGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCATGTATCKCTGTGCCAGCAGCCTCGGACAGATTAATGAAAAACTGTTTTTTGGCAGT	CASSLGQINEKLFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	1	5	4	3	2	19	31	40	34	42	TCRBV07,TCRBV11													CASSLGQINEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTGCAGCCGGACAGGAGGGAACCTACGAGCAGTACTTCGGGCCG	CASSAAGQEGTYEQYF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	1	4	2	5	6	24	37	49	42	55		TCRBV24-01,TCRBV24-or09_02												CASSAAGQEGTYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCCGGGGGGGAAGCTTTCTTTGGACAA	CATSDPGGEAFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	36	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	3	8	1	8	2	0	24	39	-1	41	48		TCRBV24-01,TCRBV24-or09_02												CATSDPGGEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCGATCCGGGGGACATGAATACTGAAGCTTTCTTTGGACAA	CSAPDPGDMNTEAFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	45	TCRBV20						TCRBJ01	TCRBJ01-01	01	5	0	6	5	10	5	26	35	51	45	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPDPGDMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTACAGGGATATGGCTATACCTTTGGTTCG	CSARDLQGYGYTF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	3	20	3	16	26	40	49	43	65		TCRBV20-01,TCRBV20-or09_02												CSARDLQGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGTAGCGGGCTTGATCCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	33	4.1496906594235705E-4		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	5	4	1	3	6	26	43	53	46	59		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
RRGACWCSGCMSTGTATCTCTGYGCCAGCAACCCGACAGGGGGCGATGGCTACACCTTCGGTTCG	CASNPTGGDGYTF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	0	6	4	1	20	30	44	34	45	TCRBV07,TCRBV23													CASNPTGGDGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTGGACAGGGGGCGAAACATTCAGTACTTCGGCGCC	CASSLDRGRNIQYF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	1	0	6	0	1	18	-1	43	32	44	TCRBV05,TCRBV07,TCRBV11													CASSLDRGRNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTCTAGCGGGGGGGCCTAAGAGACCCAGTACTTCGGGCCA	CASSSSGGA*ETQYF	Stop	VDJ	1	32	4.023942457622856E-4		45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	4	0	3	0	3	18	-1	43	31	46	TCRBV07,TCRBV11													CASSSSGGA*ETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATCGGCAGGATTGGGCACTGAAGCTTTCTTTGGACAA	CASSESAGLGTEAFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	45	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	4	4	6	23	38	46	42	52		TCRBV06-01,TCRBV06-08												CASSESAGLGTEAFF+TCRBV06-X+TCRBJ01-01	TCRBV06	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTCACTACAGGGGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFTTGGSYNEQFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	48	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	3	1	1	6	1	24	36	50	42	51		TCRBV24-01,TCRBV24-or09_02												CASSFTTGGSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCTCTCTCAGAGGGGGGCTCCACAGCCAAACTGTTTTTTGGCAGT	CASSSLSEGGSTAKLFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	51	TCRBV24						TCRBJ01	TCRBJ01-04	01	6	5	1	11	10	11	24	36	52	46	63		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLSEGGSTAKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGGCCAGGGGCTATAGGGACCTACGAGCAGTACTTCGGGCCG	CSARPGAIGTYEQYF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	2	4	9	26	35	45	39	54		TCRBV20-01,TCRBV20-or09_02												CSARPGAIGTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCACAACCTTCCCATTTCATACACATAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	32	4.023942457622856E-4		55	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	6	5	17	1	26	40	60	57	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCTAAGTCCGGGTAGCACAGATACGCAGTATTTTGGCCCA	CASSLSPGSTDTQYF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	8	4	0	6	1	23	36	46	42	47	TCRBV01,TCRBV04					01,02								CASSLSPGSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTCGGGGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLFGDSNQPQHF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	2	8	3	0	2	1	26	41	48	43	49		TCRBV12-03,TCRBV12-04												CASSLFGDSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAAGGAAATACCTAGGAACTACGAGCAGTACTTCGGGCCG	CASKEIPRNYEQYF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	4	8	3	9	3	22	32	45	41	48		TCRBV12-03,TCRBV12-04				01,02								CASKEIPRNYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATTATATTCTAGCTCCAGATACGCAGTATTTTGGCCCA	CASSQDYILAPDTQYF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	48	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	0	4	7	4	7	2	26	43	55	50	57		TCRBV03-01,TCRBV03-02				01,02								CASSQDYILAPDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAAGGATTAAGGACAGGACTTCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	31	3.898194255822142E-4		53	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	1	4	4	8	4	26	41	56	49	60		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAAACTGTTGAGGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	31	3.898194255822142E-4		44	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	2	3	10	1	1	6	26	41	45	42	51		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGAAGGGACACCAACCACCGGGGAGCTGTTTTTTGGAGAA	CASSQEGTPTTGELFF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	0	6	4	1	5	23	40	47	41	52	TCRBV04,TCRBV23													CASSQEGTPTTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCAGACTGGTGCCATTTCAATTCGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	30	3.7724460540214275E-4		52	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	0	10	4	2	15	26	43	47	45	62		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGAGGGACAGGGGGCCTACACTGAAGCTTTCTTTGGACAA	CASSQEGQGAYTEAFF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	3	3	2	26	40	55	43	57		TCRBV03-01,TCRBV03-02												CASSQEGQGAYTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGGGAAGGATCACTGAAGCTTTCTTTGGACAA	CASSLGRITEAFF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	3	0	8	4	0	5	26	-1	44	40	49		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGRITEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTATTGCGGGGGGTCACAGATACGCAGTATTTTGGCCCA	CASSLLRGVTDTQYF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	7	1	2	2	1	26	41	51	43	52		TCRBV12-03,TCRBV12-04												CASSLLRGVTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TSRGGGACTCAGCTKTGTAYTTCTGTGCCAGCAGCCCTCGGGACTTTTCGGATGGCTACACCTTCGGTTCG	CASSPRDFSDGYTF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	4	0	10	6	4	6	23	35	45	39	51	TCRBV09,TCRBV12					01,02								CASSPRDFSDGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCAAGACAGCCGAATCAGCCCCAGCATTTTGGTGAT	CATSDPRQPNQPQHF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	5	4	5	3	24	38	48	43	51		TCRBV24-01,TCRBV24-or09_02												CATSDPRQPNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTACCGCCGGCAAATAATGAGCAGTTCTTCGGGCCA	CSASVPPANNEQFF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	9	0	7	9	4	26	37	49	46	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVPPANNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATATAGACAGAGTCTTTAATCAGCCCCAGCATTTTGGTGAT	CSARDIDRVFNQPQHF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	2	5	4	4	7	26	40	49	44	56		TCRBV20-01,TCRBV20-or09_02												CSARDIDRVFNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGACTTATAGGGCACAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	29	3.646697852220713E-4		46	TCRBV03						TCRBJ02	TCRBJ02-05	01	0	5	3	2	5	2	26	43	52	48	54		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAAGCTCTCGGGTCACAACACTGAAGCTTTCTTTGGACAA	CASKLSGHNTEAFF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	7	8	4	2	6	4	23	33	43	39	47	TCRBV06,TCRBV10					01,02								CASKLSGHNTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGGRGACWCRGCMCTGTATCTCTGYGCCAGCAACCCCGGGACAGGGAACGGCTACACCTTCGGTTCG	CASNPGTGNGYTF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	3	8	3	3	22	34	46	37	49	TCRBV05,TCRBV23													CASNPGTGNGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTCCCGTATATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPVYSNQPQHF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	5	9	0	4	2	26	38	44	42	46		TCRBV12-03,TCRBV12-04				01,02								CASSPVYSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTAGTGGGGGCCGGTTACGAGCAGTACTTCGGGCCG	CASSLVGAGYEQYF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	6	0	4	5	4	24	36	47	41	51		TCRBV24-01,TCRBV24-or09_02												CASSLVGAGYEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCAGGACAAGAGACCCAGTACTTCGGGCCA	CATSDSGQETQYF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	4	4	2	0	1	24	-1	44	40	45		TCRBV24-01,TCRBV24-or09_02												CATSDSGQETQYF+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGCAAAGGCCTCTGGAAACACCATATATTTTGGAGAG	CASSAKASGNTIYF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	42	TCRBV12						TCRBJ01	TCRBJ01-03	01	5	5	4	0	4	1	22	34	41	38	42		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAKASGNTIYF+TCRBV12-X+TCRBJ01-03	TCRBV12		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCGGCCCAAAAGTGGTCCGAAATACCGAGGAGCTGTTTTTTGGAGAA	CASGPKVVRNTEELFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	48	unresolved						TCRBJ02	TCRBJ02-02	01	4	0	10	10	7	13	23	36	45	43	58	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPKVVRNTEELFF+X+TCRBJ02-02	unresolved		TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGRAGACWCRGCMCTGTATCTCTGCGCCAGCAGCCAAGATCGTACGGGACTAGCGGGAGTAGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	27	3.395201448619285E-4		56	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	0	2	8	6	5	23	40	60	46	65	TCRBV04,TCRBV23													X+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGTTGAGGGGAGACAGGGAGGCGAAAAACTGTTTTTTGGCAGT	CSARVEGRQGGEKLFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	2	3	8	9	4	26	39	55	48	59		TCRBV20-01,TCRBV20-or09_02												CSARVEGRQGGEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGCCGCATTGGGGCTACACCTTCGGTTCG	CSARDGPHWGYTF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	8	0	8	1	8	26	40	45	41	53		TCRBV20-01,TCRBV20-or09_02												CSARDGPHWGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTTCTGGACAGGAGGGGCCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	27	3.395201448619285E-4		46	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	4	4	4	6	26	39	50	43	56		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCGGGGGGACAGAGCAGTTCTTCGGGCCA	CASSFGGTEQFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	36	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	3	8	1	10	0	3	26	-1	47	40	50		TCRBV12-03,TCRBV12-04												CASSFGGTEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGCCCGACGTTCCAGCCACGGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	3.2694532468185706E-4		44	unresolved						TCRBJ02	TCRBJ02-05	01	4	2	7	5	2	12	23	35	40	37	52	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCGCCCCACAGGGAGAAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	26	3.2694532468185706E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	3	3	2	7	3	19	31	44	38	47	TCRBV05,TCRBV11													X+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTACGGACTAGCGGGCCCCCAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	26	3.2694532468185706E-4		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	1	4	5	1	6	18	33	45	34	51	TCRBV07,TCRBV11					01,02								X+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTACCGGGACACCCGGGAAAAACTGTTTTTTGGCAGT	CASSYRDTREKLFF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	6	8	4	5	24	36	46	40	51		TCRBV24-01,TCRBV24-or09_02												CASSYRDTREKLFF+TCRBV24-X+TCRBJ01-04	TCRBV24	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGAGGGGGCCCGGCCTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	3.2694532468185706E-4		47	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	5	0	3	1	7	24	39	47	40	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-05	TCRBV24	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCCCAAATTGACTAGTGGGACGATGGGAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	26	3.2694532468185706E-4		53	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	2	8	4	8	12	22	33	47	41	59		TCRBV12-03,TCRBV12-04				01,02								X+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAGGGGGAAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	26	3.2694532468185706E-4		41	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	1	2	1	1	26	40	48	41	49		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATGGGGGGGGAGCACAGATACGCAGTATTTTGGCCCA	CASSEWGGSTDTQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	9	0	0	1	1	23	38	46	39	47		TCRBV06-01,TCRBV06-08												CASSEWGGSTDTQYF+TCRBV06-X+TCRBJ02-03	TCRBV06	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCATGCCGGGGGAGTACAATGAGCAGTTCTTCGGGCCA	CATMPGEYNEQFF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	39	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	8	8	2	4	3	2	24	34	43	37	45		TCRBV24-01,TCRBV24-or09_02												CATMPGEYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTCTCCGACTCTAAGCACAGATACGCAGTATTTTGGCCCA	CATSDSPTLSTDTQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	48	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	10	0	4	3	24	40	48	44	51		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDSPTLSTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCCGACAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CATSDPTGGTGELFF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	1	4	3	0	24	38	-1	41	50		TCRBV24-01,TCRBV24-or09_02												CATSDPTGGTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGCTAGCGGGAGTTCGTACACCGGGGAGCTGTTTTTTGGAGAA	CSAASGSSYTGELFF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	4	2	3	1	5	26	35	46	36	51		TCRBV20-01,TCRBV20-or09_02												CSAASGSSYTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGCGGAGCAGATACGCAGTATTTTGGCCCA	CSARGGADTQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	36	TCRBV20						TCRBJ02	TCRBJ02-03	01	3	8	0	4	0	4	26	-1	41	37	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARGGADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGCCTGGACAGAGCCCTACGAGCAGTACTTCGGGCCG	CSARAWTEPYEQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	1	5	2	3	3	26	39	48	42	51		TCRBV20-01,TCRBV20-or09_02												CSARAWTEPYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGCCGCCCTTTAATAGGATGTTGGAAACACCATATATTTTGGAGAG	CASSQAAL**DVGNTIYF	Stop	VDJ	1	25	3.1437050450178563E-4		54	TCRBV03						TCRBJ01	TCRBJ01-03	01	1	1	8	3	13	3	26	42	58	55	61		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAAL**DVGNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCCGCATCGGGGGGGCCCCAGATACGCAGTATTTTGGCCCA	CASRIGGAPDTQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	12	8	0	4	9	3	26	31	48	40	51	TCRBV09,TCRBV12													CASRIGGAPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCCTTCGGCTACTAGCGGCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	24	3.017956843217142E-4		47	TCRBV05			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	3	5	2	9	0	19	31	-1	40	48		TCRBV05-06,TCRBV05-07				01,02								X+TCRBV05-X+TCRBJ02-05	TCRBV05	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCTTCGGGGGCAGAACTACGAGCAGTACTTCGGGCCG	CASSSLRGQNYEQYF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	45	unresolved						TCRBJ02	TCRBJ02-07	01	4	6	0	3	6	4	18	31	43	37	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSLRGQNYEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTMSCTCCCAGACATCTGTRTACTTCTGTGCCAGCAGACCCAGGGGAGGCACTGAAGCTTTCTTTGGACAA	CASRPRGGTEAFF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	39	unresolved						TCRBJ01	TCRBJ01-01	01	6	4	2	4	3	3	26	37	46	40	49	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRPRGGTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAACTGACAGGGGGCGCTGGCTATGGCTACACCTTCGGTTCG	CASSELTGGAGYGYTF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	48	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	2	0	4	2	5	23	38	50	40	55		TCRBV06-01,TCRBV06-08												CASSELTGGAGYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCAGCAGTAATCAGGGCAGGACTGAAGCTTTCTTTGGACAA	CASSNQGRTEAFF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	5	3	4	24	36	44	39	48	TCRBV06,TCRBV10													CASSNQGRTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTGGGGAACAGGGGAGAATGCAGTATTTTGGCCCA	CASSGEQGRMQYF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	2	11	6	5	23	34	47	40	52	TCRBV02,TCRBV09													CASSGEQGRMQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGGCCCCGGACAGGGGAAACTCACCCCTCCACTTTGGGAAC	CASSLAPDRGNSPLHF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	1	2	10	4	4	19	35	48	39	52	TCRBV05,TCRBV11													CASSLAPDRGNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
SGACTCGGCYSTSTATCTCTGTGCCAGCAGCTTAGACGCGACAGGGCACACAGATACGCAGTATTTTGGCCCA	CASSLDATGHTDTQYF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	2	3	2	6	2	19	33	46	39	48	TCRBV05,TCRBV07													CASSLDATGHTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCTTAAGGAGCGGGATTGAAAATGAGCAGTTCTTCGGGCCA	CASSLRSGIENEQFF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	45	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	6	3	7	3	5	19	34	44	37	49	TCRBV07,TCRBV11													CASSLRSGIENEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGGGGTGGAAGTTAGCTCTGGAAACACCATATATTTTGGAGAG	CSAREGVEVSSGNTIYF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	51	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	6	1	0	0	10	26	-1	45	40	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAREGVEVSSGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAAGGAACACTGAAGCTTTCTTTGGACAA	CSARRNTEAFF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	33	TCRBV20						TCRBJ01	TCRBJ01-01	01	2	5	5	1	0	0	26	-1	-1	38	40		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAGACTAGCGGGGGTAACTACGAGCAGTACTTCGGGCCG	CSAETSGGNYEQYF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	2	2	3	3	3	26	34	49	37	52		TCRBV20-01,TCRBV20-or09_02												CSAETSGGNYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCTGAGCAATCCATTTCTTTCTCTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	23	2.8922086414164276E-4		50	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	6	7	5	2	17	26	39	44	41	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGACGCGGGATGGGGGGCGAGACCCAGTACTTCGGGCCA	CASRRGMGGETQYF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	42	TCRBV03						TCRBJ02	TCRBJ02-05	01	6	6	0	5	10	0	26	37	-1	47	53		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRGMGGETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TTCTGTGCCAGCAGCCAAGATTCGCGGACGGAGGCCGTTAGTAGTTCTTCCTACAATGAGCAGTTCTTCGGGCCA	CASSQDSRTEAVSSSSYNEQFF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	66	TCRBV03			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	10	1	1	9	14	3	20	34	29	48		TCRBV03-01,TCRBV03-02												CASSQDSRTEAVSSSSYNEQFF+TCRBV03-X+TCRBJ02-01	TCRBV03	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
SGACTCGGCYRTGTATCTCTGTGCCAGCAGCTTAGGGGACTATCGTGGCGAGCAGTACTTCGGGCCG	CASSLGDYRGEQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	0	9	6	0	6	19	-1	42	35	48	TCRBV07,TCRBV11					01,02								CASSLGDYRGEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTGGACAGACTCACAGATACGCAGTATTTTGGCCCA	CASSLDRLTDTQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	1	5	2	0	3	18	-1	38	32	41	TCRBV07,TCRBV11													CASSLDRLTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTCCCCAAGATGGGCCATGGATATATTTTTGGGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	22	2.7664604396157133E-4		59	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	8	0	7	9	18	18	31	44	40	62	TCRBV07,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCTTGGCTGGGGGAGGAACTGAAGCTTTCTTTGGACAA	CASSLAGGGTEAFF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	2	9	1	5	6	1	19	33	45	39	46	TCRBV07,TCRBV11													CASSLAGGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCCTTCCCCCCATCCCAAGAGACCCAGTACTTCGGGCCA	CSAPFPPSQETQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	42	TCRBV20						TCRBJ02	TCRBJ02-05	01	5	4	6	1	10	2	26	35	47	45	49		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPFPPSQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTGGAAAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CSASVESSYNEQFF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	42	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	1	8	0	3	3	26	37	43	40	46		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASVESSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGTGACTAGCGGAAGCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CSASVTSGSSGANVLTF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	3	2	5	0	3	3	26	37	49	40	52		TCRBV20-01,TCRBV20-or09_02				01,02								CSASVTSGSSGANVLTF+TCRBV20-X+TCRBJ02-06	TCRBV20	TCRBD02-01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAATTTGGGACGGGGGCAGATACGCAGTATTTTGGCCCA	CASSQFGTGADTQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	2	8	2	4	7	0	23	38	-1	45	51	TCRBV01,TCRBV04													CASSQFGTGADTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGACGGACAGAACTATGGTTACACCTTCGGTTCG		Out	VDJ	1	21	2.6407122378149995E-4		37	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	5	11	2	9	24	35	43	37	52		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGTTCAGAGGGCGCAGGCTACGAGCAGTACTTCGGGCCG	CASSSEGAGYEQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	11	0	3	2	6	22	35	42	37	48	TCRBV12,TCRBV21													CASSSEGAGYEQYF+X+TCRBJ02-07	unresolved	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTAGGGATTTGAGGACTGAAGCTTTCTTTGGACAA	CASSRDLRTEAFF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	0	8	5	1	7	22	34	39	35	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRDLRTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAATCCAGGGGGAGCAGTACTTCGGGCCG	CSARIQGEQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	33	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	7	3	0	26	38	-1	41	47		TCRBV20-01,TCRBV20-or09_02												CSARIQGEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCAATTATGGGGTGGGAGGGCTATGGCTACACCTTCGGTTCG	CSAIMGWEGYGYTF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	42	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	6	9	0	4	11	0	26	34	-1	45	52		TCRBV20-01,TCRBV20-or09_02												CSAIMGWEGYGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01*02	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAGGGACAGGGGTCGTCCTACGAGCAGTACTTCGGGCCG	CASSQEGQGSSYEQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	48	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	2	1	0	3	26	-1	53	43	56		TCRBV03-01,TCRBV03-02												CASSQEGQGSSYEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACYSRRGGACTCAGCYRTGTAYTTYTGTGCCAGCAGTTTCGACAGGGATTCACCCCTCCACTTTGGGAAC	CASSFDRDSPLHF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	3	8	3	0	23	35	-1	38	45	TCRBV02,TCRBV12													CASSFDRDSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCGTCTTGTAGACTCCGACGTACAATAAGCAGTTCTTCGGGCCA	CASSVL*TPTYNKQFF	Stop	VDJ	1	20	2.514964036014285E-4		48	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	2	10	11	8	13	24	36	48	44	61	TCRBV09,TCRBV21					01,02								CASSVL*TPTYNKQFF+X+TCRBJ02-01	unresolved	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTGGTGGCGGGGAGCTATGGCTACACCTTCGGTTCG	CASSLVAGSYGYTF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	0	7	3	4	2	2	19	35	43	37	45	TCRBV05,TCRBV11													CASSLVAGSYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCATGTATCKCTGTACCAGCAGCTTGGCCGGCGCCAACTATGGCTACACCTTCGGTTCG	CTSSLAGANYGYTF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	42	unresolved						TCRBJ01	TCRBJ01-02	01	3	9	0	2	0	7	19	-1	36	33	43	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSLAGANYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTCATGGGGGGCGCAGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSWGAQGNQPQHF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	48	TCRBV24						TCRBJ01	TCRBJ01-05	01	6	6	0	2	5	5	24	36	47	41	52		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSWGAQGNQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTAGGCGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CATSDLGGGSSYNEQFF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	51	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	1	0	2	2	24	41	51	43	53		TCRBV24-01,TCRBV24-or09_02												CATSDLGGGSSYNEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGAATACTACAGGGCCAGCTCCTACGAGCAGTACTTCGGGCCG	CSAEYYRASSYEQYF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	3	0	7	4	26	35	48	42	52		TCRBV20-01,TCRBV20-or09_02												CSAEYYRASSYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCATTGCGGGACAGAAATGAAAAACTGTTTTTTGGCAGT	CSALRDRNEKLFF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	0	5	5	5	1	26	34	46	39	47		TCRBV20-01,TCRBV20-or09_02												CSALRDRNEKLFF+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGGACAGGGGGAAACTACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	20	2.514964036014285E-4		49	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	0	1	3	0	6	26	-1	53	42	59		TCRBV12-03,TCRBV12-04												X+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGGGGAATCCTGGCGGAGAATAATTCACCCCTCCACTTTGGGAAC	CARGILAENNSPLHF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	45							TCRBJ01	TCRBJ01-06	01	9	0	8	5	0	13	18	-1	30	26	43	TCRBV11,TCRBV12	TCRBV11-03,TCRBV12-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CARGILAENNSPLHF+X+TCRBJ01-06			TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTAAAGGGATACTGAGACCGGATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	19	2.3892158342135708E-4		49	TCRBV12						TCRBJ02	TCRBJ02-07	01	2	0	8	4	2	13	22	37	43	39	56		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ02-07	TCRBV12		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCTTACCTAACAGGAACACTGAAGCTTTCTTTGGACAA	CASSLPNRNTEAFF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	1	7	0	26	38	-1	45	49		TCRBV03-01,TCRBV03-02												CASSLPNRNTEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGTCTAAACAGGGGGCAGGGCTATGGCTACACCTTCGGTTCG	CASSLNRGQGYGYTF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	3	0	4	5	4	22	33	47	38	51	TCRBV07,TCRBV11													CASSLNRGQGYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCGCCGGGACAGGACTCCTATAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	18	2.2634676324128565E-4		47	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	4	7	4	8	19	31	43	35	51	TCRBV07,TCRBV11													X+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATATACAGCCAGGCACAGATACGCAGTATTTTGGCCCA	CATSDIQPGTDTQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	5	1	2	4	24	39	45	41	49		TCRBV24-01,TCRBV24-or09_02												CATSDIQPGTDTQYF+TCRBV24-X+TCRBJ02-03	TCRBV24	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAAGAGGGACACCTCCTACGAGCAGTACTTCGGGCCG	CASKRDTSYEQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	0	6	0	3	1	22	32	41	35	42		TCRBV12-03,TCRBV12-04												CASKRDTSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTACAGGGGGCTATAGCACAGATACGCAGTATTTTGGCCCA	CASSTGGYSTDTQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	3	0	0	0	3	26	-1	47	38	50		TCRBV12-03,TCRBV12-04												CASSTGGYSTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGTAGCAGGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVAGGTGELFF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	4	5	0	26	37	-1	42	49	TCRBV09,TCRBV12													CASSVAGGTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGATGAGTTAATGAAGCCTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	17	2.1377194306121421E-4		55	unresolved						TCRBJ01	TCRBJ01-02	01	5	2	7	4	25	0	23	34	-1	59	62	TCRBV02,TCRBV09			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCAAGGCAACTGGGGATATTTTAGCAATCAGCCCCAGCATTTTGGTGAT	CSARDQGNWGYFSNQPQHF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	57	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	8	0	12	5	24	38	54	50	59		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDQGNWGYFSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGTAGCGGGGGACTTACCTACGAGCAGTACTTCGGGCCG	CSARGSGGLTYEQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	5	2	2	3	5	26	37	49	40	54		TCRBV20-01,TCRBV20-or09_02												CSARGSGGLTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAACAACGGGACAGCTCAATCAGCCCCAGCATTTTGGTGAT	CASSLTTGQLNQPQHF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	0	5	3	5	2	26	41	53	46	55		TCRBV12-03,TCRBV12-04												CASSLTTGQLNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTGGACAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSWTGSYEQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	3	1	0	0	26	-1	-1	39	47		TCRBV12-03,TCRBV12-04												CASSWTGSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCACGGGGAACTATGGCTACACCTTCGGTTCG	CASSTGNYGYTF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	36	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	6	8	3	2	2	0	26	37	-1	39	44		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSTGNYGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD02-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TGGRGGACTCAGCYWTGTAYTTCTGTGCCAGCAGTTTACAGGGGGGTAATCAGCCCCAGCATTTTGGTGAT	CASSLQGGNQPQHF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	5	3	1	4	3	2	23	34	45	37	47	TCRBV02,TCRBV09													CASSLQGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCGGCCGTGTATCTCTGYGCCAGCAGCCGGACTCCGTGGGGGGGCCGACTAGCGGGAGTCAGTCCAGATACGCAGTATTTTGGCCCA	CASSRTPWGGRLAGVSPDTQYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	66	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	2	2	4	19	6	15	27	58	46	64	TCRBV07,TCRBV11,TCRBV23													CASSRTPWGGRLAGVSPDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCTTAGGAGGGGCGGGGGAGACCCAGTACTTCGGGCCA	CASSLGGAGETQYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	1	7	3	5	5	0	19	35	-1	40	46	TCRBV07,TCRBV11													CASSLGGAGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCTTGACGGCCATTGAGGATCCCCAAACATTTTGGTGAT		Out	VDJ	1	16	2.011971228811428E-4		43	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	3	11	1	16	10	9	18	32	46	42	55	TCRBV05,TCRBV11													X+X+TCRBJ01-05	unresolved	TCRBD02-01*02	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCAGCTCCACAGGGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSTGGNQPQHF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	3	2	2	2	0	18	31	-1	33	40	TCRBV07,TCRBV11													CASSSTGGNQPQHF+X+TCRBJ01-05	unresolved	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCACTTTGGGGTAAGTGAACACTGAAGCTTTCTTTGGACAA	CASSPTLG*VNTEAFF	Stop	VDJ	1	16	2.011971228811428E-4		48	unresolved						TCRBJ01	TCRBJ01-01	01	5	6	2	0	8	4	18	30	42	38	46	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPTLG*VNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTTAGAGGGTGAGGCACGTCAGTACTTCGGGCCG	CASSLEGEARQYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	39							TCRBJ02	TCRBJ02-07	01	1	5	3	10	0	10	18	-1	38	34	48	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEGEARQYF+X+TCRBJ02-07			TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGTCACCGGACAGGGTTACACCAACACCGGGGAGCTGTTTTTTGGAGAA	CVTGQGYTNTGELFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	9	1	3	2	0	7	24	-1	41	33	48		TCRBV24-01,TCRBV24-or09_02												CVTGQGYTNTGELFF+TCRBV24-X+TCRBJ02-02	TCRBV24	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTCAGGGCCGAGCAGTACTTCGGGCCG	CATSDFRAEQYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	36	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	6	0	1	24	-1	46	41	47		TCRBV24-01,TCRBV24-or09_02												CATSDFRAEQYF+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATCCGGGACTTGCCTATGGCTACACCTTCGGTTCG	CATSDPGLAYGYTF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	42	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	3	0	10	4	2	3	24	39	47	41	50		TCRBV24-01,TCRBV24-or09_02				01,02								CATSDPGLAYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD02-01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGTCCTCAGTTACTCACTGAAGCTTTCTTTGGACAA	CASSPQLLTEAFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	39	TCRBV12						TCRBJ01	TCRBJ01-01	01	5	4	5	4	3	5	22	34	40	37	45		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPQLLTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTGCCAGCAGCACGACAGGGGGCGGCACAGATACGCAGTATTTTGGCCCA	CASSTTGGGTDTQYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	2	0	1	3	1	22	33	46	36	47		TCRBV12-03,TCRBV12-04												CASSTTGGGTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCGTCACCGGGACAGGGGTAGAAATGAGCAGTTCTTCGGGCCA	CSARHRDRGRNEQFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	0	2	7	7	4	26	35	52	42	56		TCRBV20-01,TCRBV20-or09_02												CSARHRDRGRNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCTTAAACGTTGCACAGGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLNVAQGGNEQFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	3	1	6	8	1	20	35	51	43	52	TCRBV07,TCRBV11													CASSLNVAQGGNEQFF+X+TCRBJ02-01	unresolved	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCAAGATGGACAGGGCTCTGGAAACACCATATATTTTGGAGAG	CASSQDGQGSGNTIYF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	1	3	0	1	0	26	43	-1	44	52	TCRBV03,TCRBV12													CASSQDGQGSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCCTCCCTTGGACTAGCGGGACGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLPWTSGTATGELFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	54	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	5	1	3	4	7	4	24	36	55	43	59	TCRBV12,TCRBV21													CASSLPWTSGTATGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGACCGTGACAGGGGATCCTATGGCTACACCTTCGGTTCG	CATSDRDRGSYGYTF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	2	2	4	4	3	24	38	50	42	53		TCRBV24-01,TCRBV24-or09_02												CATSDRDRGSYGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTTTTGGCGGGAGATCAGATACGCAGTATTTTGGCCCA	CASSFGGRSDTQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV12			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	7	2	4	2	2	22	36	45	38	47		TCRBV12-03,TCRBV12-04												CASSFGGRSDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGGAATACAGGGGACTGGGAGACCCAGTACTTCGGGCCA	CASRNTGDWETQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	3	2	5	4	5	22	33	44	37	49		TCRBV12-03,TCRBV12-04												CASRNTGDWETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGAAGGCTTATGCGGGGGCGAGGTAACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	1.8862230270107137E-4		55	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	1	7	2	5	10	7	23	39	56	49	63	TCRBV01,TCRBV04													X+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGCACTTGGAGGGGACGTAGATGAGCAGTTCTTCGGGCCA	CSARALGGDVDEQFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	45	TCRBV20			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	3	10	0	8	7	7	26	37	50	44	57		TCRBV20-01,TCRBV20-or09_02												CSARALGGDVDEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGGACTCSGCCGTGTATCTCTGTGCCAGCAGCCAAGACAGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDRNTGELFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	5	1	3	0	20	32	-1	35	40	TCRBV04,TCRBV07,TCRBV11													CASSQDRNTGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCTTCGCGACATTAGGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSPFATLGYTGELFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	51	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	2	6	3	7	7	26	39	50	46	57		TCRBV03-01,TCRBV03-02												CASSPFATLGYTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGAAGGGGGGCGAAGGACAGCGGCGACTGAAGCTTTCTTTGGACAA	CASSQEGGRRTAATEAFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	54	TCRBV03						TCRBJ01	TCRBJ01-01	01	0	1	5	5	11	5	26	43	60	54	65		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEGGRRTAATEAFF+TCRBV03-X+TCRBJ01-01	TCRBV03		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGTAGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSVGTGELFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	36	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	5	4	4	3	0	26	37	-1	40	43		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVGTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCAGCGGGCCCGGGACTGAAGCTTTCTTTGGACAA	CASSSGPGTEAFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	39	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	6	4	5	1	6	26	37	44	38	50		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSSGPGTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
ACGACTCGGCCCTGTATCTCTGTGCCAGCAGCTTAAGTAGCCCCTATGGCTACACCTTCGGTTCG	CASSLSSPYGYTF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	39	TCRBV05	TCRBV05-04	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	2	5	7	4	3	2	20	34	41	37	43						01,02								CASSLSSPYGYTF+TCRBV05-04+TCRBJ01-02	TCRBV05-04*01	TCRBD02-01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGACCCGGGACAGAACACGGCTACACCTTCGGTTCG	CASRPGTEHGYTF	In	VDJ	15	823	0.010349077008198784	0.011594978796545457	39	TCRBV07	TCRBV07-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	5	8	4	5	18	29	40	33	45														CASRPGTEHGYTF+TCRBV07-02+TCRBJ01-02	TCRBV07-02*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATCTCTGTGCCAGCAGCTCCGTGACGGGCAATGAGCAGTTCTTCGGGCCA	CASSSVTGNEQFF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	39	TCRBV07	TCRBV07-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	8	4	6	6	0	18	31	-1	37	41						01,02								CASSSVTGNEQFF+TCRBV07-02+TCRBJ02-01	TCRBV07-02*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGCCGGGACAGTGGGCAAGAGACCCAGTACTTCGGGCCA	CASSGRDSGQETQYF	In	VDJ	108	5995	0.07538604697952819	0.0844616013186999	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	5	2	4	4	18	30	41	34	45														CASSGRDSGQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCCCTGGAGGGAGAGCAACAGATACGCAGTATTTTGGCCCA	CASPGGRATDTQYF	In	VDJ	5	300	0.0037724460540214276	0.004226602234463714	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	10	0	3	3	6	18	27	36	30	42														CASPGGRATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTTAGCGGGCTACAATGAGCAGTTCTTCGGGCCA	CASSPLAGYNEQFF	In	VDJ	4	247	0.003105980584477642	0.003479902506375125	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	5	4	3	4	0	18	30	-1	34	41						01,02								CASSPLAGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTGCTTGGAGTACAAGAGACCCAGTACTTCGGGCCA	CASSLVLGVQETQYF	In	VDJ	3	179	0.002250892812232785	0.0025218726665633497	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	1	10	2	2	5	2	18	34	43	39	45														CASSLVLGVQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGGACTAGCGGGAGGTCGACAGATACGCAGTATTTTGGCCCA	CASSGTSGRSTDTQYF	In	VDJ	3	161	0.0020245460489914996	0.002268276532495527	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	5	0	1	3	0	3	18	-1	45	30	48														CASSGTSGRSTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATCGAGGGAGGGGCAGGGGGCTACGAGCAGTACTTCGGGCCG	CASIEGGAGGYEQYF	In	VDJ	3	142	0.0017856244655701423	0.002000591724312825	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	7	4	1	3	12	0	18	28	-1	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASIEGGAGGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGTCGACTAGCGGGTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSSSTSGFSYNEQFF	In	VDJ	2	121	0.0015215532417886424	0.0017047295679003649	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	2	4	0	4	2	18	31	45	35	47						01,02								CASSSSTSGFSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGGAGGGGGACTGAAGCTTTCTTTGGACAA	CASSLDGRGTEAFF	In	VDJ	2	113	0.001420954680348071	0.0015920201749813326	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	8	0	5	0	2	18	-1	43	35	45														CASSLDGRGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGGGACTAGCGGGGTAACCCAGTACTTCGGGCCA	CASSSGTSGVTQYF	In	VDJ	2	103	0.0012952064785473568	0.001451133433832542	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	8	2	2	18	31	46	33	48														CASSSGTSGVTQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGTCACAGGAGGCGCGCCACAGATACGCAGTATTTTGGCCCA	CASSGHRRRATDTQYF	In	VDJ	2	96	0.0012071827372868568	0.0013525127150283887	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	3	4	2	4	8	18	30	39	34	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGHRRRATDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCACGCTGACAGGGGTGAGGGGCTACACCTTCGGTTCG	CASSTLTGVRGYTF	In	VDJ	1	80	0.001005985614405714	0.0011270939291903239	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	2	8	5	5	18	30	43	35	48														CASSTLTGVRGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTATCATCAGGGGCGAGCACTGAAGCTTTCTTTGGACAA	CASSLSSGASTEAFF	In	VDJ	1	75	9.431115135053569E-4	0.0010566505586159286	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	2	4	4	4	18	33	43	37	47														CASSLSSGASTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGGCGGGGGGCCTGGCGTGAGCAGTTCTTCGGGCCA	CASSLDGRGAWREQFF	In	VDJ	1	71	8.928122327850712E-4	0.0010002958621564125	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	1	9	3	7	18	35	46	38	53														CASSLDGRGAWREQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATCCAAAAGCAGACTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	70	8.802374126049997E-4		44	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	2	4	5	3	9	1	18	33	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGAAAGATGGGGGCTCGGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	70	8.802374126049997E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	6	0	4	7	5	18	30	43	37	48														X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGTTCCATAGACAGGTCCCACAATGAGCAGTTCTTCGGGCCA	CASSRSIDRSHNEQFF	In	VDJ	1	69	8.676625924249283E-4	9.721185139266544E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	2	4	5	9	4	18	30	45	39	49														CASSRSIDRSHNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAAACACCGGGACAGGGCAAGAGCAGTACTTCGGGCCG	CASSSNTGTGQEQYF	In	VDJ	1	63	7.922136713444998E-4	8.875864692373801E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	3	7	8	3	18	31	48	39	51														CASSSNTGTGQEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCATTAGGGGCCGTAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASIRGRSSYNEQFF	In	VDJ	1	61	7.670640309843569E-4	8.59409121007622E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	0	2	6	18	28	35	30	41														CASIRGRSSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTGGCGATCTATGAACACTGAAGCTTTCTTTGGACAA	CASSWRSMNTEAFF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	4	9	0	0	0	6	18	-1	34	31	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSWRSMNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCTTGCCGGGGGCAAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	53	6.664654695437856E-4		47	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	3	6	0	3	9	1	18	32	47	41	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGATACAGCCGCAACTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	52	6.538906493637141E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	3	5	0	4	3	18	30	38	34	41														X+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAAGGACGGACCAGCGAGCACAGATAYGCAGTATTTTGGCCCA	CASSGKDGPASTDXQYF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	1	7	11	5	20	18	30	39	35	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGKDGPASTDXQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGAGGTCTCCTATAATTCACCCCTCCACTTTGGGAAC	CASSLEVSYNSPLHF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	3	10	1	0	0	1	18	-1	37	32	38														CASSLEVSYNSPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCTATACAGGTTTAAACACTGAAGCTTTCTTTGGACAA	CASSFYTGLNTEAFF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	4	2	4	4	18	32	41	36	45														CASSFYTGLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGTGTTCCCTGGAAACACTATATATTTTGGAGAG	CASSLDVFPGNTIYF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	0	1	8	13	10	6	18	35	48	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDVFPGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCTAGCGGGCCCTTACGAGCAGTACTTCGGGCCG	CASSSLAGPYEQYF	In	VDJ	1	47	5.91016548463357E-4	6.621676833993153E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	4	4	2	4	18	31	41	33	45						01,02								CASSSLAGPYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGACGGGACGCCAAAAGGGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	43	5.407172677430712E-4		53	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	0	0	7	2	1	10	18	35	41	36	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGGACTAGCGGGGGGGCTGAGAGATACGCAGTATTTTGGCCCA	CASSLEGLAGGLRDTQYF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	54	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	0	0	5	0	5	18	-1	51	35	56														CASSLEGLAGGLRDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACCCGGACAGGGGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLPGQGESTDTQYF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	1	1	0	3	2	18	33	46	36	48														CASSLPGQGESTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAGCCGGGACAGTTAAACTGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	40	5.02992807202857E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	8	8	18	30	45	38	53														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCCTAACACAGGGGAATCAGCCCCAGCATTTTGGTGAT	CASSLTLTQGNQPQHF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	2	4	8	0	18	33	-1	41	48														CASSLTLTQGNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGACTGGGACAGGGGGCGTCCTACGAGCAGTACTTCGGGCCG	CASRLGQGASYEQYF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	0	0	1	3	1	18	29	44	32	45														CASRLGQGASYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGAGGGGGTCAGGGGCGAGCAGTACTTCGGGCCG	CASSFEGVRGEQYF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	4	2	6	9	0	18	32	-1	41	47														CASSFEGVRGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGTGGGTTGGGTGAAGAAAAACTGTTTTTTGGCAGT	CASSLGGLGEEKLFF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	1	0	9	8	2	9	18	34	39	36	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGGLGEEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGGAGAGCACAGATACGCAGTATTTTGGCCCA	CASSLEESTDTQYF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	0	10	2	0	0	0	18	-1	-1	35	39														CASSLEESTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGGGGGGAGGACAGACTAATGAAAAACTGTTTTTTGGCAGT	CASRGGGQTNEKLFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-04	01	6	1	5	2	7	0	18	29	-1	36	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRGGGQTNEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGTTAGCCGGGGCGGTGAACACTGAAGCTTTCTTTGGACAA	CASSLLAGAVNTEAFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	3	7	0	0	7	2	18	32	44	39	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLLAGAVNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAACAACTTAGAAGGGACAGGGTACGAGCAGTACTTCGGGCCG	CANNLEGTGYEQYF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	0	3	4	1	0	18	35	-1	36	45														CANNLEGTGYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCCCGGGACAATACAATGAGCAGTTCTTCGGGCCA	CASSFPGQYNEQFF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	0	6	4	3	1	18	32	41	35	42														CASSFPGQYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACAGGCCTTTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSLQAFNTGELFF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	4	4	2	0	5	18	-1	37	33	42														CASSLQAFNTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCGAGAGGGACGAGCTCTGGAAACACCATATATTTTGGAGAG	CASSLARGTSSGNTIYF	In	VDJ	1	28	3.520949650419999E-4	3.9448287521661336E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	3	0	7	0	7	3	18	32	44	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLARGTSSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTACTGGACAGGGGAGGTGAACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	3.395201448619285E-4		46	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	1	2	5	2	6	18	33	44	35	50														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCAGAGGGCAGTATCTACCCGAATCAGCCCCAGCATTTTGGTGAT	CASSSEGSIYPNQPQHF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	51	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	8	0	4	0	12	18	-1	39	35	51														CASSSEGSIYPNQPQHF+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCCAGCCGGGACAGTTGAACTGCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	3.395201448619285E-4		52	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	5	2	8	8	18	30	45	38	53														X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAATAACCCTCGAGGGACAAAAGTGGCTACACCTTCGGTTCG		Out	VDJ	1	26	3.2694532468185706E-4		49	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	6	7	11	4	18	33	50	44	54														X+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGTCTATGCAGGGGGGGAAAACGAGCAGTACTTCGGGCCG	CASSLVYAGGENEQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	48	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	1	4	1	5	6	5	18	34	47	40	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVYAGGENEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCACAGCTCTGAGGCAGCCTGCTAATCGTTTATTTTGGTGAT		Out	VDJ	1	25	3.1437050450178563E-4		50	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-05	01	4	3	5	17	3	25	18	31	38	34	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-05	TCRBV11-03*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCAGGGGGCCCCTATGGCTACACCTTCGGTTCG	CASSLAGGPYGYTF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	0	4	2	2	18	32	42	34	44														CASSLAGGPYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCGGACGGTGAAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	2.8922086414164276E-4		43	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	5	1	7	2	3	6	18	30	37	33	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCAGGGGGTCTTCTCTCTGGAAACACCATATATTTTGGAGAG	CASSPGGLLSGNTIYF	In	VDJ	1	23	2.8922086414164276E-4	3.2403950464221813E-4	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	4	1	0	1	6	18	30	38	31	44														CASSPGGLLSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCGGACGACTAGCCCAGCACCAAGAGACCCAGTACTTCGGGCCA	CASGRLAQHQETQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	8	2	7	0	4	5	18	27	38	31	43						01,02								CASGRLAQHQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTGGCCGCGGGGGGGGACACAGATACGCAGTATTTTGGCCCA	CASSLAAGGDTDTQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	7	0	2	4	2	18	32	45	36	47														CASSLAAGGDTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCGGACAGGGTGTCAACTATGGCTACACCTTCGGTTCG	CASSFGQGVNYGYTF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	1	3	2	1	4	18	32	41	33	45														CASSFGQGVNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCCGGGGGGGCCGCTACGAGCAGTACTTCGGGCCG	CASSSRGGRYEQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	8	0	3	2	3	18	31	41	33	44														CASSSRGGRYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTACTAGCGGAAAAGGGGAGACCCAGTACTTCGGGCCA	CASSFTSGKGETQYF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	3	5	5	1	7	18	32	41	33	48						01,02								CASSFTSGKGETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTACCTGAAGGGGGCAAGCTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	19	2.3892158342135708E-4		53	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	3	5	0	0	7	3	18	32	46	39	49														X+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTAATATAGGGTACATAATCACCCCTCCACTTTGGGAAC	CASSLI*GT*SPLHF	Stop	VDJ	1	18	2.2634676324128565E-4		45	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-06	01	2	5	3	10	4	7	18	33	41	37	48				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLI*GT*SPLHF+TCRBV11-03+TCRBJ01-06	TCRBV11-03*01		TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTTTCTTCGTGGGAAGAGACCCAGTACTTCGGGCCA	CASSLSSWEETQYF	In	VDJ	1	18	2.2634676324128565E-4	2.535961340678229E-4	42	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	0	9	3	10	0	18	30	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLSSWEETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCGGGACTAGCCCCCTGGGGAGAGCAGTACTTCGGGCCG	CASSSGLAPWGEQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	0	7	7	1	10	18	31	41	32	51						01,02								CASSSGLAPWGEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAAGGACGGACCAGCGAGCACAGATACGCAATATTTTGGCCCA	CASSGKDGPASTDTQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	51	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-03	01	5	1	7	15	5	24	18	30	39	35	63				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGKDGPASTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACAGGGTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLGTGSYNEQFF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	1	3	1	0	0	18	-1	-1	34	42														CASSLGTGSYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCGGACAGGGAGCCCCACTGAAACTTTCTTTGGACAA	CASSRTGSPTETFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	1	3	12	1	13	18	30	39	31	52														CASSRTGSPTETFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGCTCTACTAGCGGGAGGCACACAGATACGCAGTATTTTGGCCCA		Out	VDJ	3	174	0.0021880187113324278		52	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	2	3	1	2	4	2	26	41	57	45	59														X+TCRBV12-05+TCRBJ02-03	TCRBV12-05*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGTGACAGGGACGGCGAGCAGTACTTCGGGCCG	CASGLGDRDGEQYF	In	VDJ	3	164	0.002062270509531714	0.002310542554840164	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	2	3	6	2	4	26	42	51	44	55														CASGLGDRDGEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTAGCGGGGCTGGGGAGGAACGAGCAGTACTTCGGGCCG	CASGLAGLGRNEQYF	In	VDJ	2	125	0.0015718525225089282	0.001761084264359881	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	6	3	5	0	10	26	-1	47	40	57														CASGLAGLGRNEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTCCAGTAATGGGGGATGAGCAGTTCTTCGGGCCA	CASGPVMGDEQFF	In	VDJ	2	92	0.001156883456566571	0.0012961580185688725	39	TCRBV12	TCRBV12-05	01				TCRBJ02	TCRBJ02-01	01	5	6	1	8	8	0	26	38	-1	46	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASGPVMGDEQFF+TCRBV12-05+TCRBJ02-01	TCRBV12-05*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTCGGCGGAGAACTCACCGGGGAGCTGTTTTTTGGAGAA	CASGFGGELTGELFF	In	VDJ	1	61	7.670640309843569E-4	8.59409121007622E-4	45	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	3	7	5	4	2	6	26	40	46	42	52						01,02								CASGFGGELTGELFF+TCRBV12-05+TCRBJ02-02	TCRBV12-05*01	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCACCGGGACAGGGGAGTCCTACGAGCAGTACTTCGGGCCG	CASTGTGESYEQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	12	0	2	1	7	2	26	31	48	38	50														CASTGTGESYEQYF+TCRBV12-05+TCRBJ02-07	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAATAAGGGGGACAGCCTACGTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	3	170	0.0021377194306121425		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	0	5	4	6	6	20	30	43	36	49														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATTAAAGCAGGGGGCAGGCGAGCAGTACTTTGGGCCG	CASSQLKQGAGEQYF	In	VDJ	2	99	0.001244907197827071	0.0013947787373730259	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	0	19	5	16	20	36	49	41	65														CASSQLKQGAGEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAGCAGGTGATGAGCACTGAAGCTTTCTTTGGACAA	CASSQEQVMSTEAFF	In	VDJ	2	89	0.0011191589960263567	0.0012538919962242353	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	4	4	4	3	7	20	35	42	38	49														CASSQEQVMSTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCACGACAGGGCGAGCAATCAGCCCCAGCATTTTGGTGAT	CASSHDRASNQPQHF	In	VDJ	1	59	7.419143906242141E-4	8.312317727778639E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	1	4	2	20	31	42	35	44														CASSHDRASNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTCCCCGGGACTAGCGGAGGATACACAGATACGCAGTATTTTGGCCCA	CASSFPGTSGGYTDTQYF	In	VDJ	1	58	7.293395704441426E-4	8.171430986629848E-4	54	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	6	0	5	2	7	6	20	31	49	38	55						01,02								CASSFPGTSGGYTDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGCTCGGGGCCCAGATACGCAGTATTTTGGCCCA	CASSQARGPDTQYF	In	VDJ	1	58	7.293395704441426E-4	8.171430986629848E-4	42	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-03	01	2	7	0	4	4	1	20	35	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQARGPDTQYF+TCRBV23-01+TCRBJ02-03	TCRBV23-01*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACCGATGACGGGGCAGGGGCACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	58	7.293395704441426E-4		47	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	4	2	4	12	0	20	30	-1	42	48														X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCACGGCGTTCCGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	36	4.526935264825713E-4		43	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	4	9	0	4	4	7	20	33	40	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAAGATTTAGGACAGAATGAAAAACTGTTTTTTGGCAGT	CASSQDLGQNEKLFF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	1	5	5	6	0	20	35	-1	41	47														CASSQDLGQNEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCACTCAAAGAGACGAGGTAACACCGGGGAGCTGTTTTTTGGAGAA		Out	VDJ	1	30	3.7724460540214275E-4		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	11	1	2	6	1	20	35	45	41	46														X+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACCCGGACGGATGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	3.1437050450178563E-4		44	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	3	1	7	5	3	6	20	34	41	37	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAATTAAGGAGGGACAGGGGGTTCTTCGGGCCA		Out	VDJ	1	25	3.1437050450178563E-4		40	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	2	0	2	15	8	0	20	35	-1	43	53														X+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCCCAGGGATGCGAGGCATGGCTACACCTTCGGTTCG	CASSPRDARHGYTF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	3	6	1	9	20	33	39	34	48														CASSPRDARHGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGCCGGGACCTGGGGCTATGGCTACACCTTCGGTTCG	CASSQAGTWGYGYTF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	45	TCRBV23	TCRBV23-01	01				TCRBJ01	TCRBJ01-02	01	2	0	7	4	3	6	20	35	43	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGTWGYGYTF+TCRBV23-01+TCRBJ01-02	TCRBV23-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATCAAGGACTCGCTACGAGCAGTACTTCGGGCCG	CASSQSRTRYEQYF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	1	10	3	2	2	20	37	44	39	46						01,02								CASSQSRTRYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACCGGGGACTATAAAGCGGGAGAGCAGTACTTCGGGCCG		Out	VDJ	1	16	2.011971228811428E-4		47	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	2	0	9	7	3	10	20	35	45	38	55						01,02								X+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAATGGGACAGGGGCACCGGGGAGCTGTTTTTTGGAGAA	CASSQWDRGTGELFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	0	2	4	0	0	20	-1	-1	36	46														CASSQWDRGTGELFF+TCRBV23-01+TCRBJ02-02	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACAAGCACTGCGGCAGATACGCAGTATTTTGGCCCA	CASTSTAADTQYF	In	VDJ	90	5045	0.06343996780846034	0.0710773609095648	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	7	7	5	4	8	0	23	33	-1	41	45						01,02								CASTSTAADTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTAAGCGGGATGGTTACGAGCAGTACTTCGGGCCG	CASTKRDGYEQYF	In	VDJ	5	257	0.0032317287862783563	0.0036207892475239156	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	6	3	4	3	4	23	33	43	36	47														CASTKRDGYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCGCGTCGTGGTAGCGATTAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	4	247	0.003105980584477642		50	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	5	6	3	11	3	23	37	53	48	56						01,02								X+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCAGTGCGGGGCCAGATACGCAGTATTTTGGCCCA	CASSSSAGPDTQYF	In	VDJ	3	154	0.0019365223077309995	0.0021696558136913733	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	4	7	3	4	5	1	23	36	47	41	48														CASSSSAGPDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACCGGGCAGGGGATACGCAGTATTTTGGCCCA	CASDRAGDTQYF	In	VDJ	3	150	0.0018862230270107138	0.002113301117231857	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	3	6	7	0	23	32	-1	39	44														CASDRAGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCACGGGACAGGCCTATGGCTACACCTTCGGTTCG	CASSSTGQAYGYTF	In	VDJ	2	123	0.0015467028821487853	0.001732906916130123	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	4	4	4	1	23	36	48	40	49														CASSSTGQAYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTGCGGGGAAACAATGAGCAGTTCTTCGGGCCA	CASSYLRGNNEQFF	In	VDJ	2	118	0.0014838287812484281	0.0016624635455557279	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	7	3	5	2	2	23	38	46	40	48														CASSYLRGNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGATAGCGGACCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYDSGPNTGELFF	In	VDJ	2	113	0.001420954680348071	0.0015920201749813326	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	5	5	0	2	2	23	38	46	40	48						01,02								CASSYDSGPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGGCAGACAAGGGGGGAGACCCAGTACTTCGGGCCA	CASSYRQTRGETQYF	In	VDJ	2	108	0.001358080579447714	0.0015215768044069373	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	5	1	5	9	0	23	38	-1	47	53														CASSYRQTRGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACAACAGGAGAAGCTTTCTTTGGACAA	CASSYTTGEAFF	In	VDJ	2	107	0.0013455057592676426	0.0015074881302920581	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	4	8	3	1	23	38	46	41	47														CASSYTTGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTYAAGGGACAGGGGTCATGGCTACACCTTCGGTTCG	CASSXRDRGHGYTF	In	VDJ	2	92	0.001156883456566571	0.0012961580185688725	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	6	3	2	23	36	49	39	51														CASSXRDRGHGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTAGCGGGGGGCTCCTACGAGCAGTACTTCGGGCCG	CASSLAGGSYEQYF	In	VDJ	2	85	0.0010688597153060712	0.0011975372997647192	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	4	5	1	0	0	0	23	-1	-1	36	46														CASSLAGGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAAGATAGGAGTGAACACCGGGGAGCTGTTTTTTGGAGAA	CASKIGVNTGELFF	In	VDJ	1	78	9.808359740455712E-4	0.0010989165809605658	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	7	10	2	1	5	1	23	33	42	38	43														CASKIGVNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCCCGGACTAGCGGGATAAATGAGCAGTTCTTCGGGCCA	CASSYPRTSGINEQFF	In	VDJ	1	77	9.682611538654998E-4	0.0010848279068456867	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	1	3	7	4	2	23	38	54	42	56														CASSYPRTSGINEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGACAGGGAAGTCCGGGGAGCTGTTTTTTGGAGAA	CASSYWTGKSGELFF	In	VDJ	1	76	9.556863336854283E-4	0.0010707392327308077	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	1	1	3	6	0	4	23	-1	47	39	51														CASSYWTGKSGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCGGGGGGTACAGATACGCAGTATTTTGGCCCA	CASRAGGTDTQYF	In	VDJ	1	63	7.922136713444998E-4	8.875864692373801E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	7	1	3	1	1	23	34	43	35	44														CASRAGGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGACGGGACAATATATACGAGCAGTACTTCGGGCCG	CASGRDNIYEQYF	In	VDJ	1	62	7.796388511644284E-4	8.73497795122501E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	6	4	4	5	23	32	42	36	47														CASGRDNIYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCAGCGGTCTAGCGGGCAACAATGAGCAGTTCTTCGGGCCA	CASSGLAGNNEQFF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	4	4	5	4	2	23	34	46	38	48						01,02								CASSGLAGNNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGATTAAGACAGGGTGGAACTGAAGCTTTCTTTGGACAA	CASGLRQGGTEAFF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	2	3	5	7	4	23	32	46	39	50														CASGLRQGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAACAGATACGCAGTATTTTGGCCCA	CASSYSTDTQYF	In	VJ	1	56	7.041899300839998E-4	7.889657504332267E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	0	0	3	0	1	23	-1	40	-1	41														CASSYSTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGACAGATGAACACTGAAGCTTTCTTTGGACAA	CASSYSGQMNTEAFF	In	VDJ	1	55	6.916151099039283E-4	7.748770763183477E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	5	0	0	1	23	-1	47	40	48														CASSYSGQMNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGACAGGGGAGCCCACGAGCAGTACTTCGGGCCG	CASSYDRGAHEQYF	In	VDJ	1	55	6.916151099039283E-4	7.748770763183477E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	2	2	5	0	5	23	-1	46	38	51														CASSYDRGAHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCAAGAACAGGGGGCCTCTGCATGGTCCCTCCACTTTGGGAAC	CASSYQEQGASAWSLHF	In	VDJ	1	55	6.916151099039283E-4	7.748770763183477E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	3	0	14	5	11	23	38	52	43	63														CASSYQEQGASAWSLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCAGGGGGCTCCTATGGCTACACCTTCGGTTCG	CASSYSGGSYGYTF	In	VDJ	1	50	6.287410090035713E-4	7.044337057439524E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	5	0	4	0	2	23	-1	47	40	49														CASSYSGGSYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGTGTCCATGCGGGATTCGCCTACGAGCAGTACTTCGGGCCG	CAISVHAGFAYEQYF	In	VDJ	1	49	6.161661888234998E-4	6.903450316290734E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	5	7	3	2	6	4	23	35	47	41	51														CAISVHAGFAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCCGACGGGAGCAATGAGCAGTTCTTCGGGCCA	CASSYSDGSNEQFF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	8	2	6	3	0	23	40	-1	43	49														CASSYSDGSNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTAAATCTGGCGGGGGGGCCAAAGATACGCAGTATTTTGGCCCA	CASTKSGGGAKDTQYF	In	VDJ	1	48	6.035913686434284E-4	6.762563575141943E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	7	0	5	9	4	23	33	51	42	55														CASTKSGGGAKDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACCGATCGACTAGCGGGAGTGTAAGGTGCGTCAGATACGCAGTATTTTGGCCCA	CATDRLAGV*GASDTQYF	Stop	VDJ	1	48	6.035913686434284E-4		54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	10	2	2	4	6	12	23	30	48	36	60														CATDRLAGV*GASDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCGCGGAGGGAATGAGCAGTTCTTCGGGCCA	CASSYRGGNEQFF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	2	10	0	7	3	0	23	38	-1	41	47														CASSYRGGNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCGGACAGGGGGCGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSSGQGANTGELFF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	4	1	1	0	2	0	23	36	-1	38	48														CASSSGQGANTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCACAGATTACAATGAGCAGTTCTTCGGGCCA	CASSPTDYNEQFF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	5	4	3	2	23	35	42	38	44														CASSPTDYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGTAAGAGAACAGGGGGTCACTACGAGCAGTACTTCGGGCCG	CASRGKRTGGHYEQYF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	3	1	3	10	3	23	34	52	44	55														CASRGKRTGGHYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCGAGGGGAGGTACTGAAGCTTTCTTTGGACAA	CASRARGGTEAFF	In	VDJ	1	43	5.407172677430712E-4	6.05812986939799E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	5	6	1	23	34	46	40	47														CASRARGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGCAAGGGGAGGCACTGAAGCTTTCTTTGGACAA	CASRARGGTEAFF	In	VDJ	1	42	5.281424475629999E-4	5.9172431282492E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	1	4	6	0	23	34	-1	40	46														CASRARGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGTACAGGGACGAGGCACTGGGGAGCTGTTTTTTGGAGAA	CASSVQGRGTGELFF	In	VDJ	1	42	5.281424475629999E-4	5.9172431282492E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	8	3	10	23	34	43	37	53														CASSVQGRGTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAATGTCCACAGGGCCCCTAACCGGGGAGCTGTTTTTTGGAGAA	CASSPMSTGPLTGELFF	In	VDJ	1	42	5.281424475629999E-4	5.9172431282492E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	5	10	6	23	34	50	44	56														CASSPMSTGPLTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCTCGGAACGGGAGGGCCCGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYPRNGRARNTGELFF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-02	01	2	8	0	1	8	4	23	38	54	46	58														CASSYPRNGRARNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTCTAGCGGGAGGTACCTACGAGCAGTACTTCGGGCCG	CASTLAGGTYEQYF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	7	4	1	2	2	2	23	33	46	35	48														CASTLAGGTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACTAATCCATCTCTAGCGGGTCGCTTTGACACCTACGAGCAGTACTTCGGGCCG	CASTNPSLAGRFDTYEQYF	In	VDJ	1	36	4.526935264825713E-4	5.071922681356458E-4	57	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	7	4	4	2	11	11	23	33	52	44	63						01,02								CASTNPSLAGRFDTYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTGGCAGGGGGGGGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	34	4.2754388612242843E-4		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	1	4	1	4	2	3	23	39	48	41	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGCGACCCTGGGGCGTTCACTGAAGCTTTCTTTGGACAA	CASSYSGDPGAFTEAFF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	7	0	4	10	3	23	40	55	50	58														CASSYSGDPGAFTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGACTCATACTCGAGCAGTACTTCGGGCCG	CASSGLILEQYF	In	VDJ	1	34	4.2754388612242843E-4	4.790149199058877E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	1	10	6	0	6	23	-1	40	35	46						01,02								CASSGLILEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGACCAGGCAGAGGATACGCAGTATTTTGGCCCA	CASDQAEDTQYF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	8	4	4	6	3	5	23	32	39	35	44														CASDQAEDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACGGACGGATACAACTAATGAAAAACTGTTTTTTGGCAGT	CASRRTDTTNEKLFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-04	01	6	1	7	0	2	5	23	34	40	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRRTDTTNEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01		TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACCTCTCTCATTAGCGGGGGTGAGCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	32	4.023942457622856E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	7	5	2	6	10	4	23	33	52	43	56														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCAGTTACCTCGGGACAGGGGGCTCTGGAAACACCATATATTTTGGAGAG	CVSSYLGTGGSGNTIYF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	0	1	0	3	0	23	38	-1	41	52														CVSSYLGTGGSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGAGTGGGCCAAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYASGPNTGELFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	8	0	2	6	2	23	38	48	44	50														CASSYASGPNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGGTCTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSRSYSNQPQHF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	5	8	5	0	0	5	23	-1	38	35	43						01,02								CASSRSYSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTAACCAGGGGTCAGACACTGAAGCTTTCTTTGGACAA	CASSNQGSDTEAFF	In	VDJ	1	31	3.898194255822142E-4	4.367488975612505E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	2	3	3	4	23	35	44	38	48														CASSNQGSDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTTTCAAGTCTCCTACGAGCAGTACTTCGGGCCG	CASSSFQVSYEQYF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	4	4	6	0	5	3	23	36	43	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSFQVSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAACCGGGACTAGCGGGAGATCCTACGAGCAGTACTTCGGGCCG	CASRTGTSGRSYEQYF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	0	2	1	4	1	23	34	52	38	53														CASRTGTSGRSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCAGTGAAGCAGATTAACTATGGCTACACCTTCGGTTCG	CAVKQINYGYTF	In	VDJ	1	30	3.7724460540214275E-4	4.226602234463715E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	12	4	5	1	7	2	23	28	38	35	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAVKQINYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCCGGGACAGGGCGCTACGAGCAGTACTTCGGGCCG	CASSPGTGRYEQYF	In	VDJ	1	29	3.646697852220713E-4	4.085715493314924E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	3	3	2	23	35	47	38	49														CASSPGTGRYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGATCCCAGGGAACGAGCAGTACTTCGGGCCG	CASSYSIPGNEQYF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	5	5	1	23	40	50	45	51														CASSYSIPGNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCGGGACTAGCGGGAGGTACAATGAGCAGTTCTTCGGGCCA	CASRPGTSGRYNEQFF	In	VDJ	1	27	3.395201448619285E-4	3.803942011017343E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	6	0	1	4	4	0	23	34	-1	38	53														CASRPGTSGRYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGACAGGGGGAGGGGGTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLTGGGGSNQPQHF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	51	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	1	0	1	6	23	36	46	37	52														CASSLTGGGGSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTACCTCTCGTCGGGGCGAGGCACTGAAGCTTTCTTTGGACAA	CASSYYLSSGRGTEAFF	In	VDJ	1	26	3.2694532468185706E-4	3.663055269868553E-4	51	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	1	7	0	4	10	4	23	39	54	49	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYYLSSGRGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCTTATCCTCCTACGAGCAGTACTTCGGGCCG	CASSSLSSYEQYF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	4	4	10	0	1	4	23	36	39	37	43						01,02								CASSSLSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCACGGGGGCTAGGCACAGATACGCAGTATTTTGGCCCA	CASSYSRGLGTDTQYF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	48	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	0	6	0	1	2	3	23	40	48	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSRGLGTDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCGGGAAGGGAGTGCGACAGATACGCAGTATTTTGGCCCA	CASSREGSATDTQYF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	8	3	3	1	10	23	34	40	35	50														CASSREGSATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGGGAAGCGGGGTAAGCTCCTACGAGCAGTACTTCGGGCCG	CASRGSGVSSYEQYF	In	VDJ	1	22	2.7664604396157133E-4	3.099508305273391E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	6	3	0	4	4	23	34	45	38	49														CASRGSGVSSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCGAAACCTAGAGGGGGGCAACGAGCAGTACTTCGGGCCG	CASSRNLEGGNEQYF	In	VDJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	5	5	1	5	10	3	23	35	51	45	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSRNLEGGNEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTACCAGCAGTGGACTAGCGGGAGACCGACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	2.6407122378149995E-4		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	1	2	5	0	4	23	-1	48	35	52														X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTACGGGAAACTAACTATGGCTACACCTTCGGTTCG	CASSLRETNYGYTF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	8	3	0	2	2	23	36	43	38	45														CASSLRETNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCACATCAGGGTACTACGAGCAGTACTTCGGGCCG	CASTSGYYEQYF	In	VDJ	1	20	2.514964036014285E-4	2.8177348229758097E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	7	4	3	3	3	2	23	33	41	36	43														CASTSGYYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCAGGACAGGGTCAACACCGGGGAGCTGTTTTTTGGAGAA	CASSQDRVNTGELFF	In	VDJ	1	19	2.3892158342135708E-4	2.6768480818270193E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	1	3	2	3	2	23	34	45	37	47														CASSQDRVNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCTAGCATGGGCGGAGGCACTGAAGCTTTCTTTGGACAA	CASMGGGTEAFF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	7	10	1	4	5	0	23	33	-1	38	43														CASMGGGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGACATCTACGAGCAGTACTTCGGGCCG	CASSWDIYEQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	6	3	0	1	23	-1	42	36	43														CASSWDIYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGGACAGGGCCCCACGAGCAGTACTTCGGGCCG	CASSGTGPHEQYF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	3	5	0	4	23	-1	44	35	48														CASSGTGPHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCAACGAGGGCTAGCAGGCACGAGCAGTACTTCGGGCCG		Out	VDJ	1	17	2.1377194306121421E-4		43	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	4	7	5	9	4	23	34	48	43	52						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAATCAGACAGGACCGCTATGGCTACACCTTCGGTTCG	CASRIRQDRYGYTF	In	VDJ	1	17	2.1377194306121421E-4	2.3950745995294384E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	4	4	5	4	23	34	45	39	49														CASRIRQDRYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGTTTACAGGGGGCATTGGCTACACCTTCGGTTCG	CASSYSFTGGIGYTF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	7	4	2	23	40	53	44	55														CASSYSFTGGIGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGAGGCGGGGTCGTGGACTAACTATGGCTACACCTTCGGTTCG	CASSYEAGSWTNYGYTF	In	VDJ	1	16	2.011971228811428E-4	2.2541878583806478E-4	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	7	3	0	3	7	23	38	47	41	54														CASSYEAGSWTNYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATCAGCTCTAGCGGGGGGCACGCCGGGGAGCTGTTTTTTGGAGAA	CAISSSGGHAGELFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	4	1	6	2	4	23	34	47	36	51														CAISSSGGHAGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGTCGAGGTGGCGACAGGGCCTCCTCCTACGAGCAGTACTTCGGGCCG	CASRGGDRASSYEQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	9	2	3	0	10	4	23	31	48	41	52														CASRGGDRASSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGCTCAATGAGCAGTTCTTCGGGCCA	CASSYSLNEQFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	36	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	10	0	6	0	1	23	-1	42	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAAGCGCAGAGGGTCCTACGAGCAGTACTTCGGGCCG	CASSYSKRRGSYEQYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	11	0	1	8	0	23	40	-1	48	53														CASSYSKRRGSYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACGCGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSYAGATGELFF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	2	7	2	4	0	1	23	-1	45	38	46														CASSYAGATGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTCTTTGGAATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSALWNSNQPQHF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	45	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	5	1	8	0	7	1	23	35	45	42	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSALWNSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGAGCCACAGGGGCCTCTCTGGAAACACCATATATTTTGGAGAG	CASRSHRGLSGNTIYF	In	VDJ	1	15	1.8862230270107137E-4	2.1133011172318574E-4	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	2	0	5	3	23	34	46	39	49														CASRSHRGLSGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGCGGTGGGGGATACGCAGTATTTTGGCCCA	CASSLAVGDTQYF	In	VDJ	3	141	0.0017730496453900709	0.0019865030501979458	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	4	5	5	6	0	5	24	-1	43	37	48						01,02							Vb 18	CASSLAVGDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD02-01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCCCCGCGGGACTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPRGTGANVLTF	In	VDJ	2	126	0.0015844273426889996	0.0017751729384747601	45	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	6	7	3	2	5	0	24	35	-1	40	46													Vb 18	CASSPRGTGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTGTCTAGGCAGGGATCCAATGAGCAGTTCTTCGGGCCA	CASSLSRQGSNEQFF	In	VDJ	2	117	0.0014712539610683567	0.0016483748714408487	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	6	4	3	6	10	3	24	35	50	45	53													Vb 18	CASSLSRQGSNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGAAAGCGGGGAGACCCAGTACTTCGGGCCA	CASSLESGETQYF	In	VDJ	2	114	0.0014335295005281424	0.0016061088490962115	39	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	6	4	5	5	0	24	37	-1	42	48						01,02							Vb 18	CASSLESGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAACGGATTTTGAAGCTTTCTTTGGACAA	CASSLTDFEAFF	In	VDJ	2	107	0.0013455057592676426	0.0015074881302920581	36	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	4	1	8	7	4	3	24	37	44	41	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSLTDFEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGGACTAGCGGGAGGGCCCCGAGAGACCCAGTACTTCGGGCCA	CASSPGLAGGPRETQYF	In	VDJ	2	95	0.0011946079171067854	0.0013384240409135097	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	2	1	0	4	0	5	24	-1	54	39	59													Vb 18	CASSPGLAGGPRETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD02-01*02	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCTAGCTCACCAATTCTCATTGGGGGGCGTAGGACAGATACGCAGTATTTTGGCCCA	CASSPILIGGRRTDTQYF	In	VDJ	2	94	0.001182033096926714	0.0013243353667986306	54	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	2	6	0	3	10	5	24	39	55	49	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPILIGGRRTDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGCCAGCAACTATGGCTACACCTTCGGTTCG	CASSPASNYGYTF	In	VDJ	2	94	0.001182033096926714	0.0013243353667986306	39	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-02	01	3	4	5	2	3	1	24	38	44	41	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPASNYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01		TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGACTAGCGTCGTCGTACAATGAGCAGTTCTTCGGGCCA	CASSPGLASSYNEQFF	In	VDJ	2	94	0.001182033096926714	0.0013243353667986306	48	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	1	6	4	1	6	24	38	48	39	54						01,02							Vb 18	CASSPGLASSYNEQFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01	TCRBD02-01	TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAAGGGGCTCTGAACACTGAAGCTTTCTTTGGACAA	CASSPQGALNTEAFF	In	VDJ	2	94	0.001182033096926714	0.0013243353667986306	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	0	1	3	24	40	46	41	49													Vb 18	CASSPQGALNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCTCTCGGACAGCTGGAACACTGAAGCTTTCTTTGGACAA	CASSLSDSWNTEAFF	In	VDJ	2	91	0.0011443086363864996	0.0012820693444539934	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	1	6	3	24	35	47	41	50													Vb 18	CASSLSDSWNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTAAGGACAGGCTCTACTACGAGCAGTACTTCGGGCCG	CASSPKDRLYYEQYF	In	VDJ	2	89	0.0011191589960263567	0.0012538919962242353	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	1	4	3	3	5	24	38	48	41	53													Vb 18	CASSPKDRLYYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCCGGGACAGGGGAGCAAGAGACCCAATACTTCGGGCCA	CASSSGTGEQETQYF	In	VDJ	1	80	0.001005985614405714	0.0011270939291903239	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	0	2	14	3	14	24	36	49	39	63													Vb 18	CASSSGTGEQETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACGGGAAAAACAGTCGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	68	8.550877722448569E-4		50	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	1	0	8	0	0	11	24	-1	44	40	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTGAACAGGGGATTCACCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	59	7.419143906242141E-4		46	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	2	2	3	5	24	38	48	41	53													Vb 18	X+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAAGAGGGGGCGCTGGGGCAGATACGCAGTATTTTGGCCCA	CASSLRGGAGADTQYF	In	VDJ	1	57	7.167647502640712E-4	8.030544245481057E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	4	5	0	4	4	7	24	37	48	41	55													Vb 18	CASSLRGGAGADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACAGGACAGGGGTGTGGTTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQDRGVVGANVLTF	In	VDJ	1	56	7.041899300839998E-4	7.889657504332267E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	2	3	1	6	24	37	47	38	53													Vb 18	CASSQDRGVVGANVLTF+TCRBV18-01+TCRBJ02-06	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-06*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCCGACAGGGGGGAGACCCAGTACTTCGGGCCA	CASSADRGETQYF	In	VDJ	1	51	6.413158291836427E-4	7.185223798588314E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	2	1	5	3	0	24	36	-1	39	48													Vb 18	CASSADRGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACAGGGGTCGAACACTGAAGCTTTCTTTGGACAA	CASSPQGSNTEAFF	In	VDJ	1	46	5.784417282832855E-4	6.480790092844363E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	5	2	1	0	2	24	-1	45	40	47													Vb 18	CASSPQGSNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGAAAGGGAAGATTTCTTCGGGCCA	CASSPPEREDFF	In	VDJ	1	45	5.658669081032141E-4	6.339903351695572E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-01	01	0	0	8	16	5	4	24	41	50	46	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPEREDFF+TCRBV18-01+TCRBJ02-01	TCRBV18-01*01		TCRBJ02-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGTAGGGTCCTCGGTCAACAATCAGCCCCAGCATTTTGGTGAT	CASSPVGSSVNNQPQHF	In	VDJ	1	44	5.532920879231427E-4	6.199016610546782E-4	51	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	3	5	3	3	3	11	24	38	45	41	56				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPVGSSVNNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGTTTCCTACAGGCGCAGATACGCAGTATTTTGGCCCA	CASSPFPTGADTQYF	In	VDJ	1	43	5.407172677430712E-4	6.05812986939799E-4	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	3	3	4	4	7	2	24	38	50	45	52													Vb 18	CASSPFPTGADTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGGAACAGGGTCCCTACGAGCAGTACTTCGGGCCG	CASSPEQGPYEQYF	In	VDJ	1	41	5.155676273829285E-4	5.77635638710041E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	3	3	2	3	2	24	38	47	41	49													Vb 18	CASSPEQGPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGGCCACAGGGGGCGCCCGGTATGGCTACACCTTCGGTTCG	CASSPPATGGARYGYTF	In	VDJ	1	38	4.7784316684271416E-4	5.353696163654039E-4	51	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	0	5	4	6	24	41	54	45	60													Vb 18	CASSPPATGGARYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGGGACAGCATTCAGTACTTCGGCGCC	CASSPRDSIQYF	In	VDJ	1	37	4.6526834666264273E-4	5.212809422505248E-4	36	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	0	5	9	2	0	24	38	-1	40	47													Vb 18	CASSPRDSIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCATTGACAGGGGGTAGCACCGGGGAGCTGTTTTTTGGAGAA	CASSPLTGGSTGELFF	In	VDJ	1	35	4.4011870630249986E-4	4.931035940207667E-4	48	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	2	2	1	4	2	3	24	39	50	41	53													Vb 18	CASSPLTGGSTGELFF+TCRBV18-01+TCRBJ02-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-02*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCGGCGGAGCCAGGGGTAATGAAAAACTGTTTTTTGGCAGT	CAGGARGNEKLFF	In	VDJ	1	33	4.1496906594235705E-4	4.649262457910086E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	11	4	2	4	8	0	24	30	-1	38	44													Vb 18	CAGGARGNEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-04*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCCCCCGGGACAGCTTGGCTGGGGAGAGCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	33	4.1496906594235705E-4		50	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	0	5	7	4	15	24	33	44	37	59													Vb 18	X+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCTCGAAAGGATTCGGCGAACACTGAAGCTTTCTTTGGACAA	CASSPRKDSANTEAFF	In	VDJ	1	32	4.023942457622856E-4	4.5083757167612955E-4	48	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	3	1	8	1	6	6	24	38	47	44	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPRKDSANTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGTACGGACAGGGAATCACTGAAGCTTTCTTTGGACAA	CASSYGQGITEAFF	In	VDJ	1	25	3.1437050450178563E-4	3.522168528719762E-4	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	3	4	4	3	24	35	47	39	50													Vb 18	CASSYGQGITEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCAAAAAGGGGAGACACTGAAGCTTTCTTTGGACAA	CASSPPKRGDTEAFF	In	VDJ	1	24	3.017956843217142E-4	3.3812817875709716E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-01	01	0	5	2	3	4	2	24	41	50	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPPKRGDTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01		TCRBJ01-01*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCACCGTCAGATACGCAGTATTTTGGCCCA	CASSPPSDTQYF	In	VJ	1	21	2.6407122378149995E-4	2.9586215641246E-4	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-03	01	0	0	0	4	0	2	24	-1	41	-1	43													Vb 18	CASSPPSDTQYF+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01		TCRBJ02-03*01	3582B	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				1690	1508	143	37	0	941	786	133	22	0	79524	70979	6771	1774	0	0.162724793	8.05323601	0.148314893	8.41298866				65576	0.0214674566	0.0844615996	0.0753860474	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/09/2016 09:51:17	Age (Range):45-65 Years (Late Adulthood),Age:53 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 1,overall survival (days):overall survival (days) 329,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 257,type of chemo:carbo/taxol	0.8923076679865777	MSKCC- Snyder- P01-02		1408.0	
